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Abstract 	  
The application of organocatalysis has expanded significantly in recent years. 
Organocatalysts can give good enantioselectitvity and hence provide an efficient access to 
chiral building blocks for organic synthesis. The first chapter in this thesis discusses the 
possibility to improve the enantioselectivity of the asymmetric Kornblum-DeLaMare (KDLM) 
rearrangement on a six-membered cyclic endoperoxide. Toste has developed efficient 
bifunctional catalysts derived from quinine and quinidine for the asymmetric KDLM 
rearrangement on eight- and seven-membered cyclic endoperoxides, but these catalysts can 
only provide moderate enantioselectivity for six-membered cyclic endoperoxides. We 
successfully developed an efficient Bucherer reaction to introduce an amine group on the 
quinoline ring of quinine and then synthesised various quinine derived catalysts with different 
hydrogen bond donors. We then examine these compounds as catalysts for the KDLM 
rearrangement of six-membered cyclic endoperoxides. 
 
In the second chapter, we attempted to achieve the total synthesis of (−)-lycorine. The total 
synthesis started with TBS-protected 4-hydroxycyclohexenone. Our synthesis features a 
stereoselective Michael addition to establish the cis-relative stereochemistry between the C3 
and C3a stereocentres on the six-membered ring. The 1,3-benzodioxole group is introduced 
by an efficient Suzuki coupling. Then, a highly stereoselective Cope-type hydroamination is 
performed to introduce the two stereogenic centres of the (−)-lycorine core. Various 
conditions were examined in order to optimise the Cope-type hydroamination. The double 
bond between C2 and C3 was constructed by an efficient anti-elimination. We therefore have 
developed an efficient method to construct the stereocentres and the double bond in (−)-
lycorine, which were difficult to construct previously. 
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Abbreviations 
 
Ac Acetyl FC Flash chromatography 
AcCl Acetyl chloride g Grams 
Ac2O Acetic anhydride h Hours 
AcOH 
AIBN 
Acetic acid 
Azobisisobutyronitrile 
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mL 
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DEAD Diethyl azodicarboxylate MS Mass spectrometry 
DIAD Diisopropyl 
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nPrOH 
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NMP 
Sodium acetate 
N-Methyl-2-
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ee 
equivalents 
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EtOAc Ethyl acetate Q Quinine 
EtOH Ethanol QD Quinidine 
EtSH Ethane thiol TIPS Triisopropylsilyl 
r.t. Room temperature TLC Thin layer 
chromatography 
TBAF Tetrabutylammonium 
fluoride 
TMS 
TPP 
Trimethylsilyl 
5,10,15,20- 
TBAI Tetrabutylammonium 
iodide 
 Tetraphenylporphyrin 
TBS tert-Butyldimethylsilyl pTSA para-Toluenesulfonic 
Tf Trifluoromethylsulfonyl  acid 
TFA Trifluoroacetic acid UV Ultra violet 
THF Tetrahydrofurane   
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1.  Asymmetric Kornblum-DeLaMare (KDLM) Rearrangement 
 
1.1 Introduction 
 
1.1.1 The Kornblum-DeLaMare (KDLM) Rearrangement and Its  
           Mechanism1 	  
Kornblum and DeLaMare discovered the base-catalysed decomposition of a dialkyl peroxide 
to form a ketone and an alcohol in 1951 and later this reaction was named as the Kornblum-
DeLaMare rearrangement. When these base-catalysed reaction conditions are applied to 
cyclic endoperoxide II prepared from the reaction between a singlet oxygen and a cyclodiene 
I, the product is a 4-hydroxycycloenone IV (Scheme 1).  
 
 
 
Scheme 1. The Kornblum-DeLaMare rearrangement and its mechanism as reported by  
                   Kornblum-DeLaMare.1 
 
The bases that catalyse this reaction are usually tertiary amines, such as triethylamine or 
Hünig’s base, and the catalytic mechanism is believed to be concerted.2 If a chiral base is 
used, the KDLM rearrangement can in principle give a chiral 4-hydroxyenone from a prochiral 
endoperoxide, and since the base is not consumed in the reaction this can be achieved with a 
sub-stoichiometric quantity of the enantiomerically pure base. 
 
Taylor’s research has shown that the KDLM rearrangement on 1,2-dioxane could also be 
catalysed by Co(II) complexes (Scheme 2).3,4 
 
 
 
Scheme 2. The Kornblum-DeLaMare rearrangement catalysed by Co(II) salen   
                   complexes, as developed by Taylor.3,4 
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In his method, the endoperoxides were opened by a radical mechanism, in which Co(II) gave 
a single electron to the peroxides to form an oxygen radical, such as radical 2, and then a 1,5-
hydrogen abstraction gave a Co(III)-ketyl radical followed by release of Co(II) to give 4-
hydroxyketone 3 thereby completing the catalytic cycle. 
 
Taylor’s research also showed that a chiral Co(II) salen or β-ketoiminato complex could 
desymmetrise meso-endoperoxides to give chiral 4-hydroxyketones. For example, the 
enantiomeric excess of 4-hydroxyketone 3 could be up to 78%. 
  
1.1.2 The Application of an Endoperoxide in the Total Synthesis of 
           (+)-Trianthine 
 
Cyclic endoperoxides have been applied as important intermediates in natural product 
syntheses.5-7 In Oppolzer’s asymmetric total synthesis (+)-trianthine5, by following Hudlicky’s 
method8, the chirality originated from chiral cis-diol 5, which was produced by microbial 
dihydroxylation of chlorobenzene (Scheme 3).  
 
 
 
Scheme 3. Oppolzer’s synthesis of building block 3 for the synthesis of (+)-trianthine.5 
 
Reagents and conditions: a) microbial dihydroxylation; b) DMP, pTSAH2O, CH2Cl2, r.t., 90 %; 
c) O2, 5,10,15,20-tetraphenyl-21H,23H-porphine (TPP), CCl4, 90%; d) thiourea, 40~75% 
 
Dihydroxycyclohexadiene 5 was protected as an acetonide, and then acetonide 6 reacted 
with oxygen under UV light irradiation in the presence of a photosensitiser, in which singlet 
oxygen was generated in situ. Singlet oxygen reacted with this diene 6 to form endoperoxide 
7. Hydrogenolysis of the endoperoxide 7 by thiourea gave enone 8, which was a key building 
block for the total synthesis. However, this method has two disadvantages. Firstly, this bio-
catalytic oxidation on chlorobenzene to generate the vicinal diol is difficult to reproduce in 
good yields in comparison to benzene. Secondly, only enantiomer 8 is available by this 
method because of the nature of this bio-process. With enantiomer 8, the resulting product 
from our proposed total synthesis would give unnatural (+)-lycorine.  
 
Cl Cl
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In order to overcome these limitations, we planned to develop an alternative method, which 
could produce either enantiomer of enone 8 from a common starting material depending on 
the conditions applied. Endoperoxide 11 is a good choice of common starting material as it is 
an achiral meso-compound (Scheme 4).  
 
 
 
Scheme 4. Synthesis of meso-endoperoxide 7 and the proposed desymmetristion. 
 
Reagents and conditions: a) microbial dihydroxylation; b) DMP, pTSAH2O, CH2Cl2, r.t., 1 h, 
85%; c) O2, TPP, CCl4, 0°C, 8 h, 95%; d) chiral amine, desymmetrisation 
 
The bio-oxidation process on benzene has been established for more than 20 years and 
repeated by several different groups.9 Dihydroxycyclohexadiene 9 is commercially available 
although it is expensive. After protecting diol 9 as the acetonide, photooxygenation of 
acetonide 10 gives the meso-endoperoxide 7 as in Hudlicky’s work.8 If a chiral amine is used 
to promote the KDLM rearrangement in the next step (Step d), desymmetrisation of the 
endoperoxide to give enantiopure 4-hydroxycyclohexenone 8 should be achieved. Ideally, this 
enantioselective catalysis could allow an efficient access to either of the enantiomers 
depending on which enantiomer of the chiral amine is used. 
 
1.1.3 Toste’s Desymmetrisation of meso-Endoperoxides10 
 
In 2006, Toste and co-workers developed the first efficient asymmetric Kornblum-DeLaMare 
(KDLM) rearrangement to make 4-hydroxyenones by using a chiral base to desymmetrise 
endoperoxides.10 They screened various chiral bases for the KDLM rearrangement on eight-
membered cyclic endoperoxide 12 to give 4-hydroxycyclooctenone 13. After testing wide 
range of chiral amines, they found that Cinchona alkaloids could provide a relatively good 
levels of enantioselectivity and they focused on examining different cinchona alkaloid derived 
bases on the KDLM rearrangement (Table 1). 
 
 
 
 
 
 
 
 
 
OH
HO
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O OH
benzene 9 10 11 (+)-8 or (-)-8
a b c d
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Entry Catalyst Solvent Yield (%) 13, ee (%)  
1 QD EtOAc 51 10 
2 (DHQD)2PHAL EtOAc 38 32 
            3 (DHQD)2AQN EtOAc 67 72 
4 deMeQDAc EtOAc 99 99 
5 deMeQDAc CH2Cl2 99 99 
6 deMeQAc CH2Cl2 99 -97 
 
 
 
Table 1. Toste’s screen of chiral bases for the KDLM rearrangement.10 
 
Although quinidine only gave poor enantioselectivity (Entry 1), the dimeric cinchona alkaloid 
catalysts could give moderate yields and enantiomeric excess (Entries 2 and 3). When 
bifunctional catalysts, deMeQDAc and deMeQAc, which were derived from quinidine (QD) 
and quinine (Q) respectively, were examined, the yield and enantiomeric excess was 
improved significantly (Entries 4 and 5). 6’-Hydroxyquinidine-derived bifunctional catalyst 
deMeQDAc was original developed by Deng11 by the demethylation of the 6’-methyl ether on 
the quinoline ring and protection of the 9-hydroxyl group as the acetate in quinidine (QD). This 
catalyst provided the best catalytic performance and gave high reaction rate, yield, and 
enantiomeric excess in CH2Cl2 at r.t. for the KDLM rearrangement. Furthermore, 
pseudoenantiomeric 6’-hydroxquinine-derived catalyst deMeQAc also gave high yields and 
enantiomeric excess for preparing the other enantiomer (Entry 6). 
 
Toste’s research provides a convenient access to chiral medium-size cyclic 4-
hydroxycyclohexenones and both of the enantiomers can be synthesised by switching the 
chiral catalysts. They extended the substrate scope to different ring-sizes with various 
substituents on the rings (Scheme 5). 
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Scheme 5. Scope of Toste’s asymmetric KDLM rearrangement.10 
  
Reagents and conditions: a) 5 mol% deMeQAc, CH2Cl2, r.t.; b) 10 mol% deMeQAc, CH2Cl2, 
r.t. 
 
For the study on a series of eight-membered cyclic endoperoxides, the yields and ee for the 
KDLM reaction were excellent (4-hydroxycyclooctenone 15, up to 99% yield and 99% ee). 
Seven-membered cyclic endoperoxides were also good substrates for deMeQDAc catalyst 
with 83% ~ 99% yields and 83% ~ 99% ees (4-hydroxycycloheptenone 17, 19, and 21). 
However, when deMeQDAc catalyst was applied to six-membered cyclic endoperoxides, only 
moderate to good levels of enantiomeric excess were obtained. For example, more sterically 
biased endoperoxides 22 and 24 gave 96% ee and 89% ee respectively (Scheme 4). The 
enantiomeric excess for less sterically biased endoperoxide 26 deteriorated to 70% and 
significant lower levels of selectivity were observed for the simplest six-membered 
endoperoxide 28: only 50% ee. 
 
Toste proposed a transition state model to explain the origin of the enantioselectivity in these 
reactions (Figure 1). 
 
 
 
Figure 1. Toste’s proposed transition state model for the asymmetric KDLM  
                 rearrangement.10 
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In his model, the 6’-hydroxyl group of the bifunctional catalyst provides hydrogen bonding to 
direct the way the substrate approaches to the reactive centre, and the tertiary amine, which 
is the reactive centre of the bifunctional catalyst, catalyses the KDLM rearrangement. 
 
This model was considered to be consistent with the fact that the steric bias of the cyclic 
substrates appears to have an important impact on the enantioselectivity. With larger ring 
structures (eight- or seven-membered rings), the enantiomeric excess is usually better. Six-
membered rings only give moderate enantioselectivity unless sterically demanding 
substituents are present.  
 
Further evidence for a steric effect is that the tetrasubstituted alkene endoperoxide gives only 
3% ee for 4-hydroxycyclohexenone 33 (Figure 2) compared to disubstituted 4-
hydroxycyclohexenone 32 (50% ee) and the more sterically biased 4-hydroxycyclohexenone 
31 (70% ee). 
 
 
 
Figure 2. The role of steric effects on the ee of products formed by KDLM reactions on  
                six-membered endoperoixdes.10 
 
Toste’s asymmetric KDLM rearrangement has been applied by Iwabuchi to the synthesis of 
chiral seven-membered 4-hydroxyenone 35 during his formal synthesis of (+)-
sundiversifolide6 (Scheme 6). 
 
 
 
Scheme 6. Iwabuchi’s formal synthesis of (+)-sundiversifolide.6 
 
Reagents and conditions: a) deMeQAc, 5 mol%, r.t., 91%, 86% ee; b) Ac2O, NEt3, 4-DMAP, 
THF, 94%; c) Lipase PS, phosphate buffer : acetone (9 : 1), 4 °C, 75%, 95% ee 
 
The KDLM rearrangement on endoperoxide 34 could give 4-hydroxyenone 35 in 86% ee. The 
enantiomeric excess could be further increased to 95% ee using an enantioselective 
hydrolysis catalysed by Lipase PS in phosphate buffer. This research exemplifies the practical 
application of an asymmetric KDLM rearrangement in natural product syntheses. 
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1.2 An Examination of Toste’s Asymmetric Kornblum-DeLaMare  
      Rearrangement on Endoperoxide 11 
 
1.2.1 Synthesis of deMeQAc Catalyst 
 
Cinchona alkaloids have attracted a huge amount of interest from synthetic chemists,12-14 and 
cinchona alkaloid-derived catalysts or ligands have been applied in various reactions12,15-22. 
With the aim to develop an asymmetric total synthesis of (−)-lycorine, the chiral enone 8 was 
required as a starting material and we planned to examine Toste’s KDLM rearrangement on 
endoperoxide 11 as a method of obtaining this key synthetic intermediate. Therefore, 
deMeQAc was synthesised for this purpose from quinine (Q) by a literature procedure11 
(Scheme 7). 
 
 
 
Scheme 7. Synthesis of the deMeQAc catalyst from quinine (Q) according to the  
                   method of Deng.11 
 
Reagents and conditions: a) CH3CH2SH, NaH, DMF, 130°C, 17 h, 79%; b) TIPSCl, imidazole, 
DMF, 0°C à r.t., 80%; c) AcCl, NEt3, CH2Cl2, 0°C à r.t., d) TBAF in THF, r.t., 58% 
 
The phenolic methyl ether in quinine was deprotected using the sodium salt of ethanethiol in 
DMF and the resulting phenol was protected as silyl ether 37. The 9-hydroxyl group was then 
protected as an acetate ester and then the silyl ether was removed by TBAF to complete the 
synthesis of deMeQAc. 
 
1.2.2 Solvent, Additives and Reaction Temperature Effects on the KDLM  
         rearrangement of Endoperoxide 11 
 
With deMeQAc in hand, the six-membered cyclic endoperoxide 117,23 was examined in the 
asymmetric KDLM rearrangement (Table 2).  
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Entry Solvent Catalyst (mol %) Temp. Additives ee 
1 CH2Cl2 5 r.t. - 64 
2 CHCl3 2 r.t. - 62 
3 EtOAc 2 r.t. - 65 
4 THF 2 r.t. - 58 
5 ACN 2 r.t. - 50 
6 DMF 2 r.t. - 19 
7 CH2Cl2 2 r.t. CuCl 63 
8 CH2Cl2 2 r.t. LiCl 66 
9 CH2Cl2 2 r.t. LiBr 38 
10 CH2Cl2 2 -20 °C - 63 
 
Table 2. Optimisation of enantioselective KDLM rearrangement on endoperoxide 11. 
 
Reagents and condition: a) deMeQAc, additives, solvent 
 
Toste’s standard deMeQAc-catalysed KDLM reaction conditions gave only moderate 
enantiomeric excess (64% ee) on endoperoxide 11 (Entry 1). Various solvents were then 
examined in the KDLM reaction to improve the enantioselectivity. Non-polar solvents, such as 
CHCl3, EtOAc, and THF, gave similar or lower enantiomeric excess than CH2Cl2 (Entries 2-4). 
When the solvent was changed to acetonitrile and DMF, the ee dropped to 50% and 19% 
respectively (Entries 5 and 6).  
 
It is perhaps not surprising that polar solvents have a detrimental effect on the 
enantioselectivity because polar solvents interfere with the proposed hydrogen bonding 
between the substrate and the catalyst. Therefore, the inefficient bonding in the transition 
state deteriorates the enantioselectivity. CuCl, LiCl and LiBr were investigated as additives, 
but no improvement was observed (Entries 7, 8, and 9). This asymmetric KDLM 
rearrangement was also examined at -20 °C in CH2Cl2 and gave 63% ee, which was very 
similar to the enantioselectivity at r.t. (Entry 10). 
 
From these results we concluded that the impact of hydrogen bonding on the 
enantioselectivity could not be further improved by incorporation of additives, changing the 
solvent, or lowering the reaction temperature.  
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1.2.3 The effect of Protecting Group Size on the Enantioselectivity of the  
         KDLM rearrangement 
 
From Toste’s results and his proposed transition state model, the steric bulk of the protecting 
groups present on the cyclic structure could have a significant impact on the enantioselectivity. 
We therefore decided to examine if more sterically demanding ketal protecting groups could 
improve the enantioselectivity of the KDLM rearrangement on the six-membered 
endoperoxide.  
 
Ketal formation on diol 38 and bis-elimination of the two bromine substituents allowed the 
preparation of cyclohexyl ketal 40 and diphenyl ketal 42 to examine this hypothesis (Scheme 
8).23 
 
 
Scheme 8. Synthesis of cyclohexadienes 40 and 42 having cyclohexyl and diphenyl  
                   ketal protecting groups.23 
 
Reagents and condition: a) pTSA, THF, 50 °C, 68%; b) DBU, TBAI, CH2Cl2, reflux, 59~68%; c) 
pTSA, THF, reflux, 73% 
 
Cyclohexyl ketal 40 and diphenyl ketal 42 were evaluated under Toste’s KDLM 
rearrangement conditions (Table 3). 
 
Entry R, R Catalyst (%) Yields (%) ee 
1 CH3, CH3 5 45 64 
2 -(CH2)3- 5 31 64 
3 Ph, Ph 5 16 65 
4 Ph, Ph 2 19 65 
 
Table 3. Examination of steric effects on the enantioselectivity of the KDLM   
               rearrangement. 
 
Reagents and conditions: a) TPP, 1O2, CH2Cl2, 0°C; b) deMeQAc, CH2Cl2, r.t. 
O
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Unfortunately, these larger protecting groups did not improve the enantioselectivity. The 
KDLM rearrangement gave 64% and 65% ee for cyclohexyl ketal 43 and diphenyl ketal 44 
respectively (Entries 2 and 3). Reducing the catalyst loading showed no influence on the 
enantioselectivity (Entry 4). The ees obtained were actually very similar to those obtained 
using the bis-MOM protecting group (Endoperoxide 24, Scheme 4) in Toste’s research. These 
results indicated that the size of the diol protecting groups had little impact on the 
enantioselectivity for the six-membered cyclic endoperoxides.  
 
                                         Racemic                                                    Asymmetric 
     
                                               
 
                                         Racemic                                                   Asymmetric 
   
 
 
                                                
 
                                          Racemic                                                  Asymmetric 
     
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	                               
 
 Diagram 1. HPLC chromatograms for the racemic and enantiomeric enriched 4- 
                     hydroxyhexenones 8, 43, and 44 formed by asymmetric KDLM  
                     rearrangement. 
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1.3  The Effect of Various Hydrogen Bond Donors on the Asymmetric   
       KDLM Rearrangement  	  
1.3.1 Conventional Synthesis of the 6’-Aminoquinine Derived Catalysts 
 
Another factor we could modify to potentially enhance the enantioselectivity in the asymmetric 
KDLM rearrangement was the nature of the hydrogen bond donor in the quinine-derived 
catalysts. The original hydrogen bond donor was the phenolic proton and we considered that 
this group might be advantageously replaced by an aniline (45) derived hydrogen bond donor. 
For example, amides, sulfonamides, ureas, thioureas, and squaramides24 could be examined 
as the hydrogen bond donor in the quinine-derived bifunctional catalysts (Figure 2). 
 
 
 
Figure 2. Proposed catalysts containing various hydrogen bond donors derived from  
                6’-aminoquinine (AQ) 
 
6’-Aminoquinine was synthesised by Hiemstra and co-workers in 2006 when they developed 
an asymmetric organocatalytic Henry reaction (Scheme 9).25 
 
 
 
Scheme 9. Hiemstra’s synthesis of 6’-aminoquinine-derived bifunctional catalyst 49.25 
 
Reagents and conditions: a) PhNTf2, DMAP, CH2Cl2, 85%; b) Pd(OAc)2, BINOL, Cs2CO3, 
Ph2=NH, THF; then citric acid, THF, H2O, 78%; c) 3,5-(CF3)2PhNCS, THF, 57% 
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They firstly transformed the 6’-hydroxyl group of the quinine derivative 46 to the phenolic 
triflate 47 using the McMurry reagent, followed by Buchwald amination26 to introduce the 
nitrogen atom and hydrolysis of the resulting imine to give 6’-aminoquinine derivative 48. This 
derivative was then coupled with 3,5-bis-trifluoromethylphenyl isothiocyanate to form the 
thiourea derived catalyst 49. 
 
However, we did not use Hiemstra’s method to introduce the nitrogen atom because the 
McMurry reagent and the source of nitrogen from benzophenone imine is relatively expensive. 
We therefore aimed to develop a more efficient method to access to 6’-aminoquinine 45 via a 
Bucherer reaction. 
 
1.3.2 Bucherer Amination and Its Mechanism27 
 
The Bucherer reaction is a reaction that converts phenols to anilines or anilines to phenols in 
the presence of sulfurous acid or sodium bisulfite in aqueous solution. Bucherer28 developed 
this reaction in 1904 and the products of the Bucherer reaction depended on the position of 
the equilibrium between the phenols and anilines. Although benzene derivatives are not good 
substrates for the Bucherer reaction, this reaction has been applied to extended aromatic 
systems, such as anthracene, phenanthrene, and heterocyclic compounds. The detailed 
mechanism of the Bucherer reaction was investigated by Seeboth and he proposed the 
following pathway for this transformation (Scheme 10).27 
 
 
 
Scheme 10. Seeboth’s proposed mechanism for the Bucherer reaction.27 
 
He proposed a series of dearomatisation, substitution, and aromatisation steps between 
phenol and aniline intermediates, wherein the position of the various equilibria depended on 
the solubility of the relevant intermediates and other factors. 
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1.3.3 Attempted Bucherer Amination on deMeQ (54) with Aqueous  
         Ammonia as the Nitrogen Source 
 
Since our objective was to develop an efficient and economical synthesis of 6’-aminoquinine 
derivatives via a Bucherer amination, ammonia would be the ideal source of nitrogen because 
of its ready availability and low price. Therefore, the first conditions we studied were to heat 
deMeQ and ammonium sulfite monohydrate in aqueous ammonia solution at 150 °C in a 
sealed tube for four days (Scheme 11).	  	  	  
 
 
Scheme 11. Direct amination of deMeQ (54) in aqueous ammonia solution. 
 
Reagents and conditions: a) NH4OH, (NH3)2SO3⋅H2O, H2O, 150 °C~200 °C, 0 ~ 11 % 
 
Unfortunately, after several attempts, the yields were variable and a significant amount of 
unidentified compounds were formed. The reaction temperature was then increased to 200 
°C but only black decomposed mixtures were formed. The major disadvantage of aqueous 
ammonia as a nitrogen source is that the pressure in the glass reaction vessels is very high at 
180 - 200 °C and ammonia may escape during the reaction.  
 
Being aware of the potential explosion of the glass reaction vessels, a less volatile nitrogen 
source was sought. The nitrogen source has to have a high boiling point and to be miscible 
with water as well as being readily available. Benzylamine appeared to be an ideal nitrogen 
source with high boiling point (bp. 185 °C) and good miscibility with water. It is also possible 
to remove the resulting benzyl group from the aniline nitrogen by a hydrogenolysis reaction. 
 
1.3.4 Bucherer amination of deMeQ with benzylamine 	  
With the aim to realise these advantages, benzylamine was examined as the nitrogen source 
in our Bucherer amination. deMeQ (54) and benzylamine were stirred in water at 145~150 °C 
in the presence of sodium bisulfite in a sealed tube (Table 3). 
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Entry Solvent ratio 
(Benzylamine/Water : v/v) 
Time 
(Days) 
Yield (%) 
1 1/8 4 74 
2 1/4 4 20-301 
3 1/4 2 20-301 
4 1/8 1 70 
5 1/8 2 75 
6 1/8 2 722 
1White solids with red oil. 21 gram scale. 
 
Table 3. Optimisation of the benzylamination of deMeQ 
 
Reagents and conditions: a) 50 mg of deMeQ, NaHSO3, benzylamine and H2O, 145~150 °C 
 
Different solvent ratios (v/v) of benzylamine and water were examined (Entries 1 and 2). 
Benzylamine/water = 1/8 proved to be a good ratio because aniline 56 is insoluble in water 
and therefore water can facilitate the equilibrium toward the amino product by precipitation. 
Higher ratios of benzylamine were not advantageous as oily solids were formed and it was 
difficult to precipitate more products from the oily mixture. In terms of reaction time, two days 
were sufficient for this reaction to reach complete conversion (Entries 2 and 3). Incomplete 
consumption of deMeQ was observed in a shorter reaction period (Entry 4). Optimised 
conditions gave a white solid with 75% yield (Entry 5). A gram-scale reaction also gave a 
similar yield (Entry 6). The major side product in this reaction was dibenzylamine as oil. 
 
Purifying aniline 56 proved straightforward after cooling down the reaction mixture; the 
product was precipitated as a white to brown powder and only filtration was required. Adding 
more water and sonification could facilitate solidification when an oily mixture was obtained. 
 
1.3.5 Hydrogenolysis of the Benzyl Protecting Group 
 
6’-Aminoquinine 57 could be obtained by the hydrogenolysis of the benzyl group from N-
Benzyl-6’-aminoquinine 56 (Table 4).  
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Entry Solvent ratio 
(MeOH/AcOH : v/v) 
Time (h) Outcome 
1 Methanol 18 No hydrogenolysis. 
Hydrogenation of the double bond.  
2 10/1 18 No hydrogenolysis. 
Hydrogenation of the double bond.   
Two sets of quinoline NMR signals present. 
3 10/1 40 No hydrogenolysis. 
Hydrogenation of the double bond.  
Quinoline ring is also hydrogenated. 
4 1/1 18 Same results as entry 2 	  
Table 4. Attempted selective hydrogenolysis of benzyl protecting group using H2 and  
               Pd(OH)2/C 
 
Reagents and conditions: a) H2 (1 atm), solvent, Pd/C (5 mol%), r.t. 
 
Pearlman’s catalyst [10 % Pd(OH)2/C] was firstly examined as the catalyst for the 
hydrogenolysis under H2 at r.t.. However, these conditions could only hydrogenate the double 
bond but not remove the benzyl group (Entry 1). Acetic acid was therefore added to facilitate 
the hydrogenolysis (Entry 2). Similarly, only hydrogenation of the double bond was observed 
without hydrogenolysis of the benzyl group after 18 hours. Notably, two new sets of 
unidentified quinine ring signals were noted in the 1H NMR spectrum of the crude reaction 
mixtures. The reaction duration was increased to 40 hours but, unfortunately, the quinoline 
ring was hygrogenated (Entry 3). Higher ratio of acetic acid in the solvent did not improve the 
hydrogenolysis reaction (Entry 4). 
 
In order to avoid hydrogenating the quinoline ring, we anticipated that transfer hydrogenation 
using ammonium formate as the hydrogen source rather than H2 might increase the reaction 
rate of hydrogenolysis and that therefore these conditions might selectively deprotect the 
benzyl group (Table 5). 
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Entry Catalyst Time T/°C Debenzylation1 
(conversion) 
Number of 
Debenzylated 
Products (a/b)2 
1 Pd(OH)2/C 18 r.t. Trace - 
2 Pd(OH)2/C 18 50 100% 2 ( 1 : 0.65 ) 
 33 Pd(OH)2/C 18 r.t Trace - 
 43 Pd(OH)2/C 18 50 77 % 2 ( 1 : 0.35) 
5 Pd/C 18 r.t. Trace - 
6 Pd/C 18 50 56 % + S.M, 1 
 73 Pd/C 18 r.t. Trace - 
 83 Pd/C 18 50 50 % + S.M. 1 
94 Pd/C 42 50 100% 1 
105 Pd/C 90 50 100% 1 
1Conversion is reported. 2Ratio of debenzylated products. 3Formic acid, 25 µL. 410+10 equiv.  NH4COOH is added. 
5100 mg 6’-N-benzyl aminoquinine 56, NH4COOH is added in portions (10+10+10) equiv. 
 
Table 5. Hydrogenolysis of N-benzyl group using Pd catalysis with ammonium formate          
              as the hydrogen source. 
 
Reagents and conditions: a) 20 mg of N-benzyl aminoquinine 56, 10 equiv, NH4COOH, Pd  
catalysts (5 mol%), MeOH 
 
Pd(OH)2/C and Pd/C were both tested as catalysts for the hydrogenolysis reaction. At room 
temperature, neither conditions achieved hydrogenolysis (Entries 1, 3, 5, and 7). When the 
reaction temperature was elevated to 50 °C, hydrogenolysis was achieved under the catalysis 
of Pd(OH)2/C with one set of unidentified deprotected quinoline ring signals in the 1H NMR 
spectrum of the crude materials (Entries 2 and 4, 100% and 77% conversion). Fortunately, 
Pd/C could also catalyse the hydrogenolysis to deprotect the benzyl group at 50 °C and gave 
a single product with 56% conversion (Entry 6). Formic acid had no significant impact on the 
conversion (Entries 4 and 8). 
 
With the aim to improve the hydrogenolysis, a longer reaction time (42 hours) and adding 
ammonium formate in two portions were required to consume all the starting material (Entry 
9). The 1H NMR spectrum of the crude reaction mixture was relatively clean. However, in a 
scaled-up (100 mg) reaction, two sets of NMR signals were observed after work up even 
though only one set of 1H NMR signals was apparent as the reaction progressed (Entry 10). It 
is probable that the aminoquinine 57 is unstable in the air. This may also explain why no 
aminoquinine 57 was recovered after silica-gel chromatography. 
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1.3.6 Protection of the 9-Hydroxyl Group in 6’-Aminoquinine 
 
As indicated above, we concluded that the aminoquinine 57, which contains a free hydroxyl 
group after hydrgenolysis of the protected aminoquinine 56, is unstable in the air. This was 
surprising because 9-ether aminoquinine derivatives have been synthesised by the 
Hiemstra,25 Deng,29 and Shi30,31 groups, and none of them have reported any stability issues 
(Figure 3). 
 
 
 
Figure 3. Known 9-alkoxy and 9-hydroxy aminoquinine derivatives. 
 
The difference between those known aminoquinines and our aminoquinine 57 is that 
aminoquinine 57 has a 9-hydroxyl group instead of an ether linkage. In order to stabilise the 
aniline 57 we decided to introduce an acetyl group at the 9-position before hydrogenolysis. 
Towards this end, the plan was to protect the aniline using Boc2O and then acylate the 
secondary alcohol (Scheme 12).  
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Scheme 12. Protecting strategies for aminoquinine 56. 
 
Reagents and Conditions: a) Boc2O, DMAP, NEt3, methanol, 52%; b) AcCl, DMAP, pyridine, 
r.t., 1 h, 84%. 
 
However, from the 1H NMR spectrum of the crude reaction mixture following attempted 
introduction of an N-Boc group using Boc2O, no Boc protection was observed on the nitrogen. 
Instead, the secondary alcohol was protected as a tert-butyl carbonate. This result showed 
that the secondary hydroxyl group was more reactive than the aniline nitrogen, presumably 
the sterically hindered environment around the nitrogen made aniline even less reactive than 
we had anticipated. Therefore, we planed to examine the possibility that the hydroxyl group in 
aminoquinine 56 could be selectively acylated in the presence of the unprotected aniline to 
give acetate 62 (Scheme 13).  
 
 
 
Scheme 13. Planned synthesis of 6’-aminoquinine derivatives 63. 
 
Reagents and conditions: a) acylation agent; b) hydrogenolysis 
 
The subsequent hydrogenolysis of the benzyl group in acetate protected aminoquinine 62 
was anticipated to be straightforward to give 6’-aminoquinine 63. By this method, the 
protection of the aniline by the Boc group could be avoided. 
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1.3.7 Selective Acylation of 6’-Aminoquinine 56 
 
The acylation of 6’-aminoquinine 56 was first examined with various acylating agents, bases, 
and solvents (Table 6). 
 
 
 
Entry Scale 
(mg) 
Acylation 
agent 
(equiv) 
Solvent Base 4-DMAP 
(equiv) 
Outcome 
1 10 AcCl  
(1.0) 
pyridine - 0.1 ~30% amide 
formation 
2 10 Ac2O 
(1.0) 
pyridine - 0.1 Slow conversion, 23% 
unidentified mixtures 
formed 
3 50 AcCl 
(1.0) 
THF n-BuLi - Black oil precipitated, 
31% isolated yield 
4 50 AcCl 
(1.0) 
DMF NaH - Black mixtures formed 
5 50 Ac2O  
(1.2) 
DMF NEt3 0.1 Clean, 69% isolated 
yield+ starting 
material 
6 416 Ac2O  
(1.6) 
DMF NEt3 0.1 Similar to entry 5 but 
no starting material, 
54% isolated yield 
(246 mg) 
 
Table 6. Acylation of 6’-aminoquinine 56 with various acylating agents, bases, and  
               solvents. 
 
Reagents and conditions: a) acylation reagents, base, additives, solvent, 0 °C then r.t. 
 
In the initial attempt to acylate the 9-hydroxyl group in 6’-aminoquinine 56, acetyl chloride was 
examined: no desired ester was formed but instead around 30% of the undesired amide was 
formed (Entry 1). By contrast, only the desired ester was formed when acetic anhydride was 
applied as an acylating agent. No amide was formed. However, the reaction rate was slow 
and the reaction was not complete after 16 hours at room temperature (Entry 2). 
Deprotonation of the 9-hydroxyl group by strong bases was then examined to improve the 
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selectivity and reactivity toward acetyl chloride. Unfortunately, a black oil precipitated when n-
BuLi was added and the isolated yield was only 31% (Entry 3). NaH was also examined as 
the deprotonating reagent but the reaction solution became black in 30 seconds after 
deprotonation (Entry 4). Aminoquinine 56 appeared to be unstable after deprotonation. We 
then attempted to enhance the reactivity of 9-hydroxyl group towards acetic anhydride using a 
polar solvent. Acetic anhydride as acylating reagent was examined in DMF without 
deprotonating the alcohol. Although the conversion was not complete, these conditions gave 
a 69% isolated yield (Entry 5).  More equivalents of acetic anhydride were added in a larger 
scale reaction but the yield was not improved (Entry 6). 
 
1.3.8 Deprotection of the Benzyl Group in Aminoquinine 62 by  
         Hydrogenolysis 
 
According to our previous experience of hydrogenolysis of aminoquinine 56 using transfer 
hydrogenation conditions, Pd/C can catalyse hydrogenolysis of the N-benzyl group more 
efficiently than Pd(OH)2/C for this type of compound. Consequently, we explored these 
transfer hydrogenation conditions for the hydrogenolysis of aminoquinine 62 (Table 7). 
 
 
 
Entry Solvent Hydrogen 
Source 
T (°C) Time (hours) Outcome1 
1 MeOH NH4COOH 50 18 no hydrogenolysis 
9-acetate group 
hydrolysis 
2 THF NH4COOH 50 18 no hydrogenolysis 
3 EtOAc NH4COOH 50 18 no hydrogenolysis 
4 CH3COOH H2 (1 atm) r.t. 3 50% conversion 
5 CH3COOH H2 (1 atm) r.t. 7 100% conversion, 56% 
yield 
1By 1H NMR spectrometry. 
 
Table 7. Hydrogenolysis of 6’-aminoquinine 62. 
 
Reagents and Conditions: a) Pd/C (5 mol%), hydrogen source, solvent 
 
Our initial finding was that the ester group hydrolysed in methanol (Entry 1).	  Although there 
was no hydrolysis of the ester group in non-nucleophilic solvents, such as THF and EtOAc, no 
hydrogenolysis of the benzyl group occured (Entries 2 and 3). The hydrogenolysis in acetic 
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acid was then examined. After three hours, around 50% conversion was achieved and, 
interestingly, the alkene protons from the starting material at δH = 5.78 ppm (ddd) still 
appeared in the 1H NMR spectrum of the crude product (Entry 4). Previously we had 
observed that the hydrogenolysis was significantly slower than the reduction of the double 
bond. This indicated that the hydrogenolysis was relatively faster in acidic conditions and that 
the reaction rate was comparable to the hydrogenation of the double bond. The benzyl 
protecting group was completely removed after seven hours giving a 56% yield (Entry 5). The 
crude product from the hydrogenolysis was used for the coupling reaction with 3,5-
bis(trifluoromethyl)phenyl isothiocyanate directly but only gave complex mixtures of 
compounds as evidenced by inspecting the 1H NMR spectrum (Scheme 14).	  	  
	  	  
Scheme 14. Attempted formation of the 6’-aminoquinine derived thiourea 64 from  
                    unpurified aminoquinine 63 
 
Reagents and conditions: a) 3,5-bis(trifluoromethyl)phenyl isothiocyanate, THF, r.t., 17 h 
  
The reason for the formation of complex mixtures in these reactions was originally thought to 
be due to impurities in the starting material carried over from the hydrogenolysis reaction, but 
the actual reason turned out to be the intrinsic instability of aminoquinine derived thiourea 64 
(Scheme 15).  
 
 
 
Scheme 15. Reactions to form aminoquinine derived thiourea 64 and sulfonamide 65 
 
Reagents and conditions: a) H2 (1 atm), Pd/C (5 mol%), acetic acid, r.t., 17 hours, 76%; b) 
3,5-bis(trifluoromethyl)phenyl isothiocyanate, THF, r.t., 5 hours, 36%; c) p-toluenesulfonyl 
chloride, DMAP, pyridine, r.t., 3 h, 65% 
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The coupling of aminoquinine 63 with 3,5-bis(trifluoromethyl)phenyl isothiocyanate was 
attempted several times and thiourea 64 was found to decompose on silica gel and even 
rapidly in d-chloroform (Scheme 14). The p-toluenesulfonamide derivative was also 
synthesised. It was relatively stable but still decomposed slowly. It was considered that the 
instability could be due to reactions of the 9-acetate functional group via inter- or 
intramolecular activation (Figure 4). 
 
 
 
Figure 4. Proposed modes of intermolecular and intramolecular activation of the  
                acetate group in compound 64 leading to decomposition. 
 
Intermolecular activation could occur if the thiourea hydrogen bonds to the acetate carbonyl 
group whereas intramolecular activation could occur by the nucleophilic attack of the 
quinidine nitrogen on the acetate carbonyl group. We believe that the intramolecular 
activation model is less feasible than the intermolecular activation model. The reason is that if 
the intramolecular activation occurs, then a similar effect would be also expected in the 
original deMeQAc catalyst but this is not observed experimentally. 
 
If our hypothesis of intermolecular activation is correct, these results provide two pieces of 
information. The first one is that these aminoquinine derivatives have good catalytic ability to 
activate carbonyl groups. The second is that the thiourea derivatives may have higher affinity 
toward carbonyl groups than the sulfonamide derivatives, although geometric factors may 
also be important. 
 
We considered that there were several possible purification procedures, which might avoid 
the decomposition of these aminoquinine derivatives, such as avoiding acidic conditions and 
nucleophilic solvents.  However, the stability of the aminoquinine catalysts was also expected 
to be improved significantly by exchanging the 9-acetate protective group for other protecting 
groups. For example, this acetate group could be replaced by a pivaloyl group, which is more 
sterically hindered and stable toward nucleophilic attack. Another possible way is to modify 
the 9-hydroxyl group into an ether group, which have been used by other groups (Figure 3), 
even though this would sacrifice the convenience of further tuning the steric bulk at this 
position. One advantage of our original route was that the steric factor at the 9-position could 
be modified by introducing various ester protecting groups later in the synthesis. 
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1.3.9 The Synthesis of 9-n-Butylether 6’-Aminoquinine 68 and its  
         Derivatives 
 
In the literature, all 6’-aminoquinine derivatives have ether linkages at the 9-position and 
these compounds are apparently stable towards silica-gel chromatography (Figure 3). 
However, our 6’-aminoquinine 63, which contains a 9-acetate group seems unstable. In order 
to understand how different functional groups at the 9-position may affect the stability, we 
decided to synthesise 9-n-butylether aminoquinine 68 (Scheme 16). 	  
	  	  
Scheme 16. The synthesis of 9-n-butylether aminoquinine derivative 68. 
 
Reagents and conditions: a) NaH, 1-bromobutane, DMF, 40 °C, 2 h, 91%; b) NaH, EtSH, 
DMF, 130 °C, overnight, 85%; c) Bucherer reaction (see Table 8) 
 
Alkylation of the 9-hydroxyl group on quinine (Q) could be achieved by the nucleophilic attack 
of the alkoxide anion on 1-bromobutane at 40 °C in DMF to give 66 in 91% yield after two 
hours. A nucleophilic demethylation of the methyl ether on the quinoline ring using the sodium 
salt of ethane thiol gave quinine derivative 67 in 85% yield. Quinine derivative 67 could be 
transformed to aminoquinine 68 by the Bucherer reaction using similar conditions we 
developed previously (Table 8). 	  
	  	  
Entry Scale Benzylamine/Water Reaction Time 
(days) 
Conversion1 
(%) 
1 250 mg 1/8 2 32 
2 1000 mg 1/4 2 50 
3 1000 mg 1/4 4   682 
 1By NMR spectrum. 2Isolated yield. 
 
Table 8. Benzylamination of quinine derivative 67 by a Bucherer reaction to give 6’- 
              aminoqinine 68. 
 
Reagents and conditions: a) NaHSO3, benzylamine/water, 150 °C 
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When our previous Bucherer reaction conditions were applied to quinine derivative 67, the 
conversion was 32% after two days (Entry 1). The reason for the slow reaction rate could be 
that the n-butyl ether group made the solubility of 6’-aminoquinine 67 relatively low compared 
to 6’-aminoquinine 54 with a free hydroxyl group in benzylamine/water = 1/8. Solids are still 
present at 150 °C for quinine derivatives 67 while it is a clear orange solution at 80 °C for the 
9-hydroxy-6’-hydroxy quinine 54. In order to improve the solubility, the ratio of benzylamine in 
water was increased to benzylamine/water = 1/4 and the conversion was better (50 %, Entry 
2). The starting material was depleted completely after four days with 68% isolated yield 
(Entry 3).  
 
With 9-n-butylether-6’-benzylaminoquinine 68 in hand, various solvents and temperatures 
were screened for the hydrogenolysis to deprotect the benzyl group (Table 9).  
 
	  	  
Entry  Solvent T (°C) Outcome 
1 Acetic acid r.t. No hydrogenolysis 
2 Acetic acid 60 No hydrogenolysis 
3 Methanol/aqueous 
HCl : 1/1 
r.t. Hydrogenolysis and reduction 
of the quinoline ring 
4 Trifluoroacetic acid r.t. 100% conversion, clean 
crude product 	  
Table 9. Hydrogenolysis of 9-n-butyl-6’-benzylaminoquinine 68. 
 
Reagents and conditions: a) H2 (1 atm), Pd/C (5 mol%), solvent, 17 h 
 
Initially, the hydrogenolysis conditions we developed previously were examined. Unfortunately, 
the benzyl group could not be removed in acetic acid at either r.t. or 60°C under H2 (1 atm) 
with Pd/C (Entries 1 and 2). More acidic solvents were examined for the hydrogenolysis. The 
benzyl group could be deprotected in methanol/HCl (1:1) at r.t., but, in the meantime, the 
quinoline ring was reduced to give a 2:1 diastereomeric mixture (Entry 3). When the 
hydrogenolysis was performed in trifluoroacetic acid, the benzyl protecting group was 
removed efficiently at r.t. and a clean crude product was obtained (Entry 4). The 1H NMR 
spectrum of the crude material showed one clean compound under these conditions. There 
were no benzyl protons in the 1H NMR spectrum and the mass recovery in this reaction was 
quantitative. However, one major product and one minor product were isolated after silica-gel 
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chromatography. These spectra were very similar to each other but with a significant shift of 
the 5’-hydrogen between δH = 7.41 ppm (minor) and δH = 7.66 ppm (major). A stability test (50 
°C, 24 hours) on each of the products showed that the 1H NMR spectra did not change. 
Dilution of the minor compound (1/4 of the original concentration) did not change its 1H NMR 
spectrum either. Therefore, we decided to apply crystallography to identify the actual 
structures. The major isomer could be crystallised from diethyl ether solution to give plates for 
X-ray diffraction. A single crystal X-ray structure determination on this product revealed the 
structure to be the salt: 9-n-butylether-6’-aminoquinine⋅TFA (69) (Figure 5). 
 
                            
 
Figure 5. Molecular structure of 9-n-butylether-6’-aminoquinine⋅TFA salt (69) as  
                revealed by a single crystal X-ray structure determination. 
 
It was surprising that the crystals comprised a TFA salt because the organic phase had been 
washed with aqueous NaHCO3 several times in the work up procedure and the crude product 
was purified by silica-gel chromatography. Although crystals of the minor compound could not 
be obtained, we believe that the minor product is the free base of aminoquinine salt 69. 
 
1.3.10 The Effects of Various Hydrogen-Bond Donors on the Asymmetric  
           Kornblum-DeLaMare Rearrangement 
 
With the aim to improve the enantioselectivity of the asymmetric Kornblum-DeLaMare 
rearrangement, it was planned to explore the effects of different hydrogen bond donors within 
the cinchona organocatalysts (Figure 6).  
 
                                      
 
Figure 6. Proposed modification of the aminoquinine catalysts to incoporate different  
                hydrogen bond donors. 
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With 9-n-butylether-6’-aminoquinine⋅TFA (69) salt in hand, we planned to introduce various 
amide, urea, thiourea, and sulfonamide groups into 6’-aminoquinine and to test these 
bifunctional organocatalysts on the asymmetric KDLM rearrangement.  
 
However, the 6’-amino group on the quinoline ring proved insufficiently nucleophilic to react 
with sulfonyl chlorides, such as p-toluenesulfonyl chloride. This is consistent with the previous 
observation that acetoxy protection could be introduced directly onto the C-9 alcohol using 
Ac2O in the presence of the C-6’-amino group, and only the trifluorosulfonamide derivative of 
6’-aminoquinine could be synthesised in this direct fashion. Surprisingly, thiourea derivatives 
were also unstable towards silica-gel chromatography. Subsequently, amides 70 and 71, urea 
72, sulfonate 73 and trifluorosulfonamide 74 were synthesised by reacting with the 
corresponding acyl chlorides, 1,3-bis(trifluoromethyl)phenyl isocyanate, and 
trifluoromethanesulfonic acid (Scheme 17). 
 
 
 
Scheme 17. The synthesis of 9-n-butylether aminoquinine derivative 68. 
 
Reagents and conditions: a) AcCl or trifluoroacetyl chloride, pyridine, 0 °C; b) 1,3-
Bis(trifluoromethyl)phenyl isocyanate, K2CO3, THF, r.t.; c) Trifluoromethanesulfonic acid, 
pyridine, CH2Cl2, 0 °C; d) Pd/C, H2, MeOH, r.t. 
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In our synthetic route to all these derivatives the benzyl protection group is deprotected by 
hydrogenolysis and this results in concomitant hydrogenation of the double bond at C10-C11; 
consequently, the dihydro-6’-hydroxyquinine derivative 75 was also synthesised to act as a 
control to compare with the parent compound 67 (Scheme 16). 
 
These 6’-aminoquinine and 6’-hydroxyquinine derivatives were tested for the KDLM 
rearrangement as the chiral catalysts (Table 10). 
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Entry Catalysts ee pKa1 
1 69 slow conversion - 
2 70 13 13.4 ± 0.4 
3 71 25 10.7 ± 0.4 
4 72 23 13.5 ± 0.9 
5 73 19 - 
6 74 25 2.7 ± 0.5 
7 68 13 - 
8 75 49 8.9 ± 0.4 
9 67 41 8.9 ± 0.4 
10 deMeQAc 65 8.9 ± 0.4 
1Calculated pKa data by CDS website. http://cds.dl.ac.uk. 
 
 
 
Table 10. Examination of various quinine-derived catalysts in the asymmetric  
                 KDLM rearrangement of endoperoxide 7. 
 
Reagents and conditions: a) 5 mol% catalyst, CH2Cl2, r.t. 
 
The 9-n-butylether-6’-aminoquinine⋅TFA salt (69) did not catalyse the KDLM rearrangement 
(Entry 1) and this indicated the salt is probably not a Brønsted-base catalyst. Acetamide 70 
only provided 13% ee and tirfluoroacetamide 71 provided just 25% ee (Entries 2 and 3), 
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which could perhaps be explained by the fact that the more acidic proton of trifluoroacetamide 
71 can provide a stronger hydrogen bond to increase the enantioselectivity. Urea 72 gave 
23% ee even though the pKa is similar to acetamide 70 (Entry 4). The reason for the similar 
enantioselectivity could be due to the possibility of forming two hydrogen-bond donors in a 
single molecule. Sulfonate salt 73 gave 13% ee (Entry 5). When the pKa decreased from 
catalyst 70 (pKa = 13.4 ± 0.4 ) to catalyst 71 (pKa = 10.7 ± 0.4) to catalyst 75 (pKa = 8.9 ± 
0.4), the enantiomeric excess increased from 13% ee to 25% ee to 49% ee.32 From the trend 
of ee v.s. pKa, we might predict that the more acidic tirfluoromethylsulfonamide 74 (pKa = 2.7 
± 0.5) could give a higher ee. Unfortunately, the ee was only 25% (Entry 6), similar to the ee 
from trifluoroacetamide 71. 6’-Benzylamino quinine 68 was also examined and gave a low 
13% ee (Entry 7). This was not surprising as the aniline is not a hydrogen-bond donor.  
 
We also examined dihydro-9-n-butyl quinine 75, which has a phenolic proton like Deng’s 
catalyst in Toste’s work.10 This catalyst gave a moderate 49% ee. This result could indicate 
that the phenolic proton has a better hydrogen-bond interaction with our substrate than the 
amide derivatives and therefore gives a better enantioselectivity (Entry 8). The effect of the 
double bond on the enantioselectivity can also be determined by reference to the 
performance of compounds 75 and 67. The ee was improved from 41% ee to 49% ee when 
the double bond of 9-n-butyl quinine 67 was reduced to give dihydro-9-n-butyl quinine 75 
(Entries 8 and 9). 
 
deMeQAc-Catalysed asymmetric KDLM rearrangement was also performed as a control 
experiment at the same time. The enantiomeric excess was very similar to our previous 
results, 65% ee, and was reproducible (Entry 10). By comparing entries 8, 9, and 10, it may 
indicate that the 9-ester group has an advantageous steric impact on the conformation in the 
transition state and hence a 9-ester group may be crucial for the catalysts to give good levels 
of enantioselectivity.   
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1.4 Conclusions and Future Work 
 
In this study of the asymmetric KDLM rearrangement, we have examined a series of quinine 
derived bifunctional catalysts using various conditions and for substrates with bulky ketal 
protection groups. We also have developed a Bucherer amination on quinine derivatives to 
synthesise 6’-aminoquinines and provide a more convenient synthetic route for synthesising 
these important derivatives as compared to the currently described method in the literatures. 
Various 6’-aminoquinine derivatives have been tested as catalysts for the asymmetric KDLM 
rearrangement. Although, unfortunately, we were unable to improve the enantioselectivity 
relative to what had already been discovered in the literature, we confirmed Toste’s 
hypothesis that an acidic proton in the bifunctional quinine derived catalysts is required 
to achieve good levels of enantioselectivity. 
 
In the course of developing more efficient catalysts for the asymmetric desymmetrisation of 
the six-membered endoperoxide, dimeric deMeQs and bulky substituents, such as 
naphthalene or anthracene ethers, at the 9-position have not been examined. These 
modifications could potentially provide good catalysts for the asymmetric KDLM 
rearrangement and should be examined in the future.   
 
Furthermore, there have been significant studies related to the conformational dynamics of 
the Cinchona alkaloids and their derivatives33-37. Further study on the conformational bias on 
our cinchona alkaloid derived catalysts may also provide new insights that would facilitate 
optimisation of the asymmetric KDLM rearrangement.  
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2. Towards the Asymmetric Total Synthesis of (−)-Lycorine 
 
2.1 History, Biosynthesis, and Bioactivity of (−)-Lycorine 
 
Chemists refer to natural-occurring and nitrogen-containing chemicals isolated from natural 
sources, such as plants and marine sponges, as alkaloids. Alkaloids usually have various 
bioactivities and these bioactivities usually include the ability to act as posions because 
alkaloids are often constituents of defensive mechanism to protect plants and marine sponges 
from animals or diseases. However, some alkaloids are beneficial to human health and show 
very useful pharmaceutical effects. For example, morphine was the first example of a purified 
alkaloid to show pharmaceutical function and was the first analgesic drug in modern medical 
treatment. Another example is quinine, which has anti-malatrial, analgesic, and anti-
inflammatory effects; the Quechua people have used unpurified quinine as a medicine since 
ancient times (Figure 6).  
 
 
 
Figure 6. Alkaloids: morphine and quinine (Q). 
 
The Amaryllidaceae is a large family of herbaceous plants and these plants are widely 
distributed in tropical and sub-tropical areas of the world. Amaryllidaceae alkaloids are the 
alkaloids isolated from these Amaryllidaceae plants. They can be categorised into six groups 
by their structural characteristics (Figure 7).38-40   
 
 
 
Figure 7. The six structural classes of Amaryllidaceae alkaloids.38-40 
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(−)-Lycorine is isolated from many amaryllidaceae bulbs and is the most abundant 
Amaryllidaceae alkaloid. Amaryllidaceae bulbs can contain as much as 1% (−)-lycorine by dry 
mass.41 Pure (−)-lycorine was first isolated in 1877 and its structure was determined in 1935 
by Uyeo.41,42 In the aspect of biosynthesis, (−)-lycorine is synthesised from two amino acids: 
tyrosine and phenylalanine (Scheme 18).43-45 
 
 
 
Scheme 18. Proposed outline biosynthesis of (−)-lycorine.44,45 
 
It is believed that the decarboxylation of tyrosine gives tyramine, and then tyramine reacts 
with catechualdehyde to form nor-belladine by a reductive amination. Subsequent selective 
protection of one of the three phenolic alcohols gives the OMe-nor-belladine. Sequentially, 
double single-electron oxidation, phenolic coupling, and rearomatisation affords the cyclic 
amine 78. The B- and D-rings are cyclised by a δ-conjugate addition to give enol 81 and enol 
81 is transformed to allylic alcohol 82 by reducing the enol group to the secondary alcohol 
and oxidising the allylic position to the allylic alcohol. The 1,3-dioxole group is eventually 
constructed by a oxidative cyclisation and this completes the biosynthesis of (−)-lycorine. The 
initial stereogenic centres in the C-ring are established by the nature of the enzymes that 
catalyse the rearomatisation and δ-conjugate addition (78 à 80). Subsequent stereogenic 
centres are introduced diastereoselectivly. 
 
Many biological studies have shown that (−)-lycorine and its derivatives have a wide range of 
bioactivities.38,39,46-50 (−)-Lycorine can inhibit the biosynthesis of ascorbic acid and prevent 
cyanide-insensitive respiration.49 Growth and cell division in higher plants can be suppressed 
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by (−)-lycorine.51 X-Ray crystallography has shown that (−)-lycorine can bind to the P-site for 
tRNA in the yeast ribosome.52  (−)-Lycorine and its derivatives also show detrimental effects 
in the replication of polio, small pox, and SARS viruses53-55, and restrain the growth of fungi56 
and parasites57. Moreover, recent research has also shown that (−)-lycorine has potential as 
a therapeutic agent against cancer cells, which are resistant to apoptotic stimuli. Bunce and 
co-workers demonstrated that the combination of lycorine with bezafibrate and 
medroxyprogesterone acetate has the ability to induce apoptosis of Chronic Lymphocytic 
Leukemia (CLL) cells during continuous exposure of CD40L.58  
 
2.2 Precedent Studies of the Total Synthesis of Lycorine 
 
2.2.1 Boeckman’s Total Synthesis of (±)-Lycorine59 
 
The racemic total synthesis of (±)-lycorine has been achieved by several different groups.60-62 
The first racemic total synthesis of (±)-lycorine and arguably the most elegant synthesis 
reported was developed by Boeckman and co-workers in 1988 (Scheme 19).59 
 
 
 
Scheme 19. Overview of Boeckman’s racemic total synthesis of (±)-lycorine.59 
 
Reagents and conditions: a) CH3CN, 23 °C, 15 h, 56%; b) 40% TFA/CH2Cl2, 23 °C, 40 min, 
76%; c) Pd(CH3CN)2Cl2, toluene, 23 °C, 5 h, 45% (45% starting material recovery); d) DBU, 
CHCl3, 23 °C, 2 h; e) 2-chlorotoluene, reflux, 56 h, 50−60%; f) LAH, THF 
 
They utilised their cyclopropyl acyliminium ion rearrangement chemistry to construct diene 88 
for the key Diels-Alder cyclisation.63 In their proposed mechanism, the cyclopropane and the 
double bond in cyclopropyl acyliminium ion 86 rearrange to form the five-membered 
acyliminium ion 87. Then ion 87 traps chloride ion to give amide 88. Deprotection and then 
isomerisaion of the enamine double bond provided the precursor 89 for the 5-exo-tet ring-
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closure to form pyrrolidine 90. With the correct regiochemistry of the diene, the relative 
stereochemistry of the four stereocentres in (±)-lycorine were establised simultaneously to 
give lactam 91. Removing all masking groups completed the racemic total synthesis of (±)-
lycorine in fourteen steps from 83 with an overall yield of 9% to 91 prior to the reduction. The 
yield of the reduction was not reported. 
 
2.2.2 Schultz’s Asymmetric Total Synthesis of  (+)-Lycorine64,65 
 
The first asymmetric total synthesis of lycorine was accomplished by Schultz and co-workers 
in 1996, although they made (+)-lycorine, which is the unnatural enantiomer of (−)-lycorine 
(Scheme 20).64,65 
 
 
 
Scheme 20. Overview of Schultz’s asymmetric total synthesis of (+)-lycorine.64 
 
Reagents and conditions: a) K, NH3, tBuOH (1 equiv), −78 °C; then BrCH2CH2OAc, −78 °C to 
25 °C; KOH, MeOH, 25 °C, 96%; b) AIBN, n-Bu3SnH, benzene, reflux, 51% 
 
In 1988 the Schultz group developed a diastereoselective Birch reductive-alkylation reaction 
of chiral benzamides with L-prolinol as the chiral auxiliary to make enantiopure dearomatised 
substances and applied their chemistry to introduce the chirality in their total synthesis of (+)-
Lycorine.66 L-proline derived amide 92 was alkylated diastereoselectively to give enantiopure 
amide 93 by their Birch reductive-alkylation reaction sequence and, remarkably, only one 
diastereomer was observed. After removing the chiral auxiliary, forming the pyrrolidine, and 
introducing benzodioxole, the precursor for the key radical cyclisation to construct the B-ring 
was obtained. The facially selective radical cyclisation to cyclise the B-ring gave an excellent 
stereoselectivity and only the desired diastereomer was isolated. (+)-Lycorine was then 
obtained after several manipulations of the functional groups and the stereocentres. The 
overall yield was 1.4% over fifteen steps from benzamide 92. 
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2.2.3 Tomioka’s Asymmetric Total Synthesis of (−)-Lycorine67 
 
Tomioka and co-workers developed the first asymmetric total synthesis of naturally occurring 
(−)-lycorine in 2009 (Scheme 21).67 
 
 
 
Scheme 21. Tomioka’s asymmetric total synthesis of (−)-lycorine.67 
 
Reagents and conditions: a) TMSCl, toluene, −78 °C, 0.5 h; b) POCl3, 90 °C, 8 h, 95% 
 
They developed a highly efficient asymmetric tandem conjugate addition of aryl lithium 96 to 
symmetric bis-enolate 97 exploiting ligand-control to introduce the required chirality.68 In the 
presence of ligand 98, the aryllithium reagent enantioselectively added to Michael acceptor 97 
to form the proposed enolate 99. Inclusion of chlorotrimethylsilane driving enolate formation 
proved to increase the enantioselectivity of this reaction. Subsequently, the six-membered 
ring was formed by a second intramolecular and diastereoselective Michael addition, in which 
the enolate in intermediate 99 added to the other Michael acceptor. Three chiral centres in 
compound 100 were constructed correctly in one reaction and the yield was 97% with 9:1 dr 
and 92% ee.  
 
After several steps of functional group transformation, including a Curtius rearrangement to 
remove one carbon, the pyrrolidine ring was constructed by lactam formation and reduction, 
and the ee was improved to 99% by recrystallisation. A Bischler-Napieralski reaction was 
used to construct the B-ring in compound 102. (−)-lycorine was finally synthesised after 
several more functional group transformations with 2.6% overall yield in 18 steps from bis-
enoate 97.  
 
2.2.4 Oppolzer’s Total Syntheses of (±)-α-Lycorane and (+)-Trianthine5 
 
Oppolzer and co-workers discovered the Cope-type hydroamination reaction in 199469 and 
developed an intramolecular Cope-type hydroamination for the total synthesis of (±)-α-
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lycorane and (+)-trianthine, which are two members of Amaryllidaceae alkaloids in the 
lycorine class (Scheme 22).5 
 
 
 
Scheme 22. Overvies of Oppolzer’s total syntheses of (±)-lycorane and (+)-trianthine.5 
 
Reagents and conditions: a) mesitylene, 140 °C, 17 h, 83%; b) benzene, reflux, 70 h, 93% 
 
In their research, they first established that the intramolecular Cope-type hydroamination was 
stereospecific (i.e. suprafacial), and applied this chemistry to construct pyrrolidine rings with 
the two new stereocentres from acyclic hydroxylamines 103 and 105 to pyrrolidine 104 and 
106 respectively. Their Cope-type hydroaminations were very successful and then the B-rings 
in both natural products were constructed using Eschenmoser’s salt to promote the Pictet-
Spengler-type ring closure. The overall yields for both syntheses were excellent: 43% for (±)-
α-lycorane in six steps from hydroxylamine 103 and 24% for (+)-trianthine over twelve steps 
from hydroxylamine 8. 
 
2.3 Spivey’s Proposed Total Synthesis of (−)-Lycorine 
 
2.3.1 The Initial Plan 
 
It was considered that the asymmetric total synthesis of (−)-lycorine could be accomplished 
by using a key stereospecific Cope-type hydroamination as used by Oppolzer in the 
aforementioned (±)-α-lycorane and (+)-trianthine syntheses  (Scheme 23). 
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Scheme 23. Spivey’s proposed total synthesis of (−)-lycorine – a retrosynthetic  
                     overview. 
 
In our retro-synthetic anyalysis for the total synthesis of (−)-lycorine, the C2 stereocentre 
would be established by the regioselective Mitsunobu reaction on the allylic alcohol, and the 
double bond at C3-C3a would be introduced by an anti-elimination. The B-ring was planned to 
be constructed by a Bischler-Napieralski reaction. We expected to take advantage of 
Oppolzer’s stereoselective Cope-type hydroamination to cyclise the pyrrolidine ring (D-ring) in 
compound 108 from the acyclic hydroxylamine 109, and in the mean time the two 
stereocentres at C12b and C12c relative to C3a should be constructed simultaneously. 
Hydroxylamine 109 could be made from the palladium-catalysed coupling reaction between 
benzodioxole moiety 110 and vinyl triflate 111. Vinyl triflate 111 could be made by the unusual 
stereoselective Michael addition of dithioester enolate 112 adding to protected 4-
hydroxycyclohexenone 113, and trapping the resulting enolate by Comins reagent.70 If chiral 
TBS-protected 4-hydroxycyclohexenone 113 is used as the starting material, the asymmetric 
total synthesis of (−)-lycorine should be achieved. 
 
2.3.2 Previous Work in the Group 
 
The total synthesis of Amaryllidaceae alkaloids has been a research interest in the Spivey 
group for several years, and significant progress had been achieved towards the total 
synthesis of (−)-lycorine before I was involved in this project. Ortner71 (Spivey group, 1996-
1997) initially developed the stereoselective dithioacetate conjugate addition reaction on the 
fully functionalised enone 113. He also developed a TlOH-mediated Suzuki coupling reaction 
on a model vinyl triflate system and then converted the thioamide to the amide. Later, Colley 
(Spivey group, 2000-2002) conducted a formal total synthesis of (±)-α-lycorane using Ortner’s 
stereoselective dithioacetate conjugate addition reaction and the TlOH-mediated Suzuki 
coupling reaction (Scheme 24)72. 
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Scheme 24.  Colley’s formal synthesis of (±)-α-lycorane.72 
 
Reagents and conditions: a) dithioenolate 112, THF, -45 °C; b) Comins’ reagent , THF, -78 °C 
à r.t.; c) morpholine, THF, r.t., 17 h, 83% over three steps, one pot; d) Pd(PPh3)4, LiBr, TlOH, 
r.t., 62%; e) DIBAL-H, THF, -78 °C, 58% 
 
She obtained amide 116 rather than the expected thioamide. Colley then reduced amide 116 
to aldehyde 117 using DIBAL-H in THF at -78 °C in 58% yield. Oximation, Borch reduction, 
Cope-type hydroamination, and then reduction should afford (±)-α-lycorane. 
 
Phipps (Spivey group, 2005-2006) continued the challenge of synthesising lycorine. He 
optimised the conjugate addition to include in situ amide formation using morpholine, showed 
that the TlOH-mediated Suzuki coupling did not work well on the fully functionalised vinyl 
triflate 111, developed a Pd2dba3/AsPh3-mediated Stille coupling on the fully functionalised 
vinyl triflate 111, and repeated Colley’s steps but on the fully functionalised system through to 
the Cope-type hydroamination step.73 
 
Martin (Spivey group, 2004-2008) repeated Phipps’ steps and examined various conditions 
for the Stille coupling although the yield was still irreproducible.74 She also improved the 
amide reduction using the DIBAL-H-nBuLi ate complex and repeated the Cope-type 
hydroamination. Unfortunately, the cyclised product 108 decomposed during the 
recrystallisation and so no further progress was made. Additional details relating to each 
synthetic step will be described as encountered in the discussion below. 
 
2.4 The Study of the Total Synthesis of (−)-Lycorine 
 
2.4.1 cis-Stereoselective Michael Addition67,73,74 
 
The present study started with TBS-protected 4-hydroxycyclohexenone 113. As described in 
the previous chapter, this compound was prepared in two steps and 56% overall yield from 
endoperoxide 11 in 64% ee, and thus we commenced our synthesis with a cis-stereoselective 
Michael addition of the dithioenolate 112 to the Michael acceptor 113 to give the enolate 118 
at -78 °C, which gave a higher yield and better stereoselectivity than the corresponding all 
oxygen enolate. The reaction solution was then warmed up to -40 °C  and then cooled down 
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to -78 °C again before adding Comins reagent70, according to the method developed by 
Ortner71, Phipps73, and Martin74 (Scheme 25). 
 
 
 
Scheme 25. cis-Stereoselective Michael addition and the traping of the enolate 118 by  
                     Comins reagent.71,73,74 
 
Reagents and conditions: a) dithioenolate 112 (1.2 equiv), THF, -45 °C à -10 °C, 2 h; b) 
Comins reagent (1.6 equiv), THF, -78 °C à 0 °C, 2 h; c) morpholine (5.0 equiv), THF, 0 °C to 
r.t., 17 h, 98% over three steps, one pot 
 
The resultant enolate 118 was then trapped with Comins reagent70 at -78 °C to 0 °C to form 
the vinyl triflate 111, which will be the electrophile in the subsequent palladium-catalysed 
cross coupling reaction. Converting the dithioester moiety into thioamide 119 with morpholine 
at room temperature for seventeen hours accomplished the efficient three-step and one-pot 
transformation in 98% yield from TBS-protected 4-hydroxycyclohexenone 113.  
The origin of the 1,2-cis-stereoselectivity in this reaction was envisioned to result from steric 
hindrance of the acetonide protection in TBS-protected 4-hydroxycyclohexenone 113 rather 
than from any intermolecular complexation between the lithium cation and the silylether. The 
nucleophile (dithioenolate 112) attacked from the convex side of the bicyclic system to give 
the desired cis-stereoselectivity whereas the previous studies by Martin have shown that 
dithioenolate 112 attacks the less sterically biased 4-O-TBS-2-cyclohexenone (114), lacking 
the acetonide, with complete trans-stereoselectivity (Scheme 26).75 
 
 
 
Scheme 26. Martin’s trans-Stereoselective Michael addition to 4-O-TBS-2- 
                     cyclohexenone (114).75 
 
Reagents and conditions: a) dithioenolate 112 (1.0 equiv), THF, -78 °C, 17 h; then saturated 
NH4Cl(aq), -78 °C à 0 °C, 77% 
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2.4.2 Investigation of the Stille Coupling Reaction 
 
2.4.2.1 The Baldwin Modification 
 
Unlike in previous published syntheses of lycorine in which the 1,3-benzodioxole moiety was 
already present in the starting material, or was introduced by amide bond formation, or by an 
addition reaction of an aryllithium anion, the 1,3-benzodioxole moiety in our total synthesis 
would be introduced by using palladium-catalysed cross coupling reaction between vinyl 
triflate 119 and the benzodioxole organometallic reagent.76 This step proved to be one of the 
most challenging steps in our total synthesis. The Suzuki coupling between vinyl triflate 119 
and boronic acid 121 had been examined by Ortner and then Phipps using thallium hydroxide 
as the base (Scheme 27).71,73 
 
 
 
Scheme 27. Phipps’ attempts at Suzuki coupling between vinyl triflate 119 and boronic  
                     acid 121.73 
 
Reagents and conditions: a) Pd(PPh3)4 (0.1 equiv), LiBr (3.0 equiv), TlOH (1.0 equiv), 
THF/H2O, r.t., 17 h 
 
Phipps examined this Suzuki coupling several times and, unfortunately, this Suzuki coupling 
was not successful; only the desulfurisation product 123 was observed and none of the 
desired coupling compound 122 was found.  
  
Phipps and Martin then focused on investigating the Stille coupling between vinyl triflate 119 
and aryltrialkylstannane 124. In particular, Martin extensively screened various catalysts, 
additives, solvents, and temperature. Selected conditions are illustrated in Table 11.74 
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Entry Pd source T (°C)/h Additives Solvent Results 
1 Pd2(dba)3 75/17 AsPh3, LiCl THF 50~60%1 
2 Pd2(dba)3 80-
110/1.5 
AsPh3, LiCl, CuI Dioxane Starting material1 
3 Pd2(dba)3 80/1 AsPh3, LiCl NMP 28% + ketone1 
4 Pd2(dba)3 130/1 AsPh3, LiCl NMP 44% + ketone1 
5 Pd2(dba)3 80/12 AsPh3, LiCl, CuI NMP 39% + ketone1 
6 Pd2(dba)3 80/5 AsPh3, K2CO3, CuI NMP 45%1 
7 Pd(PhCN)2Cl2 90/18 AsPh3, LiCl, CuI NMP 62%1 
8 Pd(PPh3)4 40/4 CsF, CuI DMF 20-80% depending on 
scale, irreproducible results 
1The yields were determined by 1H NMR 
 
Table 11. Martin’s screen of various catalysts, additives, solvents, and temperature for  
                 the Stille coupling between vinyl triflate 119 and alkylstannane 124.74 
 
Initially the yields of the Stille coupling were very low and irreproducible (Entries 1 to 7). She 
then discovered that Baldwin modified Stille coupling conditions could give higher yields and, 
in small scale experiments, the yields were as high as 80% (Entry 8).  
 
Baldwin and co-workers discovered the synergistic effect of copper(Ι) salts and fluoride ion in 
the Stille coupling (Table 12).77 
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Entry Reagents1 Yields (%) 
1 Pd(PPh3)4 2 
2         Pd(PPh3)4, CsF 8 
3        Pd(PPh3)4, CuI 46 
4                Pd(PPh3)4, CsF, CuI 98 
5 CsF, CuI 0 
1 Pd(PPh3)4 (0.1 equiv), CuI (0.2 equiv), CsF (2.0 equiv). 
 
Table 12. The effects of CuI and CsF on the model reaction between aryl iodide 125 and  
                 aryltrialkylstannane 126 as reported by Baldwin.77 
 
Baldwin and co-workers demonstrated that, with Pd(PPh3)4 (0.1 equiv), CuI (0.2 equiv), and 
CsF (2 equiv), the yields of this model reaction could be improved to 98% (Entry 4) compared 
to 46% without CsF (Entry 3). Baldwin suggested a mechanism in which a synergistic 
interaction of the copper and fluoride conspires to improve the Stille couplings (Scheme 28).77 
 
 
 
Scheme 28. Baldwin’s synergistic effect of copper(Ι) salts and fluoride ions in Stille- 
                     type cross-couplings.77 
 
The reason that CsF could significantly improve the yields of the Stille coupling in the 
presence of CsF is that CsF can shift the equilibrium from aryltrialkylstannane 128 to 
alkylcuprate 129 by precipitating alkylstannane 130 as the polymeric alkylstannane fluoride 
(Scheme 25). The increased concentration of the alkylcuprate species in the Stille coupling 
can facilitate the transmetallation step and hence accelerates the reaction rate. 
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However, the yields of our Stille coupling under Baldwin’s modified condition were not 
reproducible when reactions were performed on anything other than a very small scale. Yields 
could drop to 20% even on a 300 mg scale even with higher loading of the palladium catalyst.  
 
I also examined various conditions for the Stille coupling and selected examples are 
illustrated below (Table 13). 
 
 
 
Entry Pd source1 T (°C)/h Additives Solvent Outcome (yield)2 
1 Pd(PPh3)4 25/17 CsF, CuI DMF ~ 20% 
2 Pd2(dba)3 50/4 AsPh3, CsF, CuI DMA 25% + complex mixtures 
3 Pd(PPh3)4 100/20 LiCl, CuI DMF Complex mixtures 
4 Pd2(dba)3 90/7 AsPh3, LiCl, CuI DMA 23% + complex mixtures 
5 Pd2(dba)3 140/7 AsPh3, LiCl, CuI DMA 43% + complex mixtures 
110 mol% Pd was used. 2Chromatographied over Al2O3. 
Table 13. Attempts to improve the yield of the Stille coupling between vinyl triflate 119  
                 and aryltrialkylstannane 124. 
 
Repeating Baldwin’s conditions following Martin’s procedure resulted in only low yields of 
product being obtained (Entries 1 and 2). Significant amounts of desilylation product formed in 
the reaction. The desilylation indicated that CsF was a powerful desilylation reagent 
especially in a polar solvent such as DMF at elevated temperature. Clearly, CsF was not a 
compatible reagent with our substrate. 
 
After numerous failed attempts to avoid desilylation, LiCl was examined as the additive rather 
than CsF to avoid the desilylation (Entry 3). However, complex mixtures were obtained. More 
conditions for the Stille coupling were therefore examined and it was found that when the 
reaction mixture was heated to 140 °C quickly with Pd2(dba)3 (0.1 equiv), AsPh3 (0.4 equiv), 
CuI (0.1 equiv), and LiCl (3 equiv) in dimethylacetamide (DMA), a 30~43% isolated yield 
could be obtained (Entry 5). When the reaction mixture was heated gradually to 140 °C, no 
desired product was observed and complex mixtures were formed again. Initially, these 
conditions seemed not to give reproducible results and the isolated yields were occasionally 
very low. Intriguingly, when the 1H NMR spectra of the crude reaction mixtures were carefully 
analysed by comparing the integration of the product to dba ligand, the calculated yields were 
all around 40%. This indicated that the product may be lost in the purification. Finally we 
realised that the coupled product was unstable on silica gel chromatography and 
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decomposed to highly polar materials that were retained on the silica gel column. I also 
discovered that purification by Al2O3 gel chromatography could provide reproducible yields for 
the Stille coupling. 
 
We also speculated that sulfur atom in thioamide 119 might poison the palladium catalysts 
and make the catalytic cycle inefficient. In this situation the reaction would require a longer 
reaction time to complete and the desilylation would be more likely to compete. Also, if the 
catalysis could be more efficient by avoiding poisoning by sulfur, the reaction temperature 
could be lower and possibly avoid the desilyation. With this hypothesis, amide 129 rather than 
thioamide 115 was examined in the Stille coupling (Scheme 29).  
 
 
 
Scheme 29.  Amide 131 as the alternative coupling partner for the Stille coupling with  
                      aryltrialkylstannane 124. 
 
Reagents and Conditions: a) Pd(PPh3)4 (0.1 equiv), CuI (0.2 equiv), CsF (2.0 equiv), DMF, 50  
°C, 16% for 131; b) Ag2CO3 on Celite (Fetizon’s reagent), water, acetonitrile, r.t., 17 h, 
85~90% 
 
In this alternative route, desulfurisation could be achieved with Fetizon’s reagent78 in 
acetonitrile and water at ambient temperature for 17 h. Amide 129 was then examined in the 
Stille coupling under Baldwin’s conditions. Unfortunately, the Stille coupling between amide 
131 and aryltrialkylstannane 124 only gave similar outcomes to thioamide 119. There was no 
improvement for the Stille coupling. 
 
2.4.2.2 Changing the TBS Protecting Group to the TIPS Protecting Group 
 
Being aware of the fact that the byproducts from the Stille coupling were highly polar, we 
speculated that partial deprotection of the TBS protecting group could be responsible for 
those polar byproducts. Therefore, the more robust TIPS protecting group was examined to 
improve the stability of the substrate (Scheme 30).  
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Scheme 30. TIPS-protected vinyl triflate 133: Synthesis and the Stille coupling with  
                     aryltrialkylstannane 124. 
 
Reagents and conditions: a) Hünig’s base (0.5 equiv), DMF, r.t., 7 h; b) TIPSOTf (2.0 equiv), 
2,6-lutidine (3.0 equiv), DMF, r.t. for 17 h and then 40 °C for 2 h, 41% over two steps from 11, 
one pot; c) dithioenolate 112 (1.2 equiv), THF, -45 °C à -10 °C, 2 h; d) Comins reagent (1.6 
equiv), THF, -78 °C à 0 °C, 2 h; e) morpholine (5 equiv), THF, 0 °C à r.t., 73% over three 
steps from 130, one pot; f) Pd2(dba)3 (0.1 equiv), AsPh3 (0.4 equiv), LiCl (3 equiv), CuI (0.1 
equiv), DMA, 140 °C 
 
Direct deprotection of the TBS protecting group in thioamide 119 and reprotection of the 
hydroxyl group with TIPSCl or TIPSOTf was not successful as the compound containing the 
free hydroxyl group was unstable at room temperature. In order to examine our hypothesis, 
the TIPS protected 4-hydroxyhexenone 132 was therefore synthesised from endoperoxide 11 
by the base-catalysed KDLM rearrangement, followed by the reaction with TIPSCl at ambient 
temperature. Vinyl triflate 133 was synthesised by the stereoselective Michael addition, 
trapping of the corresponding enolate by Comins’ reagent, and forming thioamide with 
morpholine as described previously for the synthesis of thioamide 119. Unfortunately, vinyl 
triflate 133 did not give a better result; no coupled compound 134 was formed either under 
Baldwin’s conditions or our modified Stille coupling conditions. We did not spend much time 
attemping to optimise the Stille coupling with vinyl triflate 133, because, in this scenario, if the 
TIPS protecting group was not more stable than the TBS protecting group under the same 
reaction conditions, then the reactivity would not be better than for the TBS-protected 
thioamide 119. 
 
2.4.2.3 The Successful Suzuki Coupling  
 
Although a significant improvement had been achieved from the very low and irreproducible 
yields (sometimes no product) to reproducible and moderate yields (up to 43%) with Pd2dba3 
as the catalyst at 140°C (Table 13), this moderate yield remained unsatisfactory. We 
therefore continuously searched in the literature to find suitable conditions for this challenging 
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coupling reaction. In this context, we were interested in a report by Médard on the synthesis 
of (-)-astrogorgiadiol.79 One of the key steps in Médard’s total synthesis of (-)-astrogorgiadiol 
was the coupling of vinyl triflate 136 with an organometallic reagent formed by metallation of 
alkylbromide 137 (Scheme 31). 
 
 
 
Scheme 31. Médard’s strategic bond disconnection in the total synthesis of (-)- 
                     astrogorgiadiol.79 
 
Initially, Médard examined Fürstner’s chemistry, Kumada, Negishi, and Stille coupling to 
construct the desired sp2-sp3 C-C bond between the two components, but these methods 
proved fruitless. Notably in his Stille chemistry he examined an activated alkylstannane 
reagent, which was prepared from the alkylbromide 137 and Sn(N(TMS)2)2, with TBAF as the 
additive in the presence of Pd2(dba)3 and triphenylarsine in refluxing THF/DMF co-solvent80,81. 
However, this method, similar to the Baldwin conditions in our Stille coupling, did not give the 
desired coupling compound 141. 
 
Médard then investigated Suzuki coupling between vinyl triflate 136 and pinacol boronate 139 
(Scheme 32).79 
 
 
 
Scheme 32. Médard’s Suzuki-type coupling reaction to construct the skelton of (-)- 
                     astrogorgiadiol.79 
 
Reagents and conditions: a) PinBH, [Ir(COD)Cl]2/dppe, THF, r.t., 77%; b) PdCl2dppf.CH2Cl2, 
Cs2CO3, THF/H2O, reflux, 25% for compound 141; c) tBuLi, ether, -78°C, then 9-BBN-OMe, 
THF, -78 - 0°C; d) PdCl2dppf.CH2Cl2, K3PO4, H2O/DMF, r.t., 79% for compound 141. 
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Coupling product 141 was obtained in low yield (25%) and product 142 from the direct 
reduction was the major product. However, a more reactive 9-BBN ate complex 14082, as 
described by Marshall in his total synthesis of (+)-discodermolide, could couple with vinyl 
triflate 136 to give the desired product in a good yield (79%).  
 
These reaction conditions were therefore applied to our coupling reaction (Scheme 33).  
 
 
 
Scheme 33. The Suzuki coupling between triflate 115 and ate complex 142. 
 
Reagents and conditions: a) tBuLi, Et2O, -78°C, then 9-BBN-OMe, Et2O, -78°C – r.t.; b) 
PdCl2dppf.CH2Cl2, K3PO4, H2O/DMF, r.t., 60%; c) Ag2CO3 on Celite (Fetizon’s reagent), 
MeCN, r.t., 17% from 141; combined yield, 77% 
 
Thus, 1-bromo-3,4-(methylenedioxy)benzene (143) was subjected to bromo-lithium exchange 
by the treatment with tert-BuLi at −78°C, and then the resultant aryl lithium species reacted 
with 9-BBN-OMe at −78°C to ambient temperature to give ate complex 144. Ate complex 144 
was coupled with vinyl triflate 119 under the catalysis of PdCl2(dppf).CH2Cl2 at r.t.. The 
conditions were efficient for our Suzuki coupling and the isolated yield was 60%.  A mixture of 
thioamide 122 and amide 130 was also isolated. This mixture was then subjected to Fétizon 
reagent78 to give the amide 130 (17%). The combined yield of the coupling reaction including 
thioamide 122 and amide 130 was 77% in total. 
 
The reason for the significant improvement in yield obtained via this method compared to a 
classic Suzuki coupling could be the better transmetallation from the ate complex 144 to the 
palladium catalyst.82 An improvement in the oxidative addition of the vinyl triflate seems 
unlikely as it has been demonstrated that the oxidative addition of Pd(0) to vinyl triflates can 
occur at ambient temperature.83 However, PdCl2(dppf).CH2Cl2 has also been reported to 
facillitate the reductive elimination step in the palladium-catalysed coupling reactions because 
of the large bite angle, and this advantage may benefit the catalytic cycle.84 Avoiding 
preparation of the aryltrialkylstannane reagent and the tedious purification to remove toxic tin 
residues in the Stille coupling is another advantage of this method. 
O
TfO
O
OTBS
NS
O
O
O
Br a B OMeO
O
+ b
O
O
OTBS
NS
O
O
O
Fe
PPh2
PPh2
dppf
O
O
OTBS
NO
O
O
O
+
O
O
OTBS
NO
O
O
O
c
130, yield: 17% from 143
122, yield: 60%
impure 122
119143 144
	   55	  
2.4.3 Direct Reduction of Amide 128 to Aldehyde 144 
 
With the coupled thioamide 122 in hand, the desulfurisation was achieved by reacting 
thioamide 122 with Fétizon reagent78 in acetonitrile and water at room temperature for 
seventeen hours to give amide 130 in 95% yield (Scheme 34). 
 
 
 
Scheme 34. Desulfurisation of thioamide 122 to give mopholine amide 130. 
 
Reagents and conditions: a) Ag2CO3 on Celite (2.5 equiv) (Fétizon reagent), water/acetonitrile 
= 1/10, r.t., 17 h, 95% 
 
The following reduction of morpholine amide 130 to the aldehyde was expected in one step. 
Normally, when contemplating the synthesise of an aldehyde from an ester, one might 
envision taking two steps: first the ester is reduced to an alcohol, and then the alcohol is re-
oxidised to an aldehyde by mild oxidising reagent, for example, pyridinium chlorochromate 
(PCC). The reason is that aldehydes are naturally more prone to reduction than esters and 
therefore “over-reduction” to the alcohol is difficult to avoid. In addition, many reducing agents 
reduce amides to amines, and aldehydes are not commonly synthesised from amide 
reduction. However, when the reduced intermediates from the reaction of amides with metal 
hydride reagents, such as intermediate 145, can be maintained as the complexes at low 
temperature without collapsing into imines or aldehydes, no further reduction can occur 
(Scheme 35).  
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Scheme 35. Reduction of amide 130 by DIBAL-H-nBuLi ate complex to aldehyde  
                     146 and the proposed intramolecular stabilised intermediate 145.74,85 
 
Reagents and conditions: a) DIBAL-H (3.0 equiv) or DIBAL-H-nBuLi (1.25 equiv) ate complex, 
THF, low temperature 
 
In this scenario, only one hydride ion should be delivered to the carbonyl group and then 
quenching the complex with a proton source at low temperature should afford the aldehyde in 
one step. One type of amide that is suited to this type of reaction is the Weinreb amide class86, 
which can stabilise the reactive complexes by the oxygen atom coordinating to the metal 
centre at low temperature to give an aldehyde rather than an amine after aqueous work-up.  
 
We anticipated that morpholine amide 130 could have a similar reactivity profile to a Weinreb 
amide. The oxygen atom on the morpholine amide could stabilise the aluminum complex 145 
and avoid it collapsing into the imine before quenching the reaction with a proton source at 
low temperature. Phipps initially examined DIBAL-H as the reducing agent in THF at low 
temperature and aldehyde 146 was successfully obtained as expected. However, the yield 
was only 55% and a significant amount of over-reduced amine 147 was formed even when 
the reaction temperature was decreased to -55 °C (Scheme 34).73  
 
A reducing agent that can form a more stable intermediate 145 was required. Kim has 
developed a DIBAL-H-nBuLi ate complex as a particularly mild reducing agent, in which 
DIBAL-H complexes with nBuLi prior to reacting with the substrate; this reducing agent was 
shown to give more chemoselective reductions than DIBAL-H in some cases85. Kim also 
demonstrated that this ate complex could reduce tertiary amides to the corresponding 
aldehydes at low temperature. Fortunately, when Martin applied Kim’s method on amide 130, 
a very clean crude aldehyde 146 was obtained.74 When I conducted this experiment, the 
conversion was quantitative and no over-reduced amine was observed by the 1H NMR 
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(Scheme 32). Aldehyde 146 was unstable on silica-gel chromatography and hence the crude 
material was used directly in the next step. 
 
2.4.4 Borch Reduction of Oxime 146 to Alkylhydroxylamine 159 
 
In our retro-synthetic analysis of the total synthesis of (−)-lycorine, the pyrrolidine ring would 
be constructed by a Cope-type hydroamination and this requires alkylhydroxylamine 109 as 
substrate. This compound would be synthesised by oxime formation and then reduction 
(Scheme 36).  
 
 
 
Scheme 36. Synthesis of oxime 148 from aldehyde 146. 
 
Reagents and conditions: a) NH2OHHCl (3 equiv), NaOAc (3 equiv), MeOH, r.t., 96% 
 
Oxime 148 was synthesised by reacting aldehyde 146 with hydroxylamine hydrochloride and 
sodium acetate as the base in MeOH at r.t. for 15 mins. The 1H NMR spectrum of the crude 
material was cleaner than the 1H NMR of oxime 148 following silica-gel chromatography. The 
yield was only 67% after chromatography. We therefore decided to subject the crude oxime 
148 to the conditions of the Borch reduction without purification. 
  
Borch developed an efficient method to reduce oximes 149 to alkylhydroxylamines 150 using 
sodium cyanoborohydride (NaCNBH3) under acidic conditions (Scheme 37).87 
 
 
 
Scheme 37. The proposed mechanism for Borch reduction of oximes to give  
                     alkylhydroxylamines and the potential side reactions at pH = 4.87 
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His method is highly pH dependent and the appropriate pH range for this reaction is pH = 3~4. 
When the pH is higher than 4, alkylhydroxylamine 150 can react with oxime 149 to form 
dialkylhydroxylamine 151. Losing a molecule of hydroxylamine from dialkylhydroxylamine 151 
and then reducing the iminium ion 152 gives dialkylhydroxylamine 154 (path a, Scheme 36).  
 
When Giró Mañas in our group applied Borch reduction to reduce oxime 155 to 
alkylhydroxylamine 156 in his total synthesis of clivonine, he found that the pH control was 
crucial to the yields of alkylhydroxylamine 156 obtained and observed several side products 
(Scheme 38).88 
 
 
 
Scheme 38. Giró Mañas’ observation of the Borch reduction of oxime 155 in the total  
                     synthesis of clivonine.88 
 
Reagents and conditions: a) NaCNBH3, MeOH, pH = 3.0, 0 °C 
 
Initially, the reduction was not very successful, but he did not isolate the condensed 
dialkylhydroxylamine as Borch proposed. Instead, by using methyl orange as pH indicator, 
when the pH was higher than 4 (orange colour), a dimeric amidine 157 was formed as the 
major product by losing a molecule of water rather than a molecule of hydroxylamine (path b, 
Scheme 34). In addition, when the reaction solution was more acidic than pH = 3, 
alkylhydroxylamine 156 condensed with acetone to form nitrone 158. Interestingly, acetone 
was not the reaction solvent in this Borch reduction and so the acetone could only come from 
the acetonide protection in the substrate or one of its products. This indicated that the 
acetonide was unstable when the reaction environment was highly acidic and the pH control 
was hence crucial for both the Borch reduction and maintaining the acetonide protection. 
Finally, Giró Mañas explored suitable conditions for this reduction by carefully controlling the 
pH of the solvent and the concentration, and obtained 83% isolated yield for hydroxylamine 
156. 
 
I examined the reduction of oxime 148 by the Borch reduction following Martin’s procedure to 
synthesise alkylhydroxylamine 159 (Scheme 39).74 
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Scheme 39. Reduction of oxime 148 to give alkylhydroxylamine 159 by the  
                     Borch reduction.74 
 
Reagents and Conditions: a) NaCNBH3, MeOH, pH = 3, 0 °C, ~90% by 1H NMR 
 
Acetic acid was used to acidify the reaction solution in methanol at 0 °C, and the crude 
material was very clean on a small scale (~10 mg). However, this excellent result was 
irreproducible in scales larger than 100 mg and sometimes only side products were isolated. 
One possible explanation was that the decomposition was occurring during the work up 
procedure due to the elevated temperature and the solution was still acidic when 2 M 
NaOH(aq) was added to neutralise acetic acid. Being aware of this possibility, a reverse 
addition of the reaction solution into a cold 2 M NaOH(aq) solution was examined as the work-
up. This procedure gave reproducible clean crude material. Noticeably, alkylhydroxylamine 
159 was stable toward heating in neutral environment otherwise the Cope-type 
hydroamination in the next step to construct pyrrolidine ring would be impossible because the 
Cope-type hydroamination requires high reaction temperature. 
Alkylhydroxylamine 159 was unstable upon silica-gel chromatography. Purification by 
precipitation with HCl in aprotic solvent such as benzene, toluene, Et2O, or EtOAc was 
fruitless and only yellow oily materials were obtained. Hence the crude materials from the 
Borch reduction were subjected to the Cope-type hydroamination without further purification. 
 
For the improvement of the reduction of oxime 148 to alkylhydroxylamine159, a very recent 
report of using a FLP containing compound (frustrated Lewis pair) as the catalyst to reduce 
oximes to alkylhydroxylamines may provide an alternative synthetic route.89 
2.4.5 Cope-Type Hydroamination 
 
Cope-type hydroamination was first discovered by House in 1976 and it is the reverse 
reaction of the Cope elimination (Scheme 40).90 
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Scheme 40. Cope-type hydroamination and its five-membered cyclic transition state.90 
 
The mechanism of this thermally induced reaction was proven to be concerted by Ciganek91 
and Oppolzer.5 The reaction goes through a five-membered cyclic transition state. In principle, 
Cope-type hydroamination is stereoselective for the two newly installed stereogenic centres 
and studies have shown that the proton transfer from the nitrogen to the oxygen in compound 
160 is the rate-determinating step. Because of its excellent stereoselectivity, Cope-type 
hydroamination has been applied in natural product syntheses to construct the pyrrolidine 
rings in Amaryllidaceae alkaloids.5,90 
 
2.4.5.1 Beauchemin’s study of Cope-Type Hydroamination 
 
Beauchemin has proposed that the proton transfer step is crucial to the intermolecular Cope-
type hydroamination, and demonstrated this effect in his model study of the intermolecular 
Cope-type hydroamination between norbornene (162) and cyclohexylhydroxylamine (163) 
(Scheme 41).92 
 
 
 
Scheme 41. NaCNBH3 as the additive in Beauchemin’s intermolecular Cope-type 
                     hydroamination.92 
 
Reagents and conditions: a) nPrOH, 110 °C, 21 h 
 
Other groups’ molecular mechanism calculations also support this idea. Beauchemin thought 
that protic solvents, such as nPrOH, could mediate the proton transfer and the yields could be 
significantly improved for the Cope-type hydroamination.  
 
He also demonstrated that, in some cases, adding NaCNBH3 could improve the yields. This 
was probably due to the fact that reducing reaction environment could suppress the oxidative 
decomposition of alkylhydroxylamines. We observed that alkylhydroxylamine 156 would 
oxidise and decompose in the presence of peroxides in diethyl ether.  
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2.4.5.2 Jacobsen’s Thiourea-catalysed and Enantioselective Cope-type  
            Hydroamination93 
 
Very recently, Jacobsen described the enantioselective thiourea-catalysed intramolecular 
Cope-type hydroamination.93 Based on the previous experimental studies that polar solvents 
could enhance the reaction rate of Cope-type hydroamination and also on the computational 
studies that hydrogen-bonding interaction could stabilise the transition state in Cope 
elimination, they proposed that ureas or thioureas would accelerate Cope-type 
hydroamination by stabilising the partial negative charge on the alkylhydroxylamine in the 
transition state. In the meantime, an electron-rich aryl substituent on thiourea could further 
stabilise the partial positive charge by cation-π interaction (Scheme 42).93 
 
 
 
 
Scheme 42. Jacobsen’s model for stabilising interactions in the transition state in a  
                     Cope-type hydroamination catalysed by thioureas.93 
 
Jacobsen and co-workers screened various thioureas and selected examples from their 
research are shown below (Table 14).93 
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Reagents and conditions: a) 10 mol% catalyst, 0.1 M in hexane, 23 °C, 2 h 
 
 
 
 
 
Entry Catalyst Yield (%) ee (%) 
1 none 8 -- 
2 170 45 -14 
3 171 58 40 
4 172 85 86 
5 173 82 -89 
6 174 83 91 
  
Table 14. Jacobsen’s thiourea-catalysed enantioselective intramolecular Cope- 
                 type hydroamination reaction.93 
 
Thiourea 170 could catalyse the Cope-type hydroamination (Entry 2). Catalyst 171 with an 
extended π-systems gave better yields than catalyst 170 (Entry 3). Thioureas with two 
electron-rich aryl substituents could further strengthen the effect of π-stabilisation and further 
improve the yields and enantioselectivity (comparing Entry 4 and 2, or 5 and 3). Catalyst 174 
was finally selected to afford the best catalytic properties and impart the highest 
enantioselectivities. 
 
2.4.5.3 Application of the Cope-Type Hydroamination to the Lycorine    
            Synthesis 
 
 
Cope-type hydroamination has been applied for constructing pyrrolidine rings in natural 
products. Early work by Oppolzer demonstrated the advantageous stereoselectivity and high 
yield of the Cope-type hydroamination to condstruct the pyrrolidine ring in his total syntheses 
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of (±)-α-lycorane and (+)-trianthine.5 Later in Spivey’s total synthesis of (±)-clivonine, the 
Cope-type hydroamination was used to establish the pyrrolidine ring and the two associated 
stereogenic centres simultaneously.88,94 In the present research we planned to utilise the 
Cope-type hydroamination as one of the key steps to construct the pyrrolidine ring and two 
stereocentres in (−)-lycorine. Martin has examined toluene, toluene/EtOAc, CDCl3, and 
benzene as the solvents for the Cope-type hydroamination on alkylhydroxylamine 159 at high 
reaction temperature (Scheme 43).74 
 
 
 
Scheme 43. Martin’s study of the Cope-type hydroamination on substrate 157.74 
 
Reagents and conditions: a) degassed benzene, 90 °C, 3 days, 37% 
 
Martin’s results showed that heating alkylhydroxylamine 159 in degased benzene at 90 °C for 
3 days gave a 37% yield of the cyclised product 175 along with a complex mixture of by-
products. Unfortunately, cyclised N-hydroxyl pyrrolidine 175 decomposed to allyl alcohol 176 
with concomitant loss of the acetonide protecting group and a molecule of water when 
recrystallisation was attempted. Martin proved the structure of allyl alcohol 176 
unambiguously by X-ray crystallography.74 
 
Being aware that protic solvents can mediate the proton transfer to facilitate the Cope-type 
hydroamination, Paddock also conducted a study of the solvent effect on the Cope-type 
hydroamination on alkylhydroxylamine 177 in methanol, toluene, and a mixture of toluene and 
five equivalents of methanol at 60 °C to form N-hydroxyl pyrrolidine 178 (Table 15).95 
 
 
 
Entry Solvent Additive Yield (%) 
1 toluene - 60 
2 MeOH -  One  unidentified compound 
3 toluene MeOH (5 equiv) 74 
 
Table 15. Paddock’s study of the solvent effect on the Cope-type hydroamination.95 
 
Reagents and conditions: a) Toluene, 60 °C, 8 h, 60%; or toluene, MeOH (5 equiv), 60 °C, 8 
h, 74% 
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This study showed that methanol was not a suitable solvent for the Cope-type hydroamination 
as reactions in this solvent afforded just one unidentified compound as the major product. 
This side product was not observed either in toluene or in toluene with five equivalents of 
methanol. Methanol (5 equiv) as an additive in toluene improved the reaction rate slightly 
compared to toluene without MeOH (74% vs. 60%) and this indicated that an added proton 
source is advantageous for the Cope-type hydroamination. 
 
Prior to examining the Cope-type hydroamination on our hydroxylamine 159, I performed a 
model study for Cope-type hydroamination on hydroxylamine 179 under three conditions to 
examine the influence of the additives on the reaction (Table 16). 
 
 
 
Entry 1 2 3 
Conditions toluene1, 60 °C toluene1, catalyst 181 
(0.1 equiv), 60 °C 
tBuOH1, NaCNBH3 
(1.0 equiv), 60 °C 
Time (h) 1 2 4 41 1 2 4 41 1 2 4 41 
Conversion 
(%) 
31 46 65 100 36 51 66 100 - 42 - 100 
Comment Clean reaction Unclean reaction and  
decomposed thiourea 
catalyst 
Clean reaction 
10.014 M 
 
Table 16. Thermal Cope-type hydroamination of hydroxylamine 179. 
 
Reagents and conditions: a) Conditions as the table shows 
 
Heating alkylhydroxylamine 179 without any additives in toluene resulted in clean crude 
product with minor by-products (Entry 1). Jacobsen’s study demonstrated that a chiral 
thiourea could catalyse intramolecular Cope-type hydroamination enantioselectively.93 They 
developed thiourea catalyst 175 as the chiral catalyst, and could obtain good yields and high 
ee. We thus anticipated that achiral thiourea 181 might also catalyse the Cope-type 
hydroamination for our alkylhydroxylamine and hence 10% thiourea 181 was added as the 
catalyst (Entry 2). In the third reaction conditions, the Cope-type hydroamination was 
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examined in tBuOH with one equivalent of NaCNBH3, the conditions developed by 
Beauchemin92, to suppress redox processes competing with the desired Cope-type 
hydroamination (Entry 3).   
The conversions under all three conditions were very similar. With thiourea 181 as the 
additive, undesired products and decomposition of the catalyst were observed in the 1H NMR 
spectrum. Although Beauchemin’s conditions did not improve the reaction rate compared to 
no additives in toluene, his conditions provided the cleanest crude materials. Therefore, we 
decided to add NaCNBH3 in our intramolecular Cope-type hydroamination on 
alkylhydroxylamine 159. 
 
2.4.5.4 Constructing the Pyrrolidine Ring by the Cope-type  
             Hydroamination with NaCNBH3 as the Additive 
 
We firstly examined the Cope-type hydroamination on alkylhydroxylamine 159 with one 
equivalent of NaCNBH3 as the additive (Scheme 44). 
 
 
 
Scheme 44. Formation of N-hydroxyl pyrrolidine 175 by Cope-type hydroamination  
                     followed by reduction using Raney nickel and carbamation with ethyl  
                     chloroformate. 
 
Reagents and conditions: a) NaCNBH3 (2.2 equiv), methyl orange pH = 3-4, MeOH, AcOH, 0 
°C, 3 h; b) NaCNBH3 (1 equiv), benzene, 90 °C, 65 h; c) Raney nickel, H2, r.t., 24 h; d) 
ethylchloroformate, NEt3, CH2Cl2, r.t., 4 h, 42% over four steps. 
 
The N-hydroxyl pyrrolidine 175 proved to be relatively unstable so we decided to reduce it to 
pyrrolidine 182 using H2 under the catalysis of Raney nickel at r.t. for 24 hours. Without 
further purification, pyrrolidine 182 was reacted with ethyl chloroformate and triethylamine to 
form carbamate 183 for the convenience of purification. The overall yield from oxime 148 to 
carbamate 183 was 42% over the four steps.    
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2.4.6 Attempts to form the Six-membered B-ring Using a Banwell  
         Modified Bischler-Napieralski Reaction 
 
The last ring that has to be constructed in this total synthesis was the six-membered B-ring. 
There were several possible methods to achieve cyclisation. One method would be to use a 
Pictet-Spengler cyclisation by reacting pyrrolidine 182 with formaldehyde in the presence of 
strong acid (Scheme 45). 93,96,97  
 
 
 
Scheme 45. Proposed Pictet-Spengler cyclisation to construct the B-ring. 93,96,97 
 
Reagents and conditions: a) formaldehyde, strong acid, solvent 
 
In Cho’s racemic total synthesis of (±)-lycorine, he used a Pictet-Spengler cyclisation of 185 
with paraformaldehyde promoted by trifluoroacetic to construct the B-ring in compound 186 
(Scheme 46).60 
 
 
 
Scheme 46. Cho’s Pictect-Spengler cyclisation enroute to (±)-lycorine.60 
 
Reagents and conditions: a) paraformaldehyde, TFA, r.t., 24h, 71% 
 
However, if a Pictet-Spengler cyclisation is used in our synthesis, the product would be 
tertiary amine 184 and the purification of the amine was anticipated to be difficult due to its 
expected high polarity.  
 
Another potential method would be to use a Bischler-Napieralski cyclisation.98 For example, 
Tomioka cyclised the B-ring in compound 188 by refluxing carbamate 187 in freshly distilled 
POCl3 with 95% yield (Scheme 47).67  
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Scheme 47. Tomioka’s B-ring formation by Bischler-Napieralski cyclisation en route to  
                     (−)-lycorine.67 
 
Reagents and conditions: a) POCl3, refluxing, 8 h, 95%  
 
The disadvantage of the standard Bischler-Napieralski cyclisation is that it usually requires 
the use of POCl3, at high reaction temperature (often at reflux). These reaction conditions are 
very harsh and likely to liberate sensitive functional groups, which are incompatible with acids.  
 
In order to make the B-ring formation by Bischler-Napieralski cyclisation more efficient, 
Banwell developed mild conditions for the cyclisation by reacting carbamates with Tf2O and 
DMAP in CH2Cl2 at 0 °C and applied the conditions to synthesise the B-ring in various 
Amaryllidaceae alkaloids (Scheme 48).99  
 
 
 
Scheme 48. A comparison of the standard Bischler-Napieralski conditions and the   
                     Banwell modified conditions for ring-closure.99 
 
Reagents and conditions: a) POCl3, refluxing; b) Tf2O (5 equiv), DMAP (3 equiv), CH2Cl2, 0 °C 
à r.t. 
 
Banwell claimed that the selective amounts of reagents was crucial to this reaction. Five 
equivalents of Tf2O and three equivalents of DMAP was the most ideal reagents combination. 
In both cases, Banwell’s modified conditions gave higher yields for the cyclisation of 
carbamates 189 and 191 compared to refluxing them in POCl3 (Scheme 47).  
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With carbamate 183 in hand, we examined the B-ring formation using the Banwell modified 
Bischler-Napieralski conditions (Table 17).  
 
 
 
Entry Conditions Outcome 
1 Tf2O (5.0 equiv.), DMAP (3.0 equiv.), 0 °C to r.t., CH2Cl2, 
17 h 
Low yield (~16%) 
2 Tf2O (5.0 equiv.), DMAP (3.0 equiv.), 0 °C to r.t., CH2Cl2, 
42 h 
Complex mixture 
31 DMAP (3.0 equiv.), Tf2O (5.0 equiv.), 0 °C to r.t., CH2Cl2, 
42 h 
Complex mixture 
1Reverse adding order, adding DMAP prior to Tf2O 
 
Table 17. Examination of the Banwell modified Bischler-Napieralski conditions for  
                 cyclisation of substrate 181. 
 
An initial test using Banwell’s standard reaction conditions gave only 16% yield (Entry 1).  We 
then increased the duration of reaction and reversed the order of addition of the reagents 
(Entries 2 and 3). Unfortunately, none of these conditions gave an acceptable yield of the 
desired cyclised product. 
 
2.4.7 Constructing the C-ring Alkene by an E2 Elimination 
 
Because of the low-yielding Banwell modified Bischler-Napieralski cyclisation on carbamate 
183, we turned our attention to constructing the alkene at C3-C3a prior to cyclising the B-ring.  
 
Cho’s research has shown that carbamate 194 is sufficiently stable to be carried through 
several synthetic steps before the Bischler-Napieralski ring-closure (Scheme 49).100  
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Scheme 49. Cho’s synthesis of (±)-1-deoxylycorine by carrying carbamate through  
                     several synthetic steps.100 
 
Reagents and conditions: a) TBSCl, imidazole, CH2Cl2, r.t.; b) NaH, CS2, MeI, THF, reflux, 
86%,; c) microwave 200 °C, 5 h, 53% (93% brsm); d) TBAF, THF; e) BzOH, PPh3, DEAD, 
THF, 70% over two steps; f) Tf2O, DMAP, 72% 
 
We were therefore optimistic that our carbamate 183 would be sufficiently stable to allow an 
E2 elimination to be performed prior to the Bischler-Napieralski type ring closure. For 
introducing the double bond between C3 and C3a, there were several examples of syn-
elimination reactions to introduce the double bond in lycorine and other similar natural 
products. However, the reaction conditions were usually very harsh and the yields were 
moderate. For example, in Cho’s recent total synthesis of (±)-1-deoxylycorine, xanthate 195 
was synthesised in order to set up a Chugaev elimination to construct the alkene in 
compound 196 with a yield of 53% (93% brsm) (Scheme 48). 
 
Tomioka also used a syn-elimination strategy to construct the C3-C3a alkene in (−)-lycorine 
(Scheme 50).67 
 
 
 
Scheme 50. Tomioka’s syn-elimination reaction to construct the C-ring alkene en route  
                     to (−)-lycorine.67 
 
Reagents and conditions: a) TMSOTf, NEt3, CH2Cl2, r.t.; b) PhSeCl, CH2Cl2, 0 °C; c) NaIO4, 
THF/H2O, r.t., 52% over three steps 
 
Tomioka applied a sequence of phenylselenylation, oxidation, and syn-elimination and 
achieved a yield of 52% of alkene 201 over the three steps. 
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We require an anti-elimination in our total synthesis of (−)-lycorine and anticipated that the 
anti-elimination could give higher yields than the syn-elimination procedures. There was only 
one example of an anti-elimination in a similar structure in the literature (Scheme 51).101  
 
 
 
Scheme 51. Pandey’s anti-elimination to construct an alkene en route to (±)- 
                       Brunsvigine.101 
 
Reagents and conditions: a) MsCl, NEt3, DMAP, CH2Cl2, 0 °C to r.t.; b) DBU, toluene, 110 °C, 
2 days, 89% over two steps 
 
In Pandey’s synthesis of (±)-brunsvigine, he converted alcohol 202 into the mesylate and then 
performed an anti-elimination with DBU in toluene at 110 °C for two days to give the desired 
elimination product 203 in 89% yield. 
 
Consequently, we modified our strategy from forming the B-ring by the Bischler-Napieralski 
reaction prior to constructing the double bond to a new strategy that the alkene would be 
constructed prior to forming the B-ring (Scheme 52). 
 
 
 
Scheme 52. Introduction of the C3-C3a double bond by an anti-elimination. 
 
Reagents and conditions: a) TBAF, THF, r.t., 17 h; b) MsCl, NEt3, 4-DMAP, r.t., 4 h, 100% 
conversion; c) DBU, toluene, 110 °C, 17 h, 52% over three steps 
 
The TBS protected secondary alcohol 181 was deprotected by the treatment with TBAF in 
THF at ambient temperature for 17 h to give alcohol 202. Alcohol 202 was unstable in d-
chloroform as upon standing in CDCl3 for overnight, small white particles formed which would 
not re-dissolve in CDCl3, CH2Cl2, Et2O, or MeOH. The purified yields were 40~60% after 
silica-gel chromatography.  
 
Conversion of alcohol 202 into triflate 203b was examined next. Unfortunately, this 
sulfonylation yielded only alcohol 202. However, alcohol 202 was successfully converted into 
mesylate 203a. After purification by silica gel chromatography, several sets of 1H NMR 
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signals were still observed because of the existence of rotamers. The E2 elimination of the 
mesylate 203a proceeded smoothly with DBU in toluene at 110 °C for 17 h. The 1H NMR 
spectrum of the crude materials was clean and the yield was 52% over three steps. 
 
2.4.8  Attempts to Construct the B-ring using Banwell’s Method on  
          Carbamate 204 
 
The Banwell modified Bischler-Napieralski ring-closure of the B-ring was examined on 
carbamate 204 (Table 18).99 
 
 
 
 
Table 18. Attempted cyclisation of the B-ring on carbamate 204. 
 
The standard Banwell conditions were first examined with five equivalents of Tf2O and three 
equivalents of DMAP at 0 °C to r.t. for 17 h. Unfortunately, only the starting material was 
recovered and no desired product was observed. The reaction solution was then stirred at 40 
°C for another five hours but this higher reaction temperature did not improve the reactivity. 
Only the starting material was recovered (Entry 1). Increasing the equivalents of reagents was 
fruitless and the starting material was recovered again (Entry 2). We then changed the 
solvent to 1,2-dichloroethane and increased the reaction temperature to 80 °C but only a 
complex mixture was obtained (Entry 3). Standard Bischler-Napieralski reaction conditions 
with POCl3 were also examined but  these conditions gave a complex mixture (Entry 4).  
 
These results were very surprising to us because the Banwell modified Bischler-Napieralski 
reaction and the standard Bischler-Napieralski conditions have been applied to apparently 
very similar substrates in the total synthesis of lycorine and related structures by other 
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4 POCl3 (200 equiv), 0 °C à 80°C, ClCH2CH2Cl, 17 h Complex mixture 
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groups.62,99 The most significant structural difference seemed to be that, in the previous 
syntheses, esters were used to protect the two hydroxyl groups in the C-ring rather than the 
acetonide protection. Therefore, the reason for the lack of reactivity for this cyclisation could 
be the ring strain from the acetonide protection which makes the ring-closure conformationally 
difficult. This conformational constraint could make the structure too rigid to cyclise and 
introduce sufficient ring strain to inhibit the ring closure. With this hypothesis in mind, we 
planned to release the ring strain. Consequently, the acetonide was deprotected by stirring 
compound 206 in HCl (3 M) in THF at 80 °C for 6 hours to give diol 208 (Scheme 53).  
 
 
 
Scheme 53. Deprotection of the acetonide in compound 206 to give diol 208 
 
Reagents and conditions: a) HCl (3 M), THF, 80 °C, 6 h, quantitative yield 
 
The yield of this deprotection was essentially quantitative. 
 
2.4.9 Attempts to Invert the Allylic Alcohol Using a Regioselective  
           Mitsunobu Reaction 
 
In addition to the B-ring formation, the other remaining synthetic challenge in the late stages 
of our total synthesis was to invert the stereochemistry of the allylic alcohol in compound 208.  
At this point only the allylic alcohol has incorrect stereochemistry compared to the natural 
product and we planned to invert the stereochemistry at C2 in compound 208 using a 
regioselective Mitsunobu reaction in the presence of the secondary alcohol at C1 (Scheme 
54).  
 
 
 
Scheme 54. Proposed regioselective Mitsunobu reaction to invert the allylic  
                     alcohol (C2) in the presence of the secondary alcohol (C1). 
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The Mitsunobu reaction has been applied to invert an analogous chiral centre during the 
synthesis of lycorine and related structures previously. For example, Schultz, Tomioka, and 
Cho all used Mitsunobu reactions to invert the chirality of C2 allylic alcohols (Scheme 55). 
64,67,100 
 
 
Scheme 55. Selected previous examples of allylic alcohol inversion at C2 using  
                     Mitsunobu reactions.64,67 
 
Reagents and conditions: a) diethyl azodicarboxylate (DEAD), PPh3, AcOH, THF, r.t., 50%; b) 
DEAD, PPh3, benzoic acid, THF, r.t., 73%; c) DEAD, PPh3, p-nitrobenzoic acid, benzene, r.t.; 
d) LiAlH4, 52% from 210 
 
In the literature, it is also known that the regioselective Mitsunobu reaction of a secondary 
allylic alcohol in the presence of a non-allylic secondary alcohol can be achieved by 
controlling the number of equivalents of diisopropyl azodicarboxylate (DIAD) and the acid 
(Table 19).102  
 
 
 
Entry DIAD  
(equiv) 
PPh3 
(equiv) 
HOAc 
(equiv) 
 
216 (%) 217 (%) 218 (%) 
1 1.0 1.4 2.8 100 nd nd 
2 2.5 2.5 4 nd 20 80 
3 2.6 2.6 21 nd 12 88 
4 2.6 2.6 100 100 nd nd 
 
Table 19. Pawlak’s regioselective inversion of an allylic hydroxyl group using a  
                 Mitsunobu reaction.102 
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Pawlak found that one equivalent of DIAD could invert the allylic alcohol 215 exclusively in the 
Mitsunobu reaction; no elimination product 217 or double inversion product 218 was observed 
(Entry 1). When the amount of DIAD was increased to two and half equivalents, double 
inversion on the allylic alcohol and secondary alcohol was observed to form bis-ester 218 
without the desired mono-ester 216 (Entry 2). Interestingly, the desired regioselective 
Mitsunobu product ester 216 could still be obtained exclusively when one hundred 
equivalents of acetic acid were employed along with more equivalents of DIAD (Entry 4).  
 
The selectivity for the reaction at the allylic alcohol rather than the non-allylic alcohol was 
proposed to originate from the displacement of acetic acid selectively at the more reactive 
allylic position of dioxytriphenylphosphorane intermediate 219 (Scheme 56). 
 
 
 
Scheme 56. Structure of dioxytriphenylphosphorane intermediate 219 during the  
                     regioselective Mitsunobu alcohol inversion reported by  Pawlak.102 
 
Reagents and conditions: a) DIAD, PPh3, AcOH, THF 
 
Another factor that may affect the regioselectivity of the Mitsunobu reaction at an allylic 
position in cyclohexenes is the conformational bias. The reactivity at pseudo-axial and 
pseudo-equatorial positions is likely to be different. If the allylic alcohol occupies an 
unfavorable conformation which makes it poorly reactive, then this may increase the 
possibility of inversion at the non-allylic alcohol. Fortunately, Shull and Koreeda’s research 
showed that the reactivity difference between pseudo-axial and pseudo-equatorial positions 
was relatively small. Shull and Koreeda performed a model study on deuterium-labeled cis- 
and trans-5-tert-butyl-2-cyclohexen-1-ol (cis- and trans-220) to examine the difference of 
reactivity between pseudo-axial and pseudo-equatorial allylic alcohols in the Mitsunobu 
reaction (Table 20).103 
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Entry Solvent Yields Product distribution (%) 
 cis-221 trans-221 cis-222 trans-222 
(±)-cis-5-tert-butyl-2-cyclohexen-1-ol (cis-220, pseudo-equatorial OH) 
1 THF 93 7 78 6 9 
2 benzene 88 5 78 6 10 
3 CH2Cl2 70 4 66 8 22 
(±)-trans-5-tert-butyl-2-cyclohexen-1-ol (trans-220, pseudo-axial OH) 
4 THF 80 80 3 12 5 
5 benzene 72 80 3 11 6 
6 CH2Cl2 42 75 10 11 4 
 
Table 20. Shull and Koreeda’s investigation into the effect of pseudo-axial and pseudo-  
                 equatorial OH conformations on the Mitsunobu reaction.103 
 
Reagents and conditions: a) benzoic acid, diethyl azodicarboxylate (DEAD), PPh3, and 
solvents   
 
The yields were good for both isomers and mainly gave the SN2 products. They discovered 
that the product distributions were very similar for (±)-cis-5-tert-butyl-2-cyclohexen-1-ol (cis-
220, pseudo-equatorial OH) (Entries 1 and 2) and (±)-trans-5-tert-butyl-2-cyclohexen-1-ol 
(trans-220, pseudo-axial OH) (Entries 4 and 5). Only a small amount of retention product and 
SN2’ products (cis-222 or trans-222) were observed. This result suggested that the orientation 
of the allylic alcohols in cyclohexenes did not significantly change their reactivity in the 
Mitsunobu reaction. Additionally, they found that THF and benzene were better solvents than 
CH2Cl2 for the Mitsunobu reaction on allylic alcohols 220. 
 
We performed the Mitsunobu reaction on our diol 206 with p-nitrobenzoic acid, DIAD and 
PPh3 in THF at ambient temperature, expecting that we could achieve a regioselective 
Mitsunobu reaction on the allylic alcohol (Table 21). 
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Entry 208 
(mg) 
p-nitrobenzoic acid 
(equiv) 
DIAD 
(equiv) 
PPh3 
(equiv) 
Conc. 
(M) 
Outcome 
1 4.5 3.0 1.0 1.5 0.003 No reaction2 
2 4.5 12.0 1.0 1.9 0.003 No reaction2 
3 2.5 5.0 1.0 1.51 0.004 No reaction2 
4 6.7 5.0 1.0 21 0.05 No reaction2 
1PPh3-polymer bound. 2Starting material recovery. 
 
Table 21. Attempted regioselective Mitsunobu reaction on allylic alcohol 208 
 
Unfortunately, diol 206 was unreactive towards the Mitsunobu reaction. In all experiments, 
one equivalent of DIAD was used to avoid the undesired Mitsunobu reaction on the 
secondary alcohol at C2. We initially examined the Mitsunobu reaction with three equivalents 
of p-nitrobenzoic acid but only unreacted diol 206 was recovered (Entry 1). More equivalents 
of p-nitrobenzoic acid could not give the desired monoester product either and the starting 
material was recovered again (Entry 2). Polymer-bound PPh3 was also examined in the 
Mitsunobu reaction to simplify the purification and, similarly, only starting material was 
recovered (Entry 3). Increasing the reaction concentration was also fruitless (Entry 4). We 
were very surprised that this diol 206 was so unreactive towards the Mitsunobu reaction 
because of the aforementioned prior synthetic applications by other groups on related 
compounds. Unfortunately, there was insufficient material at this late stage of the synthesis to 
investigate this reaction further. 
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2.5 Conclusions and Future Work 
 
For the future work, the most important challenges remain the efficient construction of the B-
ring and the inversion of the allylic alcohol at C2. It is proposed that the Pictet-Spengler 
cyclisation is worth examining first for the cyclisation of pyrrolidine 182 (Scheme 57). 
 
 
 
Scheme 57. Proposed future work to complete the total synthesis of (−)-lycorine using           
                     a Pictect-Spengler reaction as the key modification 
 
If the Pictet-Spengler B-ring cyclisation is successful, then subsequent introduction of the 
double bond in compound 226 by the anti-elimination, which we have developed, should be 
straightforward. I believe that when the skeleton of lycorine has been constructed, the 
stereochemistry of the allylic alcohol could be inverted by the regioselective Mitsunobu 
reaction to give monoester 227. In addition, even if the regioselective Mitsunobu reaction is 
not successful, the selective protection of one hydroxyl group in diol 226 should be achievable. 
Protecting group removal after Mitsunobu inversion at C2 would then furnish lycorine. 
 
As a fallback, if the Pictet-Spengler B-ring cyclisation is not successful, the protecting groups 
for the two hydroxyl groups at C1 and C2 may have to be changed. All examples of the ring 
closure to form the B-ring by Banwell modified Bischler-Napieralski reactions have used ester 
protected substrates rather than ones containing acetonide protection. We suspect that the 
rigid acetonide protection in our synthesis may inhibit the ring closure. In addition, Banwell 
uses methyl carbamates for his ring closures, whereas our substrate is an ethyl carbamate.  It 
seems unlikely to be a significant factor but as a precaution it will be worth changing this 
group too (Scheme 58). 
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Scheme 58. Proposed future work to complete the total synthesis of (−)-lycorine by  
                     changing the diol protecting groups as the key modification. 
 
Exchanging the protecting groups should allow a more facile B-ring cyclisation to give 
compound 229. Deprotecting the TBS group using TBAF, forming the mesylate, and the 
subsequent anti-elimination should give alkene 230.  Alternatively, using a phosphonate as 
the leaving group rather than a mesylate may increase the yields in the elimination step. The 
acetate esters can then be hydrolysed to set the stage for a regioselective Mitsunobu reaction 
at the allylic alcohol. If the regioselective Mitsunobu reaction gives the desired compound 232, 
then reduction of the amide and ester groups should afford lycorine as the final product. 
 
For the efficient preparation of the enantiomerically pure starting enone 8, there are other 
potential methods worthy to examine in the future. For example, 4-hydroxycyclohexenone 8 
could be made from D-galactose according to the method of Mereyala for the synthesis of 4-
hydroxycyclohexenone derivative 234 (Scheme 59)104. 
 
 
 
Scheme 59. Mereyala’s synthesis of 4-Hydroxycyclohexenone derivative 234 from D- 
                     galactose.104 
 
Reagents and conditions: a) acetone, conc. H2SO4; b) PPh3, I2, imidazole, toluene, reflux, 
82% over two steps; c) NaH, HMPA, 91%; d) Hg(OAc)2, acetone−water (2:1), 0 °C, 83%; e) 
Ac2O, pyridine, DMAP r.t., 73% 
 
 
Another potential method for synthesising 4-hydroxycyclohexenone 8 might be by adapting 
the palladium-catalysed oxidative desymmetrisation of meso-cyclohexenediol dibenzoates 
developed by the Trost group (Scheme 60)105,106.  
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Scheme 60. Trost’s desymmetrisation of meso-cyclohexenediol dibenzoate.105,106 
 
Reagents and conditions: a) cat. (η3-C3H5)2Pd2Cl2, cat. (R,R)-L1, nitronate 239, THF, 9 mmole, 
(2.9 g) scale, 67% yield, 99% ee; b) para-methoxybenzylalcohol, 2.5 mol% (η3-C3H5)2Pd2Cl2, 
15 mol% PPh3, THF 
 
This method was used to synthesise enone 236 in 67% yield and 99% ee. Toste found that a 
subsequent switch of the alcohol protecting group (i.e. 236 à 237) could be achieved by 
reacting with PMP-OH/Pd, albeit with a slight erosion of the enantiomeric excess (down to 
91% ee). Ideally, this approach would be similarly effective when desymmetrising the 
acetonide-containing diol and TBS-OH could be used for the Pd-catalysed allylic substitution 
to give TBS-protected 4-hydroxycyclohexenone 113.107,108 
 
In conclusion, we have developed an efficient stereoselective Michael addition and Cope-type 
hydroamination. We also overcame the difficult Suzuki coupling and anti-elimination in our 
work towards the total synthesis of (−)-lycorine. It is anticipated that this work has laid a 
strong foundation for the successful completion of this goal in the near future. 
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3. Experimental 
 
3.1 General Information 
 
Reactions were performed under anhydrous conditions, in oven-dried glassware and under a 
nitrogen atmosphere. Solvents and Reagents: MeCN, toluene, CH2Cl2 were distilled over 
CaH2. Et2O and THF were used directly after passage through Al2O3 columns in a Grubbs 
dry- solvent system (Innovative Technology Inc.). Solvents were degassed using a freeze-
pump-thaw cycle or bubbled N2 through for one hour. Reagents were purchased from 
commercial suppliers unless otherwise stated and handled according to the COSHH 
regulations. Photooxygenation: These reactions were performed in standard pyrex@ round-
bottom flasks and direct irradiated by a 300 W tungsten lamp (General Electric TSP-56RB). 
Chromatography: Flash chromatography was performed on silica gel  (Merck Kieselgel 60 
F254 230-400 mesh) or basic alumina following the method of W. C. Still.109 Thin Layer 
Chromatography (TLC) was carried out on Merck aluminium-backed plates pre- coated with 
silica (0.2 mm, 60 F254) and were developed by either by ultraviolet fluorescence (λmax = 254 
nm) or by phosphomolybdic acid/Δ or by ninhydrin/Δ or by iodine on silica gel. Melting points: 
were determined on a Reichardt hot stage apparatus. Infra red spectra: were recorded neat 
on Perkin-Elmer Paragon 1000 Fourier transform spectrometer. Only selected absorbances 
(νmax) are reported. 1H-NMR spectra: Spectra were recorded at 400 MHz on a Bruker AV 400 
spectrometer. Chemical shifts (δH) are given in parts per million (ppm) and are referenced to 
the residual solvent peak of benzene-d6, CDCl3, DMSO-d6, CD3OD-d4, or toluene-d8. Coupling 
constants (J) were reported in Hz. 13C-NMR spectra: Spectra were recorded at 100 MHz on a 
Bruker 400 AV spectrometer. Chemical shifts (δC) are given in ppm and referenced to the 
residual solvent peaks of benzene-d6, CDCl3, DMSO-d6, CD3OD-d4, or toluene-d8. Mass 
spectra: low resolution mass spectra (m/z) and high resolution mass spectra were recorded 
on either a VG platform II or VG AutoSpec spectrometers, using electron ionisation (EI), 
electron spray ionisation (ESI), or chemical ionisation (CI). High Resolution Mass 
Spectrometry (HRMS) measurements are valid to ± 5 ppm.  
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3.2 Experimental Procedure 
 
3.2.1 KDLM Rearrangement – Substrate preparation7,23 
 
 
 
Scheme 61. Synthesis of endoperoxide 11.7,23 
 
Reagents and conditions: a) TPP, O2, CCl4, hν; b) CoTPP, CCl4; c) Li2CuBr4 CCl4/CAN, 45% 
over three steps; d) 2,2-dimethoxypropane, pTSAH2O, CH2Cl2, 90%; e) DBU, CH2Cl2; f) TPP, 
O2, CCl4 or CH2Cl2, hν, 24~45%, over two steps; g) Br2, hexane, 57%; h) OsO4, NMO, 
water/acetone=4/1, 98% 
 
(1R*, 2R*,3S*, 4S*)-3,6-Dibromocyclohexane-1,2-diol (38)7 
 
Chemical Formula: C6H10Br2O2 
Exact Mass: 271.90 
Molecular Weight: 273.95 
                                                       
To a solution of 1,3-cyclohexadiene (5.0 mL, 78.7 mmol) in CCl4 (100 mL) was added TPP 
(51.0 mg, 0.083 mmol) at 0 °C. The resultant dark solution was irradiated with a 300 W lamp 
at 0 °C under the atmosphere of O2 for 16 hours. After 1,3-cyclohexadiene was depleted 
(observed by NMR), more 1,3-cyclohexadiene (2.5 mL, 39.4 mmol) was added to the dark 
solution and irradiated again for 8 hours.  
 
To the resultant dark solution was added CoTPP (71.0 mg, 0.106 mmol) at r.t. and the 
solution was stirred at r.t. for 17 hours. To this solution was added more CoTPP (320.0 mg, 
0.476 mmol) and the solution was stirred for 2 hours.  
 
A solution of dilithium tetrabromocuprate (Li2CuBr4) was prepared by dissolving CuBr2 (28.2 g, 
126 mmol) and LiBr (21.9 g, 252 mmol) in acetonitrile (180 mL) at 0 °C and then was warmed 
up to r.t. To this cuprate solution was added the previous solution of bis-epoxide at r.t. The 
dark solution was stirred for further 1.5 hours. After removing solvent, the residue was diluted 
by ether (200 mL) and then washed by water (50 mL). The aqueous phase was extracted by 
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ether (100 mL ×2). The organic phases were combined, washed by brine (150 mL), dried over 
Na2SO4, filtered, and concentrated in vacuo to give a dark solid. The dark solid was washed 
by hexane (200 mL) and hexane/chloroform = 1/1 (200 mL) to give diol 38 as a brown powder 
(9.70 g, 35.4 mmol, 45% over three steps). 
 
 Rf = 0.40 (Et2O/hexane, 2/1); mp 81-82 °C7; 1H NMR (CDCl3, 400 MHz) δH 2.11 (br, 2H, CH2), 
2.25 (m, 2H, CH2), 2.76 (s, 2H, OH), 4.21 (m, 2H, CHO), 4.28 (m, 2H, CHBr); 13C NMR 
(CDCl3, 100 MHz) δC 72.9 (×2), 52.6 (×2), 29.9 (×2); m/z (ES−) 317.8 (formic acid adduct) 
[(MCO2H−H)−, 100%]. Spectroscopic data are in accord with literature report.7 
 
(4R*,5R*)-4,5-Dibromocyclohex-1-ene (230)23 
 
Chemical Formula: C6H8Br2 
Exact Mass: 237.90 
              Molecular Weight: 239.94 
 
To a solution of 1,4-cyclohexadiene (25.0 mL, 264 mmol) in hexane (40 mL) was added 
bromine (14.0 mL, 272 mmol) at -30 °C dropwise. The resulting mixture was diluted by 
hexane (100 mL) and filtered. The solid was washed by hexane (30 mL). The filtrate was 
washed by a solution of Na2S2O3 (30 mL, saturated) and brine, dried over Na2SO4, filtered, 
and concentrated in vacuo to give a pale yellow oil (41.5 g). The oil was distilled at 90-98 °C/5 
mbar to give dibromide 230 as white plates (35.9 g, 150 mmol, 57%). 
 
Rf = 0.56 (hexane); mp 35-37 °C23; 1H NMR (CDCl3, 400 MHz) δH 2.58 (m, 2H, CH2), 3.18 (m, 
2H, CH2), 4.50 (m, 2H, CHBr), 5.64 (m, 2H, =CH); 13C NMR (CDCl3, 100 MHz) δC 122.0 (×2),  
48.4 (×2), 31.0 (×2); m/z (EI+) 240 [(M)+, 31%]. Spectroscopic data are in accord with 
literature report.23 
 
(1S*,2R*,4R*,5R*)-4,5-Dibromocyclohexan-1,2-diol (231)23 
 
Chemical Formula: C6H10Br2O2 
Exact Mass: 271.90 
Molecular Weight: 273.95 
 
To a solution of (4R*,5R*)-4,5-dibromocyclohex-1-ene (42.0 g, 175 mmol) and NMO (21.6 g, 
184 mmol) in a mixed solvent of water/acetone = 4/1 (84 mL) was added OsO4 (1.7 mL, 2.5 
wt in t-BuOH, 0.167 mmol) at r.t. The resulting solution was stirred at r.t for 48 hours.  
 
The resulting dark solution was quenched by adding NaHSO3 (16.8 g, 161 mmol) at r.t. and 
then the pH of this solution was neutralised to pH = 7 by H2SO4. Acetone was removed under 
Br
Br
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reduced pressure and then the aqueous solution was further acidified to pH = 2 by H2SO4. 
The resulting solution was extracted by EtOAc (100 mL ×4). The organic phases were 
combined, washed with brine (150 mL), dried over Na2SO4, filtered, and concentrated in 
vacuo to give diol 231 as a white powder (46.8 g, 170.8 mmol, 98%). 
 
mp 103-107 °C23; 1H NMR (CD3OD, 400 MHz) δH 2.07 (m, 1H), 2.36 (m, 2H), 2.56 (m, 1H), 
3.69 (m, 1H), 3.90 (m, 1H), 4.18 (m, 1H), 4.32 (m, 1H) 13C NMR (CD3OD, 100 MHz) δC 71.8, 
71.4, 55.5, 54.5, 43.7, 41.7; m/z (ES−) 317.8 (formic acid adduct) [(MCO2H−H)−, 100%]. 
Spectroscopic data are in accord with literature report.23 
 
(3aR*,5S*,6S*,7aS*)-5,6-Dibromo-2,2-dimethylhexahydro-1,3-benzodioxole (232)23 
 
Chemical Formula: C9H14Br2O2 
Exact Mass: 311.94 
Molecular Weight: 314.01 
 
To a solution of (1S*,2R*,4R*,5R*)-4,5-dibromocyclohexan-1,2-diol (2.10 g, 7.67 mmol) in 
CH2Cl2 (25 mL) was added a solution of 2,2-dimethoxypropane (5.5 mL, 44.9 mmol) and 
pTSAH2O (290.0 mg, 1.52 mmol) in CH2Cl2 (20 mL) at 0 °C. The resultant solution was 
stirred at 0 °C for 2 hours and then quenched by a solution of NaOH (50 mL, 1 M). The 
mixture was extracted by CH2Cl2 (30 mL ×2) and then the organic phases were combined, 
dried over Na2SO4, filtered, and concentrated in vacuo to give a dark oil. The dark oil was 
purified by FC (SiO2, hexane/ether, 1/1) to give dibromide 232 as white needles (2.05 g, 6.5 
mmol, 87%). Rf = 0.67 (Et2O) 
 
mp 129-130 °C; 1H NMR (CDCl3, 400 MHz) δH 1.31 (s, 3H, CH3), 1.51 (s, 3H, CH3), 2.21 (m, 
1H, CH2), 2.36 (m, 1H, CH2), 2.74 (m, 2H, CH2), 4.18 (m, 2H), 4.28 (m, 1H), 4.41 (m, 1H); 13C 
NMR (CDCl3, 100 MHz) δC 109.0, 72.6, 72.1, 51.2, 48.9, 36.1, 34.6, 28.3, 26.0. Spectroscopic 
data are in accord with literature report.23 
 
(1R*,2S*,6R*,7R*)-4,4-Dimethyl-3,5,8,9-tetraoxa-tricyclo-[5.2.2.02,6]undec-10-ene (11)7  
 
Chemical Formula: C9H12O4 
Exact Mass: 184.07 
Molecular Weight: 184.19 
 
To a solution of (3aR*,5S*,6S*,7aS*)-5,6-dibromo-2,2-dimethylhexahydro-1,3-benzodioxole 
(6.00 g, 19.11 mmol) in CH2Cl2 (36 mL) was added DBU (14.2 mL, 95.0 mmol) at r.t.. The 
resulting solution was stirred under reflux for 6 hours. The solution was washed by citric acid 
solution (50 g/100 mL) vigorously for 10 minutes. The mixture was extracted by CH2Cl2 (50 
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mL ×2). The organic phases were combined, dried over Na2SO4, and filtered. To the filtrate 
was added TPP (587.0 mg, 0.955 mmol). The resulting purple solution was irradiated by a 
300 W lamp under the atmosphere of oxygen at 0 °C for 8 hours. The solvent was evaporated 
and the residue was dissolved in EtOAc (50 mL). The solution was filtered and the filtrate was 
concentrated in vacuo to give dark solids. The dark solids were purified by FC (SiO2, 
hexane/CH2Cl2, 95/5 → hexane/ether, 9/1) to give endoperoxide 11 as white needles (2.30 g, 
12.5 mmol, 65%). 
 
Rf = 0.30 (EtOAc/hexane, 1/9); mp 110-112 °C; 1H NMR (CDCl3, 400 MHz) δH 1.36 (s, 6H, 
2×CH3), 4.59 (m, 2H), 4.91 (m, 2H), 6.58 (m, 2H, =CH); 13C NMR (CDCl3, 100 MHz) δC 130.5, 
110.3, 71.9, 71.5, 25.6, 25.4; m/z (CI+) 202 [(MNH4)+, 100%]. Spectroscopic data are in 
accord with literature report.7 
 
(3aR*,4R*,7S*,7aS*)-4,7-Dibromohexahydrospiro-[1,3-benzodioxole-2,1’-cyclohexane] 
(39) 
 
Chemical Formula: C12H18Br2O2 
Exact Mass: 351.97 
Molecular Weight: 354.08 
 
To a solution of diol 38 (503.0 mg, 1.84 mmol) in CH2Cl2 (9.0 mL) was added a solution of 
1,1-dimethoxycyclohexane (1.7 mL, 11.2 mmol) and pTSAH2O (54.0 mg, 0.28 mmol) in 
CH2Cl2 (5.0 mL) at 0 °C. The resultant solution was stirred at 50 °C for 5 hours. The resultant 
solution was partitioned between water (10 mL) and EtOAc (40 mL). The aqueous phase was 
extracted by EtOAc (30 mL) and then the organic phases were combined, dried over Na2SO4, 
filtered, and concentrated in vacuo to give a yellow oil. The yellow oil was purified by FC (SiO2, 
hexane/EtOAc, 100/5) to give dibromide 39 as a colourless oil (440.0 mg, 1.24 mmol, 68%). 
 
Rf = 0.67 (hexane/ether, 8/2); IR (film) 2937, 2859, 1449, 1456, 1163, 1110, 1089, 929, 907, 
851, 772, 689, 630 cm-1; 1H NMR (CDCl3, 400 MHz) δH 4.41 (m, 2H), 4.24 (m, 2H), 2.15 (m, 
2H), 1.68 (m, 2H), 1.59 (m, 6H), 1.37 (m, 2H); 13C NMR (CDCl3, 100 MHz) δC 110.8, 78.8, 
50.4, 38.5, 35.4, 30.0, 24.8, 23.9, 23.6; HRMS (EI+) Calculated for C12H18O2Br2 (M)+: 
351.9674 Found: 351.9683 (Δ = +2.6 ppm). 
 
(3aR*,7aS*)-3a,7a-Dihydrospiro-[1,3-benzodioxole-2,1’-cyclohexane] (40) 
 
Chemical Formula: C12H16O2 
Exact Mass: 192.12 
Molecular Weight: 192.25 
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To a solution of acetal 39 (102.0 mg, 0.288 mmol) and tetrabutylammonium iodide (199.0 mg, 
0.539 mmol) in CH2Cl2 (5.0 mL) was added DBU (0.4 mL, 2.68 mmol). The resultant solution 
was stirred under reflux for 40 hours. The solution was then poured into citric acid aqueous 
solution (1 g / 2 mL) and then the mixture was stirred for 10 minutes. The mixture was 
extracted by CH2Cl2 (30 mL ×2). The organic phases were combined, dried over Na2SO4, 
filtered, and concentrated in vacuo to give dark oil. The dark oil was purified by FC (SiO2, 
pentane/ether, 95/5) to give cyclohexadiene 40 as a white amorphous solid (33.0 mg, 0.172 
mmol, 59%). 
 
Rf = 0.4 (hexane/ether, 9/1); mp 115-117 °C; IR (film) 2933, 2857, 1450, 1355, 1278, 1111, 
1091, 1043, 930, 908 cm-1; 1H NMR (CDCl3, 400 MHz) δH 5.93-5.97 (m, 2H), 5.85-5.89 (m, 
2H), 4.61 (t, J = 1.8 Hz, 2H), 1.58-1.60 (m, 8H), 1.36-1.39 (m, 2H); 13C NMR (CDCl3, 100 MHz) 
δC 125.4, 123.6, 105.3, 78.8, 36.3, 34.2, 25,2, 24.3, 24.1. 
 
(1R*,2S*,6R*,7R*)-4,4-Cyclohexyl-3,5,8,9-tetraoxa-tricyclo-[5.2.2.02,6]undec-10-ene 
 
Chemical Formula: C12H16O4 
Exact Mass: 224.10 
Molecular Weight: 224.26 
 
A solution of diene 40 (100.0 mg, 0.520 mmol) and TPP (16.0 mg, 0.026 mmol) in CCl4 (10 
mL) was irradiated by lamp (300 W) under the atmosphere of oxygen at 0 °C for 5 hours. 
After removing CCl4 under reduce pressure, the black solids were dissolved in hexane (20 
mL). The black solids in hexane were filtered and the black solids were washed by hexane 
(50 mL). The filtrate was purified by FC (SiO2, hexane → Et2O/hexane, 1/9) to give 
(1R*,2S*,6R*,7R*)-4,4-cyclohexyl-3,5,8,9-tetraoxa-tricyclo-[5.2.2.02,6]undec-10-ene as a white 
amphous solid (88.6 mg, 0.395 mmol, 76%). 
 
Rf = 0.16 (Et2O/hexane, 1/9); mp. 124-126 °C; IR (film) 2947, 2927, 2858, 1450, 1381, 1329, 
1288, 1163, 1122, 1092, 1056, 942, 926, 850, 796, 736, 733 cm-1; 1H NMR (CDCl3, 400 MHz) 
δH 6.58 - 6.46 (m, 2H), 4.87 (m, 2H), 4.53 (t, J = 2.3 Hz, 2H), 1.57 - 1.47 (m, 8H), 1.39 - 1.33 
(m, 2H); 13C NMR (CDCl3, 100 MHz) δC 130.6, 111.1, 72.0, 71.1, 35.5, 34.9, 25.1, 23.9, 23.6; 
HRMS (CI+) Calculated for C12H20NO4 (M+NH4)+: 242.1392 Found: 242.1387 (Δ = −2.1 ppm). 
 
(3aR*,4R*,7S*,7aS*)-4,7-Dibromo-2,2-diphenylhexahydro-1,3-benzodioxole (41) 
 
Chemical Formula: C19H18Br2O2 
Exact Mass: 435.97 
Molecular Weight: 438.15 
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A solution of benzophenone (530.0 mg, 2.94 mmol), trimethyl orthoformate (0.32 mL, 2.92 
mmol), and pTSA•H2O (50.0 mg, 0.263 mmol) in methanol (2.0 mL) was stirred at 50 °C for 3 
hours. The solution was concentrated to give yellow solid. A solution of diol 38 (401.0 mg, 
1.46 mmol) in THF (5.0 mL) was added to the yellow solid. The resultant solution was stirred 
under reflux for 17 h. 
 
The resulting solution was cooled down and partitioned between water (20 mL) and CH2Cl2 
(30 mL). The aqueous phase was extracted by CH2Cl2 (30 mL ×2). The organic phases were 
combined, dried over Na2SO4, filtered, and concentrated in vacuo to give pink plates. The 
pink plates were purified by FC (SiO2, hexane/CH2Cl2, 95/5 → hexane/ether, 95/5) to give 
dibromide 41 as white plates (467.0 mg, 1.07 mmol, 73%). 
 
Rf = 0.4 (hexane/ether, 97/3); mp. 102-103 °C; IR (film) 2946, 2831, 1490, 1451, 1316, 1250, 
1212, 1175, 1091, 1056, 1031, 989, 913, 773, 750, 698, 654 cm-1; 1H NMR (CDCl3, 400 MHz) 
δH 2.13 (m, 4H, 2×CH2), 4.23 (m, 2H), 4.56 (m, 2H), 7.28 (m, 6H), 7.51 (m, 2H), 7.57 (m, 2H); 
13C NMR (CDCl3, 100 MHz) δC  30.0, 49.1, 80.0, 109.9, 125.2, 125.4, 128.1, 128.3, 130.1, 
143.2,143.3; HRMS (CI+) Calculated for C19H19O2Br2 (M+1)+: 436.9752 Found: 436.9764 (Δ = 
+2.7 ppm). 
 
(3aR*,7aS*)-2,2-Diphenyl-3a,7a-dihydro-1,3-benzodioxole (42) 
 
Chemical Formula: C19H16O2 
Exact Mass: 276.12 
Molecular Weight: 276.33 
 
To a solution of acetal 41 (467.0 mg, 1.07 mmol) and tetrabutylammonium iodide (790.0 mg, 
2.14 mmol) in CH2Cl2 (10 mL) was added DBU (1.6 mL, 10.7 mmol). The resultant solution 
was stirred under reflux for 16 hours. The solution was then poured into an aqueous solution 
of citric acid (4 g / 8 mL) and then the mixture was stirred for 10 minutes. The mixture was 
extracted by CH2Cl2 (30 mL ×2). The organic phases were combined, dried over Na2SO4, 
filtered, and concentrated in vacuo to give dark oil. The dark oil was purified by FC (SiO2, 
hexane/ether, 100/3) to give diene 42 as white needles (201 mg, 0.727 mmol, 68%). 
 
Rf = 0.2 (hexane/ether, 100/3); mp 62-64 °C; IR (film) 3059, 2897, 1491, 1450, 1258, 1206, 
1176, 1090, 1060, 1026, 990, 754, 699 cm-1; 1H NMR (CDCl3, 400 MHz) δH 4.62 (t, J = 1.8 Hz, 
2H), 6.02-6.10 (m, 4H), 7.25-7.45 (m, 6H), 7.52-7.55 (m, 2H), 7.68-7.71 (m, 2H); 13C NMR 
((CD3)2CO, 100 MHz) δC 143.2, 143.0, 129.2, 129.1, 129.0, 128.6, 128.4, 127.8, 127.6, 127.5, 
125.5, 124.6, 81.2. 
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(1R*,2S*,6R*,7R*)-4,4-Diphenyl-3,5,8,9-tetraoxa-tricyclo-[5.2.2.02,6]undec-10-ene 
 
Chemical Formula: C19H16O4 
Exact Mass: 308.10 
Molecular Weight: 308.33 
 
A solution of diene 42 (20.0 mg, 0.072 mmol) and TPP (8.9 mg, 0.014 mmol) in CH2Cl2 (10 
mL) was irradiated by lamp (300 W) under an atmosphere of oxygen at 0 °C for 3 hours. After 
removing CH2Cl2 under reduced pressure, the black solids were diluted in hexane (10 mL). 
The mixture was filtered and the black solids were washed by hexane (10 mL). The filtrate 
was purified by FC (SiO2, hexane → Et2O/hexane, 1/6) to give (1R*,2S*,6R*,7R*)-4,4-
diphenyl-3,5,8,9-tetraoxa-tricyclo-[5.2.2.02,6]undec-10-ene as a colorless oil (9.1 mg, 0.030 
mmol, 42%). 
 
Rf = 0.27 (Et2O/hexane, 1/4); IR (film) 3063, 2932, 1494, 1450, 1383, 1279, 1203, 1068, 982, 
925, 758, 701, 641 cm-1; 1H NMR (CDCl3, 400 MHz) δH 7.52 (d, J = 7.3 Hz, 2H), 7.42-7.32 (m, 
3H), 7.26 (m, 5H), 6.67 (t, J = 3.9 Hz, 2H), 5.02 (q, J = 3.9 Hz, 2H), 4.47-4.41 (m, 2H); 13C 
NMR (CDCl3, 100 MHz) δC 131.0, 128.8, 128.5, 127.9, 127.0, 126.6, 71.8, 71.5; HRMS (CI+) 
Calculated for C19H17O4 (M+1)+: 309.1127 Found: 309.1114 (Δ = −4.2 ppm). 
 
3.2.2 KDLM Rearrangement – General method for the asymmetric KDLM  
         rearrangement of endoperoxides 
 
To a solution of endoperoxide 10 (20.0 mg, 0.131 mmol) in the appropriate solvent (2.0 mL)  
was added a desired quantity of catalyst (and additive if required) at desired temperature. The 
reaction was monitored by TLC. When endoperoxide 10 was depleted, the reaction solution 
was purified by rapid FC (SiO2, CH2Cl2 → ether) to remove TPP and then the ee was 
determined by HPLC analysis. 
 
(7R*)-Hydroxy-2,2-dimethyl-(7,7aS*)-dihydro-(3aR*)H-benzo-[1,3]dioxol-4-one (8)7 
  
Chemical Formula: C9H12O4 
Exact Mass: 184.07 
Molecular Weight: 184.19 
 
To a solution of endoperoxide 7 (20.0 mg, 0.131 mmol) in the CH2Cl2 (2.0 mL) was added 
deMeQAc (2.0 mg, 0.0057 mmol) and then the solution was stirred at r.t. for 6 hours. The 
resultant solution was partitioned between water (5 mL) and EtOAc (10 mL). The aqueous 
phase was extracted by EtOAc (10 mL) and then the organic phases were combined, dried 
over Na2SO4, filtered, and concentrated in vacuo to give a yellow oil. The yellow oil was 
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purified by FC (SiO2, hexane/ether, 1/1 → ether) to give 4-hydroxycyclohexenone 8 as a light 
yellow oil (5.0 mg, 0.027 mmol 21%). 
 
Rf = 0.20 (ether); 1H NMR (CDCl3, 400 MHz) δH 6.87 (dd, J = 9.0, 3.2 Hz, 1H), 6.11 (dd, J = 
9.0, 1.2 Hz, 1H), 4.58 (m, 1H), 4.46 (m, 2H), 2.53 (brs, 1H, OH), 1.41 (s, 3H, CH3), 1.40 (s, 
3H, CH3). Spectroscopic data are in accord with literature report.7 
 
(7R*)-Hydroxy-2,2-cyclohexyl-(7,7aS*)-dihydro-(3aR*)H-benzo-[1,3]dioxol-4-one (43) 
 
Chemical Formula: C12H16O4 
Exact Mass: 224.1 
Molecular Weight: 224.26 
 
To a solution of (1R*,2S*,6R*,7R*)-4,4-cyclohexyl-3,5,8,9-tetraoxa-tricyclo-[5.2.2.02,6]undec-
10-ene (10.0 mg, 0.045 mmol) in CH2Cl2 (3.0 mL) was added deMeQAc (2.0 mg, 0.006 mmol) 
at r.t. and the resulting solution was stirred at r.t. for 5 hours. The resulting solution was 
purified by FC (SiO2, CH2Cl2 → Et2O) to give 4-hydroxylcyclohexenone 43 as a light yellow oil 
(8.2 mg, 0.036 mmol, 82%). 
 
Rf = 0.31 (Et2O); IR (film) 3424, 2937, 2860, 1685, 1449, 1370, 1250, 1165, 1116, 1093, 932, 
790 cm-1; 1H NMR (CDCl3, 400 MHz) δH 6.86 (dd, J = 10.3, 3.3 Hz, 1H), 6.10 (dd, J = 10.3, 
1.5 Hz, 1H), 4.60 - 4.55 (m, 1H), 4.47 - 4.41 (m, 2H), 2.49 (br, 1H), 1.65 - 1.53 (m, 9H), 1.37 
(p, J = 5.2 Hz, 2H); 13C NMR (CDCl3, 100 MHz) δC 194.0, 147.7, 128.9, 111.3, 79.2, 73.8, 
67.4, 37.1, 35.1, 24.9, 23.9, 23.6; HRMS (CI+) Calculated for C12H17O4 (M+1)+: 225.1121 
Found: 225.1106 (Δ = −7.3 ppm). 
 
(7R*)-Hydroxy-2,2-cyclohexyl-(7,7aS*)-dihydro-(3aR*)H-benzo-[1,3]dioxol-4-one (44) 
 
Chemical Formula: C19H16O4 
Exact Mass: 308.10 
Molecular Weight: 308.33 
 
To a solution of (1R*,2S*,6R*,7R*)-4,4-diphenyl-3,5,8,9-tetraoxa-tricyclo-[5.2.2.02,6]undec-10-
ene (20.0 mg, 0.065 mmol) in CH2Cl2 (10 mL) was added deMeQAc (2.0 mg, 0.006 mmol) at 
r.t. and the resulting solution was stirred at r.t. for 5 hours. The resulting solution was purified 
by FC (SiO2, CH2Cl2 → Et2O) to give (1R*,2S*,6R*,7R*)-4,4-diphenyl-3,5,8,9-tetraoxa-tricyclo-
[5.2.2.02,6]undec-10-ene as a light yellow oil (15.4 mg, 0.049 mmol, 76%).  
 
 
Rf = 0.22 (EtOAc/Hexane, 1/2); NMR (CDCl3, 400 MHz) δH 7.55-7.63 (m, 4H), 7.37-7.24 (m, 
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6H), 6.91 (dd, J = 10.3, 2.6 Hz, 1H), 6.13 (dd, J = 10.3, 1.4 Hz, 1H), 4.68-4.65 (m, 1H), 4.61 
(d, J = 6.8 Hz, 1H), 4.49 (d, J = 6.8 Hz, 1H), HRMS (CI+) Calculated for C19H17O4 (M+1)+: 
309.1127 Found: 309.1131 (Δ = +1.3 ppm). 
 
3.2.3 KDLM Rearrangement – Preparation of the 6’-aminoquinine  
         derived organocatalysts 
 
Demethylquinine 54 (deMeQ)11 
 
Chemical Formula: C19H22N2O2 
Exact Mass: 310.17 
Molecular Weight: 310.40 
 
 
According the method reported by Deng11, to a mixture of sodium hydride (11.2 g, 60% in 
mineral oil, 280 mmol) in DMF (100 mL) was added ethanethiol (17.3 mL, 234 mmol) at 0°C 
and then the mixture was stirred for 10 minutes at r.t. (Caution: Strongly exothermic reaction! 
Explosion!). To this mixture was added a solution of quinine (15.0 g, 46.2 mmol) in DMF (150 
mL) at r.t. and the resultant solution was stirred at 130 °C for 16 hours. After cooling down, 
the orange solution was poured into aqueous NH4Cl (100 mL, saturated). The aqueous phase 
was extracted by EtOAc (100 mL ×2). The organic phases were combined and then extracted 
by HCl (2 N, 100 mL ×3). The acidic aqueous phases were combined and neutralised to pH = 
9-10 by NaOH (pellets, 25.4 g). The mixture was extracted with EtOAc (50 mL ×3). The 
organic phases were combined, dried over Na2SO4, and filtered. Crystals formed in the filtrate. 
The filtrate was stored at -20 °C for 17 h and the mixture was then filtered to give white 
powder. The volume of mother liquid was reduced to 50.0 mL to obtain more powder. The 
solids were combined and dried under a stream of N2 to give demethylquinine 54 as a white 
powder (11.8 g, 36.4 mmol, 79%). (Caution: Ethanethiol has a strong smell and keep the 
raction vessel in a fumehood all the time. The aqueous waste should be bleached.) 
 
mp. 190-192 °C; [α]20D = -153.1 (c 1.0, MeOH); 1H NMR (CDCl3, 400 MHz) δH 8.59 (d, J = 4.6 
Hz, 1H), 7.90 (d, J = 9.0 Hz, 1H), 7.62 (dd, J = 4.6, 0.8 Hz, 1H), 7.33 (d, J = 9.0 Hz, 1H), 7.30 
(s, 1H), 5.76 (ddd, J = 17.1, 10.4, 7.6 Hz, 1H), 5.53 (d, J = 3.3 Hz, 1H), 5.02 (d, J = 17.1 Hz, 
1H), 4.93 (d, J = 10.4 Hz, 1H), 3.76-3.66 (m, 1H), 3.17-3.07 (m, 2H), 2.79-2.64 (m, 2H), 2.41-
2.32 (m, 1H), 1.94-1.78 (m, 3H), 1.59 (m, 1H), 1.51-1.39 (m, 1H); m/z (ES+) 311 [(M+1)+, 
100%. Spectroscopic data are in accord with literature report.11  
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6’-Triisopropylsilyletherquinine (37)11 
 
Chemical Formula: C28H42N2O2Si 
Exact Mass: 466.30 
Molecular Weight: 466.74 
 
 
To a solution of demethylquinine (54) (500.0 mg, 1.61 mmol) in DMF (7.0 mL) was added 
imidazole (220.0 mg, 3.23 mmol) and triisopropylsilylchloride (0.7 mL, 3.32 mmol) at 0°C. The 
resultant solution was stirred at r.t. for 2 hours. The solution was then partitioned between 
aqueous NaHCO3 (30 mL) and EtOAc (50 mL). The aqueous phase was extracted by EtOAc 
(50 mL ×2). The organic phases were combined, dried over Na2SO4, filtered, and 
concentrated in vacuo to give a yellow oil. The yellow oil was purified by FC (SiO2, EtOAc → 
EtOAc/MeOH/NH4OH, 20/1/0.5) to give 6’-triisopropylsilyletherquinine (37) as a colorless 
crystalline needle (609.0 mg, 80% over two steps). 
 
Rf = 0.6 (EtOAc/MeOH/NH4OH, 20/1/0.5); 1H NMR (CDCl3, 400 MHz) δH 8.70 (d, J = 4.8 Hz, 
1H), 7.99 (d, J = 9.1 Hz, 1H), 7.45 (s, 1H), 7.44 (d, J = 4.8 Hz, 1H), 7.33 (dd, J = 9.1, 2.5 Hz, 
1H), 5.77 (m, 1H), 5.43 (d, J = 4.8 Hz, 1H), 4.96 (m, 2H), 3.34 (m, 1H), 3.25 (m, 1H), 3.07 (dd, 
J = 13.6 Hz, 10.4 Hz, 1H), 2.63-2.68 (m, 2H), 2.25 (brs, 1H), 1.80 (m, 1H), 1.64-1.70 (m, 4H), 
1.50 (brs 1H), 1.26-1.37 (m, 3H), 1.13 (d, J = 7.6 Hz, 18H); m/z (ES+) 467 [(M+1)+, 100%]. 
Spectroscopic data are in accord with literature report.11 
 
9-Acetyl-demethylquinine (deMeQAc)17 
 
Chemical Formula: C21H42N2O3 
Exact Mass: 352.18 
Molecular Weight: 352.43 
 
 
To a solution of 6’-triisopropylsilyletherquinine (37) (551.0 mg, 1.18 mmol) and triethylamine 
(0.03 mL, 2.37 mmol) in CH2Cl2 (10 mL) was added acetyl chloride (0.1 mL, 1.41 mmol) 
dropwise at 0 °C. The resulting solution was stirred at r.t. for 4 hours. The solution was then 
partitioned between CH2Cl2 (30 mL) and aqueous NaHCO3 (10 mL, saturated). The aqueous 
phase was extracted by CH2Cl2 (30 mL). The organic phases were combined, dried over 
Na2SO4, filtered, and concentrated in vacuo to give a yellow oil. 
 
To this yellow oil was added TBAF solution (3.0 mL, 3.0 mmol, 1 M in THF) at r.t.. The 
resulting solution was stirred at r.t. for 18 hours and then partitioned between EtOAc (30 mL) 
and water (10 mL). The aqueous phase was extracted by EtOAc (30 mL). The organic phases 
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were combined, dried over Na2SO4, filtered, and concentrated in vacuo to give yellow oil. The 
yellow oil was purified by FC (SiO2, EtOAc/MeOH/NH4OH, 20/1/0.5) to give yellow solids 
(310.0 mg). The yellow solid was recrystallised from EtOAc (300 mg / 6 mL) to give 9-acetyl-
demethylquinine (deMeQAc) as a white powder (240.0 mg, 0.68 mmol, 58%). 
 
Rf = 0.51 (EtOAc/MeOH/NH4OH, 10/2/0.5); 1H NMR (CDCl3, 400 MHz) δH 8.64 (d, J = 4.8 Hz, 
1H), 7.95 (d, J = 9.2 Hz, 1H), 7.66 (d, J = 2.6 Hz, 1H), 7.47 (brs, 1H), 7.29 (d, J = 4.8 Hz, 1H), 
7.22 (dd, J = 9.2, 2.2 Hz, 1H), 6.51 (d, J = 5.6 Hz, 1H), 5.76 (ddd, J = 17.5, 10.8, 7.4 Hz, 1H), 
4.99 (d, J = 17.5 Hz, 1H), 4.85 (d, J = 10.8 Hz, 1H), 3.27-3.33 (m, 1H), 3.09 (dd, J = 13.4, 
10.2 Hz, 1H), 2.68-2.75 (m, 1H), 2.59-2.64 (m, 1H), 2.31 (brs, 1H), 2.11 (s, 3H), 1.86 (m, 1H), 
1.72-1.81 (m, 2H), 1.54-1.69 (m, 2H); m/z (ES−) 396 (formic acid adduct) [(MCO2H−H) −, 
100%]. Spectroscopic data are in accord with literature report.11 
 
N-Benzyl-6’-aminoquinine 56 
 
Chemical Formula: C26H29N3O 
Exact Mass: 399.23 
Molecular Weight: 399.54 
 
 
A solution of demethylquinine 54 (deMeQ) (1.00 g, 3.22 mmol) and NaHSO3 (3.35 g, 32.2 
mmol) in benzylamine/water = 10 mL / 80 mL was stirred at 145 °C for 2 days. After cooled 
down to room temperature, the mixture was filtered to give a brown solid. The brown solid 
was washed with water and then dried by a stream of nitrogen for 17 h to give N-benzyl-6’-
aminoquinine as a yellow powder (926.0 mg, 2.32 mmol, 72%). 
 
Rf = 0.22 (MeOH); mp. 99-101°C  [α]20D = -126.0 (c 0.7, MeOH); IR (film) 2931, 2668, 1623, 
1523, 1495, 1453, 1353, 1276, 1261, 1098, 764; 1H NMR (400 MHz, CDCl3) 8.41 (d, J = 4.8 
Hz, 1H), 7.76 (d, J = 9.1 Hz, 1H), 7.50 (d, J = 4.8 Hz, 1H), 7.41 (m, 2H), 7.32 – 7.26 (m, 3H), 
7.20 (d, J = 7.3 Hz, 1H), 6.85 (d, J = 2.3 Hz, 1H), 5.65 (ddd, J = 17.5, 10.3, 7.5 Hz, 1H), 5.37 
(d, J = 3.8 Hz, 1H), 4.90 (d, J = 17.5 Hz, 1H), 4.88 (d, J = 10.3 Hz, 1H), 4.54 (d, 16.0 Hz, 1H), 
4.48 (d, 16.0 Hz, 1H), 3.47 (t, J = 10.5 Hz, 1H), 2.99 – 2.88 (m, 2H), 2.53 (td, J = 13.3, 4.7 Hz, 
1H), 2.37 (dt, J = 13.7, 3.5 Hz, 1H), 2.25 (m, 1H), 1.73 (m, 2H), 1.50 (m, 1H), 1.39 (m, 1H); 
13C NMR (CDCl3, 100 MHz) δC 149.4, 146.3, 144.0, 143.7, 141.6, 131.3, 130.5, 130.3, 129.8, 
129.1, 128.9, 123.7, 120.7, 115.7, 99.8, 73.2, 61.5, 58.4, 50.4, 48.8, 44.9, 41.8, 30.1, 29.1, 
23.3; HRMS (ES+) Calculated for C26H30N3O (M+1)+: 400.2389. Found: 400.2392 (Δ = +0.7 
ppm)  
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N-tert-Butoxycarbonyl-N-benzyl-6’-aminoquinine (60) 
 
Chemical Formula: C31H37N3O3 
Exact Mass: 499.28 
Molecular Weight: 499.66 
 
 
To a solution of N-benzyl-6’-aminoquinine 56 (150.0 mg, 0.375 mmol) in MeOH (0.5 mL) was 
added trimethylamine (0.08 mL, 0.574 mmol) and Boc2O (98.0 mg, 0.449 mmol) at r.t. The 
resulting solution was stirred under reflux for 17 h. The resulting solution was partitioned 
between EtOAc (25 mL) and water (10 mL). The organic was washed by brine (25 mL), dried 
over Na2SO4, filtered, and concentrated in vacuo to give a black oil. The black oil was purified 
by FC (SiO2, EtOAc → EtOAc/MeOH, 95/5) to give N-tert-butoxycarbonyl-N-benzyl-6’-
aminoquinine (60) as a yellow oil (79.5 mg, 0.159 mmol, 52%). Rf = 0.44 (EtOAc/MeOH, 4/1). 
 
[α]20D = -53.0 (c 1.21, MeOH); IR (film) 2928, 1745,1625, 1528, 1453, 1369, 1276, 1255,1158 
cm-1; 1H NMR (400 MHz, CDCl3) δH 8.57 (d, J = 4.8 Hz, 1H), 7.87 (d, J = 9.0 Hz, 1H), 7.39-
7.41 (m, 2H), 7.26-7.36 (m, 4H), 7.10 (dd, , J = 9.0 Hz, 2.4 Hz, 1H), 6.19 (d, J = 8.0 Hz, 1H), 
5.74 (ddd, J = 17.2 Hz, 10.4 Hz, 7.6 Hz, 1H), 4.96 (d, J = 10.4 Hz, 1H), 4.92 (m, 1H), 4.44-
4.49 (m, 1H), 4.45 (m, 2H), 3.19 (m, 1H), 2.97 (dd, J = 13.6 Hz, 10.0 Hz), 2.45-2.56 (m, 2H), 
2.20 (m, 1H), 1.78 (m, 2H), 1.65-1.71 (m, 1H), 1.50-1.57 (m, 1H), 1.44 (m, 1H), 1.39 (s, 9H); 
13C NMR (CDCl3, 100 MHz) δC 153.0, 146.3, 145.8, 143.6, 142.4, 142.0, 131.4, 128.6, 127.8, 
127.7, 127.5, 126.9, 120.9, 120.8, 118.5, 114.5, 99.3, 82.7, 76.7, 59.0, 56.9, 48.3, 46.6, 42.7, 
40.0, 27.8 (×2), 27.7, 23.7, 12.2; HRMS (ES+) Calculated for C31H38N3O3 (M+1)+: 500.2913. 
Found: 500.2896 (Δ = −3.4 ppm). 
 
O-tert-Butoxycarbonyl-N-benzyl-6’-acetamidequinine (61) 
 
Chemical Formula: C33H39N3O4 
Exact Mass: 541.29 
Molecular Weight: 541.68 
 
 
To a solution of N-tert-butoxycarbonyl-N-benzyl-6’-aminoquinine (60) (50.5 mg, 0.101 mmol) 
and DMAP (1.2 mg, 0.001 mmol) in pyridine (0.5 mL) was added acetyl chloride (8.5 µL, 0.12 
mmol) at room temperature. The resulting solution was stirred at room temperature for 1 hour 
and then was partitioned between EtOAc (25 mL) and water (10 mL). The aqueous phase 
was extracted by EtOAc (25 mL). The organic phases were combined, washed by brine (30 
mL), dried over Na2SO4, filtered, and concentrated in vacuo to give O-tert-butoxycarbonyl-N-
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benzyl-6’-acetamidequinine (61) as a yellow oil. The yellow oil was purified by FC (SiO2, 
EtOAc → EtOAc/MeOH, 8/2) to give a green oil (45.5 mg, 0.084 mmol, 84%). 
 
Rf = 0.56 (EtOAc/MeOH, 4/1); [α]20D = -0.83 (c 0.6, MeOH); IR (film) 2981, 2935,1743, 1662, 
1504, 1458, 1391, 1276, 1260, 1160 cm-1; 1H NMR (400 MHz, CDCl3) δH 8.89 (d, J = 4.8 Hz, 
1H), 8.07 (d, J = 9.0 Hz, 1H), 7.90 (s, 1H), 7.43 (d,  J = 4.8 Hz, 1H), 7.34 (dd, , J = 9.0 Hz, 2.4 
Hz, 1H), 7.15-7.22 (m, 5H), 6.00 (d, J = 8.8 Hz, 1H), 5.79 (ddd, J = 16.5 Hz, 11.2 Hz, 7.6 Hz, 
1H), 5.13 (d, J = 16.5 Hz, 1H), 5.00 (s, 1H), 4.86 (d, J = 11.2 Hz, 1H), 4.41 (s, 1H), 4.39 (s, 
1H), 3.19 (q, J = 8.6 Hz, 1H), 2.89 (dd, J = 13.8 Hz, 9.9 Hz, 1H), 2.41 (m, 2H), 2.21 (m, 1H), 
1.97-2.04 (m, 1H), 1.94 (s, 3H), 1.81 (m, 1H), 1.64 (m, 1H), 1.48 (m, 1H), 1.40 (m, 1H), 1.35 
(s, 9H); 13C NMR (CDCl3, 100 MHz) δC 170.4, 152.8, 150.8, 147.5, 145.5, 141.6, 140.6, 137.1, 
132.0, 129.0, 128.7, 128.5, 127.4, 126.4, 123.3, 119.7, 114.5, 83.0, 76.3, 59.8, 56.4, 52.8, 
42.1, 39.7, 27.6, 27.4, 25.4, 22.9; HRMS (ES+) Calculated for C33H40N3O4 (M+1)+: 542.3019, 
Found: 542.3005 (Δ = -2.6 ppm). 
 
9-Acetyl-N-benzyl-6’-aminoquinine (62) 
 
Chemical Formula: C28H31N3O2 
Exact Mass: 441.24 
Molecular Weight: 441.56 
 
 
To a solution of N-benzyl-6’-aminoquinine (56) (50.0 mg, 0.125 mmol), DMAP (1.5 mg, 0.012 
mmol), and triethylamine (22.7 µL, 0.163 mmol) in DMF (0.5 mL) was added acetic anhydride 
(14.2 µL, 0.150 mmol) at 0 °C. The resulting red solution was stirred at r.t. for 3 hours. The 
resulting red solution was diluted by EtOAc (10 mL) and then was quenched by NaHCO3 
(saturated aqueous solution, 3 mL). The mixture was washed by water (10 mL). The aqueous 
phase was extracted by EtOAc (10 mL). The organic phases were combined, washed by 
brine (20 mL), dried over Na2SO4, filtered, and concentrated in vacuo to give red oil. The red 
oil was purified by FC (SiO2, EtOAc/MeOH, 95/5 → EtOAc/MeOH, 90/10) to give 9-acetyl-N-
benzyl-6’-aminoquinine (62) as a green oil (38.1 mg, 0.086 mmol, 69%). 
 
Rf = 0.49 (EtOAc/MeOH, 4/1); [α]20D = -19.6 (c 0.7, MeOH); IR (film) 3282, 3029, 2934, 2865, 
1743, 1624, 1533, 1453, 1365, 1234, 1027, 915, 850, 825, 734, 697  cm-1; 1H NMR (400 MHz, 
CD3OD) δH 8.55 (d, J = 4.4 Hz, 1H), 7.87 (d, J = 9.2 Hz, 1H), 7.41, (m, 2H),  7.33, (m, 2H), 
7.22-7.29, (m, 2H), 7.11 (d, J = 9.2 Hz, 1H), 6.99 (s, 1H), 6.33 (d, 7.2 Hz, 1H), 5.78 (ddd, J = 
17.6, 9.6, 8.0 Hz, 1H), 4.98 (d, J = 17.6 Hz, 1H), 4.97 (d, J = 9.6 Hz, 1H), 4.55 (m, 1H), 4.46 
(s, 1H), 4.45 (s , 1H), 3.27 (m, 1H), 2.96 (dd, , J = 13.6, 10.4 Hz, 1H), 2.44-2.51 (m, 2H), 2.21 
(m, 1H), 2.03 (s, 3H), 1.77 (m, 1H), 1.59 (m, 1H), 1.39-1.49 (m, 2H); 13C NMR (CD3OD, 100 
MHz) 170.1, 146.1, 145.6, 143.7, 142.2, 141.9, 138.8, 131.3, 128.8, 127.7, 127.4, 120.9, 
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119.1, 114.4, 99.5, 74.1, 58.7, 56.6, 48.2, 42.3, 39.8, 27.8, 27.6, 24.3, 21.1; HRMS (ES+) 
Calculated for C28H32N3O2 (M+1)+: 442.2459, Found: 442.2459 (Δ = 0 ppm).   
 
9-Acetyl-6’-aminodihydroquinine (63) 
 
Chemical Formula: C21H27N3O2 
Exact Mass: 353.21 
Molecular Weight: 353.46 
 
 
To a solution of 9-acetyl-N-benzyl-6’-aminoquinine (62) (233.0 mg, 0.528 mmol) in acetic acid 
(2.0, mL) was added 10% Pd/C (110.0 mg) at room temperature. The resulting solution was 
stirred at room temperature under the atmosphere of hydrogen for 17 hours. The reaction 
mixture was diluted by EtOAc (30 mL) and then filtered through Celite to remove Pd/C. The  
organic phase was washed by H2O (15 mL ×3). The aqueous phases were combined and 
then basified to pH = 10. The aqueous phase was extracted by EtOAc (30 mL ×3). The 
organic phases were combined, washed by brine (30 mL), dried over Na2SO4, filtered, and 
concentrated in vacuo to give brown oil. The brown oil was purified by FC (SiO2, 
EtOAc/MeOH/NEt3, 7/3/0.5) to give 9-acetyl-6’-aminodihydroquinine (63) as a pale yellow oil 
(142.4 mg, 0.403 mmol, 76%). 
 
Rf = 0.27 (EtOAc/MeOH, 7/3); [α]20D = -68.21 (c 1.29, MeOH); IR (film) 3346, 3203, 2939, 
2866, 1742, 1627, 1514, 1459, 1420, 1235 cm-1; 1H NMR (400 MHz, CD3OD) δH 8.44 (d, J = 
4.6 Hz, 1H), 7.78 (d, J = 9.0 Hz, 1H), 7.35 (d, J = 4.6 Hz, 1H), 7.26 (dd, J = 9.0, 2.3 Hz, 1H), 
7.17 (d, J = 2.4 Hz, 1H), 6.43 (d, J = 4.7 Hz, 1H), 3.35 (s, 1H), 3.28-3.18 (m, 2H), 3.05 (dd, J 
= 13.5, 10.0 Hz, 1H), 2.69 (ddd, J = 14.7, 10.9, 4.9 Hz, 1H), 2.34 (m, 1H), 2.18 (s, 3H), 1.87 – 
1.77 (m, 2H), 1.70 – 1.61 (m, 1H), 1.59-1.52 (m, 1H), 1.52-1.47 (m, 1H), 1.31-1.20 (m, 2H), 
0.82 (t, J = 7.3 Hz, 3H); 13C NMR (CD3OD, 100 MHz) δC 172.4, 149.8, 146.5, 144.9, 144.3, 
131.7, 129.5, 124.2, 120.3, 103.6, 76.3, 60.4, 60.2, 44.8, 39.2, 29.7, 29.3, 27.5, 24.2, 21.9, 
13.1; HRMS (ES+) Calculated for C21H28N3O2 (M+1)+: 354.2182, Found: 354.2194 (Δ = +3.4 
ppm). 
 
9-Acetyl-6’-hydroxyl-dihydroquinine 
 
    Chemical Formula: C21H26N2O3 
 Exact Mass: 354.19 
 Molecular Weight: 354.44 
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To a solution of 9-acetyl-demethylquinine (deMeQAc) (120.0 mg, 0.340 mmol) in methanol 
(5.0 mL) was added Pd(OH)2/C (10%, 20.0 mg). The resulting mixture was stirred under the 
atmosphere of hydrogen for 17 hours. The resulting mixture was filtered through celite and 
the filtrate was concentrated to give 9-acetyl-6’-hydroxyl-dihydroquinine as a yellow oil (101 
mg, 0.285 mmol, 85%). 
 
Rf = 0.51 (EtOAc/MeOH/NH4OH, 10/2/0.5); [α]20D = -40.49 (c 16.9, MeOH); IR (film) 2961, 
2935, 1754, 1620, 1512, 1466, 1404, 1372, 1287, 1221 cm-1; 1H NMR (400 MHz, CD3OD) δH 
8.59 (d, J = 4.6 Hz, 1H), 7.93 (d, J = 9.1 Hz, 1H), 7.47 (d, J = 4.6 Hz, 1H), 7.41 (d,  J = 2.6 Hz, 
1H), 7.37 (dd, J = 9.1 Hz, 2.6 Hz, 1H), 6.44 (d, J = 5.1 Hz, 1H), 3.23 (m, 1H), 2.97-3.12 (m, 
2H), 2.69 (ddd, J = 14.3, 11.0, 5.0 Hz, 1H), 2.33 (ddd, J = 13.3, 4.9, 2.4 Hz, 1H), 2.18 (s, 3H), 
1.83 (m, 2H), 1.70 (m, 2H) 1.47-1.61 (m, 2H), 1.31 (m, 2H), 1.25 (m, 2H), 0.84 (t, J = 7.3 Hz, 
3H) ; 13C NMR (CD3OD, 100 MHz) δC 172.4, 158.8, 148.3, 146.0, 145.2, 132.5, 129.2, 124.4, 
120.7, 106.1, 76.2, 60.7, 60.2, 44.7, 39.2, 29.7, 29.3, 27.4, 21.8, 13.2; HRMS (ES+) 
Calculated for C21H27N2O3 (M+1)+: 355.2022, Found: 355.2013 (Δ = -2.5 ppm). 
 
9-n-Butyletherquinine (66)30 
 
Chemical Formula: C24H32N2O2 
Exact Mass: 380.25 
Molecular Weight: 380.53 
 
 
To a suspension of sodium hydride (1.11 g, 60% in mineral oil, 27.8 mmol) in DMF (10 mL) 
was added a solution of quinine (3.0 g, 9.25 mmol) in DMF (20 mL) dropwise at 0 °C. The 
resulting yellow mixture was stirred at r.t. for 1 hour. To this mixture was added 1-
bromobutane (2.0 mL, 18.6 mmol) and then the mixture was stirred at 40 °C for 2 hours. The 
resulting yellow solution was quenched by water (100 mL). The aqueous phase was extracted 
by EtOAc (100 mL ×3). The organic phases were combined and extracted by aqueous HCl 
solution (0.25 N, 20 mL ×5). The acidic aqueous phases were combined, basified to pH = 9-
10 by NaOH (15 mL, 2 N, aqueous solution). The cloudy aqueous phase was extracted by 
EtOAc (50 mL ×3). The organic phases were combined, washed by brine (100 mL), dried 
over Na2SO4, filtered, and concentrated in vacuo to give 9-n-butyletherquinine (66) as a 
yellow oil (3.22 g, 8.46 mol, 92%). 
 
Rf = 0.27 (EtOAc/MeOH, 1/1); 1H NMR (400 MHz, CDCl3) δH 8.72 (d, J = 4.4 Hz, 1H), 8.00 (d, 
J = 9.2 Hz, 1H), 7.40 (d, J = 4.4 Hz, 1H), 7.34 (dd, J = 9.2, 2.8 Hz, 1H), 7.29 (s, 1H), 5.68 
(ddd, J = 17.6, 10.3, 7.7 Hz, 1H), 5.05 (s, 1H), 4.91 (d, J = 17.6 Hz, 1H), 4.86 (d, J = 10.3 Hz, 
1H), 3.91 (s, 3H), 3.47-3.39 (m, 1H), 3.34 (t, J = 6.4 Hz, 2H), 3.08 (dd, J = 13.6, 10.2 Hz, 1H), 
3.06-3.00 (m, 1H), 2.69 (m, 1H), 2.60 (m, 1H), 2.22 (m, 1H), 1.85-1.67 (m, 3H), 1.64 – 1.54 
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(m, 2H), 1.49 (m, 2H), 1.40 (h, J = 7.3 Hz, 2H), 0.89 (t, J = 7.3 Hz, 3H); HRMS (ES+) 
Calculated for C24H33N2O2 (M+1)+: 381.2542, Found: 381.2534 (Δ = -2.1 ppm). 
 
9-n-Butylether-6’-hydroxyquinine (67)22 
 
Chemical Formula: C23H30N2O2 
Exact Mass: 366.23 
Molecular Weight: 366.51 
 
 
To a suspension of sodium hydride (1.77 g, 60% in mineral oil, 44.2 mmol) in DMF (20 mL) 
was added ethane thiol (2.7 mL, 36.8 mmol) at 0°C and then the mixture was stirred for 10 
minutes at r.t. (Caution: Strongly exothermic reaction! Explosion!). To this mixture was added 
a solution of 9-n-butylether-quinine (66) (2.80 g, 7.36 mmol) in DMF (30 mL) at r.t. and the 
resultant solution was stirred at 130°C for 20 hours. After cooling down, the orange solution 
was poured into water (100 mL). The aqueous phase was acidified to pH = 8~9 by HCl. The 
aqueous phase was extracted by EtOAc (100 mL ×3). The organic phases were combined 
and then extracted by HCl (2 N, 25 mL ×3). The acidic aqueous phases were combined and 
neutralised to pH=9-10 by NaOH (pellets). The mixture was extracted by EtOAc (50 mL ×3). 
The organic phases were combined, washed by brine (100 mL), dried over Na2SO4, and 
filtered. The volume of the filtrate was reduced to 20 mL and white solids were formed. The 
filtrate was then stored at -20 °C for overnight to facilitate the precipitation. The mixture was 
then filtered to give 9-n-butylether-6’-hydroxyquinine (67) as a white powder (2.3 g, 6.28 mmol, 
85%). (Caution: Ethanethiol has a strong smell and keep the raction vessel in a fumehood all 
the time. The aqueous waste should be bleached.) 
 
mp 202-205 °C (decomposed); [α]20D = -143.2 (c 0.94, MeOH); IR (film) 2932, 2870, 1619, 
1509, 1466, 1240, 1107, 907, 855, 821, 728, 646 cm-1; 1H NMR (400 MHz, CDCl3) δH 8.66 (d, 
J = 4.4 Hz, 1H), 8.48 (br, 1H), 8.07 (d, J = 2.6 Hz, 1H), 7.98 (d, J = 9.0 Hz, 1H), 7.37 (d, J = 
4.4 Hz, 1H), 7.29 (dd, J = 9.0, 2.4 Hz, 1H), 5.58 (ddd, J = 17.5, 10.3, 7.6 Hz, 1H), 5.30 (s, 1H), 
4.87 (d, J = 17.5 Hz, 1H), 4.82 (d, J = 10.3 Hz, 1H), 3.59 (m, 1H), 3.33-3.21 (m, 2H), 3.21-
3.09 (m, 1H), 2.95 (m, 1H), 2.84 (td, J = 12.7, 11.9, 5.3 Hz, 1H), 2.55 (ddd, J = 14.0, 5.5, 2.5 
Hz, 1H), 2.32 (m, 1H), 2.06 – 1.94 (m, 1H), 1.88 (m, 1H), 1.80 (m, 1H), 1.65-1.46 (m, 3H), 
1.36 (m, 3H), 0.87 (t, J = 7.3 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δC 156.9, 146.6, 144.4, 
143.6, 140.7, 131.1, 128.0, 123.3, 117.8, 114.9, 107.3, 69.1, 59.4, 56.3, 43.3, 39.4, 32.1, 27.8, 
26.9, 19.5, 13.9; HRMS (ES+) Calculated for C23H31N2O2 (M+1)+: 367.2386, Found: 367.2388 
(Δ = +0.5 ppm). 
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9-n-Butylether-6’-hydroxy-dihydroquinine (75) 
 
Chemical Formula: C23H32N2O2 
Exact Mass: 368.24 
Molecular Weight: 368.52 
 
 
A mixture of 9-n-butylether-6’-hydroxyquinine (67) (100.0 mg, 0.273 mmol) and 10% Pd/C 
(28.7 mg) in MeOH (3.0 mL) was stirred under 1 atm of H2 at r.t. for 19 hours. The resulting 
mixture was filtered through Celite and the filtrate was concentrated in vacuo to give 9-n-
butylether-6’-hydroxy-dihydroquinine (75) as a light yellow powder (91.0 mg, 0.247 mmol, 
93%). 
 
mp. 190-191 °C; [α]20D = -133.6 (c 0.7, MeOH); IR (film) 2930, 2871, 1618, 1465, 1240, 1117, 
1077, 907, 855, 728 cm-1; 1H NMR (400 MHz, CDCl3) δH 11.34 (brs, 1H), 8.64 (d, J = 4.4 Hz, 
1H), 8.08 (d, J = 2.5 Hz, 1H), 7.96 (d, J = 9.0 Hz, 1H), 7.35 (d, J = 4.4 Hz, 1H), 7.29 (dd, J = 
9.0, 2.4 Hz, 1H), 5.29 (s, 1H), 3.59 (m, 1H), 3.20 (m, 3H), 2.96 (m, 1H), 2.83 (m, 1H), 2.36-
2.22 (m, 1H), 1.87 (m, 1H), 1.81-1.75 (m, 1H), 1.52-1.47 (m, 4H), 1.35-1.28 (m, 3H), 1.15-
1.08 (m, 2H), 0.85 (t, J = 7.3 Hz, 3H), 0.71 (t, J = 7.3 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δC 
157.2, 146.4, 144.3, 143.5, 131.0, 128.0, 123.5, 117.8, 107.5, 78.3, 69.0, 59.2, 57.9, 43.3, 
36.9, 32.1, 27.4, 27.1, 25.3, 19.5, 13.9, 11.8; HRMS (ES+) Calculated for C23H33N2O2 (M+1)+: 
369.2542, Found: 369.2532 (Δ = −2.7 ppm). 
 
9-n-Butylether-N-benzyl-6’-aminoquinine (68) 
 
Chemical Formula: C30H37N3O 
Exact Mass: 455.29 
Molecular Weight: 455.63 
 
 
A mixture of 9-n-butylether-6’-hydroxyquinine (67) (1.00 g, 2.73 mmol) and sodium bisulfite 
(2.84 g, 27.3 mmol) in benzylamine / water = 20 mL / 80 mL was stirred at 150 °C for 4 days. 
The resulting mixture was partitioned between EtOAc (100 mL) and water (50 mL). The 
aqueous phase was extracted by EtOAc (100 mL ×2). The organic phases were combined, 
washed by brine (150 mL), dried over Na2SO4, filtered, and concentrated to give yellow oil. 
The oil was distilled to remove benzylamine to give a brown oil. The brown oil was purified by 
FC (SiO2, EtOAc → EtOAc/MeOH, 100/7.5) to give 9-n-butylether-N-benzyl-6’-aminoquinine 
(68) as a white powder (848.0 mg, 1.86 mmol, 68%). 
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Rf = 0.56 (EtOAc/MeOH, 4/1); mp. 136-140°C  [α]20D = -119.7 (c 0.97, MeOH); IR (film) 3281, 
2933, 2868, 1623, 1531, 1452, 1356, 1105  cm-1; 1H NMR (400 MHz, CDCl3) δH 8.57 (d, J = 
4.4 Hz, 1H), 7.89 (d, J = 9.2 Hz, 1H), 7.25-7.39, (m, 6H),  7.11 (dd, , J = 9.2 Hz, 2.4 Hz, 1H), 
6.91 (s, 1H), 5.66 (ddd, J = 17.6 Hz, 9.6 Hz, 8.0 Hz, 1H), 4.96 (br, 1H), 4.90 (d, J = 17.6 Hz, 
1H), 4.84 (d, J = 9.6 Hz, 1H), 4.48-4.50 (m, 1H), 4.42 (dd, J = 12.0 Hz, 4.0 Hz, 2H), 3.36 (m, 
1H), 3.29 (m, 2H), 3.02 (dd, J = 13.2 Hz, 10.4 Hz, 1H), 2.95 (m, 1H), 2.62 (m, 1H), 2.46 (m, 
1H), 2.21 (m, 1H), 1.72 (m, 3H), 1.54 (m, 2H), 1.40 (m, 4H), 0.89 (t, J = 7.2 Hz, 3H) ; 13C 
NMR (CDCl3, 100 MHz) δC 13.9, 19.5, 27.8, 28.0, 32.1, 40.1, 43.3, 48.2, 57.1, 59.7, 69.1, 
77.2, 99.4, 109.9, 114.0, 118.4, 120.3, 127.3, 127.4, 128.0, 128.7, 131.3, 138.6, 142.0, 143.3, 
143.8, 145.8, 145.9; HRMS Calculated for C30H38N3O (M+1)+: 456.3015. Found: 456.3031 (Δ 
= +3.5 ppm). 
 
9-n-Butyl-6’-aminodihydroquinine TFA salt (69) 
 
Chemical Formula: C25H34F3N3O 
Exact Mass: 481.26 
Molecular Weight: 481.55 
 
 
To a solution of 9-n-butylether-N-benzyl-6’-aminoquinine (68) (285.0 mg, 0.626 mmol) in 
trifluoroacetic acid (3.0 mL) was added 10% Pd/C (66.0 mg) at r.t.. The resulting mixture was 
stirred under the atmosphere of H2 (1 atm) at room temperature for 17 hours. The mixture 
was diluted by EtOAc (30 mL) and then filtered through Celite@. The filtrate was washed by 
water (30 mL ×3) and brine (30 mL), dried over Na2SO4, filtered, and concentrated in vacuo to 
give a dark solid. (When the filtrate was initially washed by water, the product was expected 
to stay in the aqueous phase. Surprisingly, the product stayed in the organic phase.) The 
organic phase was washed by NaOH (2 N, 30 mL) and brine (30 mL), dried over Na2SO4, 
filtered, and concentrated to give a brown powder. The brown powder was purified by FC 
(SiO2, EtOAc → EtOAc/MeOH/NEt3, 8/2/0.5) to give 9-n-butyl-6’-aminodihydroquinine TFA 
salt (69) as a dark yellow powder (142.4 mg, 0.296 mmol, 76%). 
 
Rf = 0.27 (EtOAc/MeOH, 7/3); mp. 183-185 °C; [α]20D = -117.7 (c 1.01, MeOH); IR (film) 3344, 
3230, 2960, 2934, 2875, 1673, 1633, 1515, 1463, 1370, 1277, 1199, 1179, 1129, 1086, 855, 
831, 764, 750, 720, 647 cm-1; 
1
H NMR (CDCl3, 400 MHz) δH 12.56 (brs, 1H), 8.58 (d, J = 4.4 
Hz, 1H), 7.88 (d, J = 8.9 Hz, 1H), 7.47 (d, J = 2.4 Hz, 1H), 7.30 (d, J = 4.4 Hz, 1H), 7.14 (dd, J 
= 8.9, 2.3 Hz, 1H), 5.59 (s, 1H), 3.95 (ddd, J = 14.5, 10.2, 3.6 Hz, 1H), 3.49 – 3.37 (m, 4H), 
3.14 (td, J = 12.1, 5.9 Hz, 1H), 2.84 (m, 1H), 2.19 (dd, J = 14.6, 7.6 Hz, 1H), 2.15-2.07 (m, 
1H), 2.02 (q, J = 3.1 Hz, 1H), 1.89-1.74 (m, 2H), 1.66-1.57 (m, 2H), 1.50-1.43 (m, 1H), 1.38 
(dt, J = 14.8, 7.6 Hz, 2H), 1.24 (m, 2H), 0.91 (t, J = 7.3 Hz, 3H), 0.79 (t, J = 7.3 Hz, 3H); 13C 
NMR (CDCl3, 100 MHz) δC 162.7 (q, J = 35 Hz), 146.8, 144.9, 142.6, 139.8, 130.8, 127.1, 
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121.7, 117.6, 116.8 (q, J = 291 Hz), 102.0, 75.2, 69.4, 59.4, 56.4, 43.5, 35.3, 31.9, 26.7, 24.9, 
24.6, 19.4, 18.0, 13.9, 11.4; 19F NMR (CDCl3, 376 MHz) -75.4; HRMS (ES+) Calculated for 
C23H34N3O (M+1, free amine)+: 368.2702, Found: 368.2701 (Δ = -0.3 ppm). A single crystal X-
ray determination was also performed on this compound - see appendix 
 
9-n-Butyl-6’-aminodihydroquininyl acetamide (70) 
 
 Chemical Formula: C25H35N3O2 
 Exact Mass: 409.27 
 Molecular Weight: 409.56 
 
 
To a solution of 6’-aminodihydroquinine TFA salt (69) (50.0 mg, 0.105 mmol) in pyridine (0.5 
mL) was added acetyl chloride (37 uL, 0.525 mmol) at 0 °C. The resulting solution was stirred 
at r.t. for 1 hour. The resulting solution was quenched by NaOH(aq) (2 N, 10 mL). The mixture 
was extracted by EtOAc (30 mL ×3). The organic phases were combined, washed by brine 
(30 mL), dried over Na2SO4, filtered, and then concentrated in vacuo to give brown oil. The 
brown oil was purified by FC (SiO2, EtOAc → EtOAc/MeOH/NEt3, 8/2/0.5) to give 9-n-butyl-6’-
aminodihydroquininyl acetamide (70) as a bright yellow powder (41.6 mg, 0.102 mmol, 97%). 
 
Rf = 0.44 (EtOAc/MeOH, 1/1); mp 65-67 °C; [α]20D = -97.6 (c 0.98, MeOH); IR (film) 3265, 
3029, 2957, 2932, 2870, 1682, 1622, 1598, 1561, 1504, 1460, 1367, 1303, 1278, 1119, 1088  
cm-1; 
1
H NMR (CDCl3, 400 MHz) δH 8.76 (d, J = 4.5 Hz, 1H), 8.64 (s, 1H), 8.18 (s, 1H), 8.16 
(s, 1H), 8.03 (d, J = 9.2 Hz, 1H), 7.40 (d, J = 4.5 Hz, 1H), 5.13 (s,  1H), 3.42 (t, J = 11.6 Hz, 
1H), 3.29 (t, J = 6.4 Hz, 2H), 3.09 (dd, J = 13.5, 9.8 Hz, 2H), 2.70 (td, J = 10, 6.4 Hz 1H), 
2.35-2.45 (m, 1H), 2.20 (s, 3H), 1.73-1.88 (m, 3H), 1.41-1.60 (m, 5H), 1.36 (m, 2H), 1.14-1.25 
(m, 2H), 0.86 (t, J = 7.3 Hz, 3H), 0.75 (t, J = 7.3 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δC 
169.0, 148.8, 145.6, 145.5, 137.0, 130.9, 126.6, 123.3, 118.3, 111.3, 79.6, 69.4, 60.4, 58.2, 
43.3, 37.1, 32.0, 27.7, 27.3, 25.3, 24.5, 21.0, 19.4, 13.9, 11.9 HRMS (ES+) Calculated for 
C25H36N3O2 (M+1)+: 410.2808, Found: 410.2815 (Δ = +1.7 ppm). 
 
9-n-Butyl-6’-aminodihydroquininyl trifluoroacetamide (71) 
 
Chemical Formula: C25H32F3N3O2 
Exact Mass: 463.24 
Molecular Weight: 463.54 
 
 
To a solution of 6’-aminodihydroquinine TFA salt (69)  (100.0 mg, 0.211 mol) in pyridine (0.5 
mL) was added trifluoroacetic acid anhydride (0.05 mL, 0.359 mmol) at 0°C. The resulting 
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solution was stirred at 0 °C for 2 hours and then quenched by NaOH(aq) (2 N, 10 mL). The 
mixture was extracted by EtOAc (30 mL ×3). The organic phases were combined, washed by 
brine (30 mL), dried over Na2SO4, filtered, and then concentrated in vacuo to give a red 
powder. The red powder were purified by FC (SiO2, EtOAc → EtOAc/MeOH/NEt3, 8/2/0.5) to 
give 9-n-butyl-6’-aminodihydroquininyl trifluoroacetamide (71) as a red powder (84.7 mg, 
0.183 mmol, 87%). 
 
Rf = 0.19 (EtOAc/MeOH, 8/2); mp 93-98 °C; [α]20D = -164.1 (c 0.80, MeOH); IR (film) 2958, 
2933, 2871, 1721, 1672, 1629, 1581, 1567, 1251, 1233, 1198, 1152, 1120, 1086, 910, 831, 
731, 646 cm-1; 
1
H NMR (CDCl3, 400 MHz) δH 8.86 (d, J = 4.4 Hz, 1H), 8.32 (d, J = 2.6 Hz, 
1H), 8.25 (dd, J = 9.5, 2.4 Hz, 1H), 8.15 (d, J = 9.5 Hz, 1H), 7.46 (d, J = 4.4 Hz, 1H), 5.15 (s, 
1H), 3.49-3.38 (m, 1H), 3.35 (t, J = 6.4 Hz, 2H), 3.11 (dd, J = 13.6, 10.4 Hz, 1H), 3.07 (m, 1H), 
2.69-2.79 (m, 1H), 2.35-2.46 (m, 1H), 1.79-1.91 (m, 3H), 1.55-1.64 (m, 2H), 1.48-1.53 (m, 3H), 
1.39 (td, J = 14.7, 7.4 Hz, 2H), 1.23 (m, 3H), 0.90 (t, J = 7.4 Hz, 3H), 0.79 (t, J = 7.4 Hz, 3H); 
13C NMR (CDCl3, 100 MHz) δC 155.4 (q, JC-CF3 = 37 Hz), 149.9, 146.5, 146.2, 134.6, 131.4, 
126.5, 123.0, 118.9, 115.8 (q, JCF3 = 287 Hz), 113.6, 80.0, 69.5, 60.5, 58.1, 43.2, 37.1, 32.0, 
27.7, 27.3, 25.3, 21.3, 19.5, 13.8, 11.9; 19F NMR (CDCl3, 376 MHz) -75.5; HRMS (ES+) 
Calculated for C25H33N3O2F3 (M+1)+: 464.2525, Found: 464.2510 (Δ = -3.2 ppm). 
 
9-n-Butyl-6’-aminodihydroquininyl-1,3-bis(trifluoromethyl)phenyl urea (72) 
 
Chemical Formula: C32H36F4N4O2 
Exact Mass: 622.27 
Molecular Weight: 622.66 
 
 
To a mixture of 6’-aminodihydroquinine TFA salt (69) (100.0 mg, 0.211 mmol) and K2CO3 
(200.0 mg, 1.45 mmol) in THF (8.0 mL) was adde 1,3-bis(trifluoromethyl)phenyl isocyanate 
(40 uL, 0.23 mmol) at r.t.. The resulting mixture was stirred for 17 hours and then filtered. The 
filtrate was concentrated to remove solvent to give brown oil. The brown oil was dissolved in 
Et2O (30 mL). The organic phase was washed by water (30 mL) and brine (30 mL), dried over 
Na2SO4, filtered, and then concentrated in vacuo to give 9-n-butyl-6’-aminodihydroquininyl-
1,3-bis(trifluoromethyl)phenyl urea (72) as a brown powder (119.6 mg, 0.192 mmol, 92%). 
 
Rf = 0.44 (EtOAc/MeOH, 8/2); mp 139-141 °C; [α]20D = -67.3 (c 1.16, MeOH); IR (film) 2960, 
2933, 2874, 1713, 1562, 1470, 1275, 1172, 1123, 928, 728, 702 cm-1; 
1
H NMR (C6D6, 400 
MHz) δH 10.00 (brs, 1H), 9.87 (brs, 1H), 8.72 (d, J = 4.4 Hz, 1H), 8.65 (s, 1H), 8.26 (s, 2H), 
7.91 (d, J = 9.0 Hz, 1H), 7.61 (d, J = 9.0 Hz, 1H), 7.35 (s, 1H), 7.20 (d, J = 4.4 Hz, 1H), 6.10 
(s, 1H), 3.89-3.70 (m, 2H), 3.63 (dd, J = 10.5, 5.0 Hz, 1H), 3.59-3.54 (m, 1H), 3.49 (m, 1H), 
3.19-3.14 (m, 1H), 3.03 (dd, J = 13.2, 10.3 Hz, 1H), 2.62 (m, 1H), 1.64-1.47 (m, 4H), 1.43-
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1.39 (m, 1H), 1.39-1.30 (m, 3H), 1.23 (s, 1H), 1.06-1.00 (m, 2H), 0.93 (t, J = 7.3 Hz, 3H), 0.53 
(t, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δC 153.6, 148.4, 145.7, 142.1, 142.0, 137.8, 
133.6 (q, J = 33 Hz), 131.2, 126.1, 123.7 (q, J = 271 Hz), 123.4, 118.1, 115.1, 114.1, 111.4, 
77.3, 69.8, 67.8, 60.1, 56.5, 43.9, 36.0, 32.5, 30.2, 26.9, 25.8, 25.1, 19.9, 18.8, 14.2, 11.5; 19F 
NMR (CDCl3, 376 MHz) -62.8; Calculated for C32H37N4O2F6 (M+1)+: 623.2821, Found: 
623.2801 (Δ = -3.2 ppm). 
 
9-n-Butyl-6’-aminodihydroquininyl trifluorosulfonamide (74) 
 
Chemical Formula: C24H32F3N3O3S 
Exact Mass: 499.21 
Molecular Weight: 499.59 
 
 
To a solution of 6’-aminodihydroquinine TFA salt (69) (100.0 mg, 0.211 mmol) and pyridine 
(34 µL, 0.420 mmol) in CH2Cl2 was added trifluoromethanesulfonic anhydride (39 µL, 0.232 
mmol) at 0 °C. The resulting solution was stirred at 0 °C for 17 hours and then diluted by 
CH2Cl2 (10 mL). The organic phase was washed by buffer (10 mL, pH = 9 – 10, 
Na2CO3/NaHCO3), dried over Na2SO4, filtered, and then concentrated in vacuo to give 9-n-
butyl-6’-aminodihydroquininyl trifluorosulfonamide (74) as a red oil (23.2 mg, 0.046 mmol, 
22%).  
 
Rf = 0.19 (EtOAc/MeOH, 8/2); 
1
H NMR (CDCl3, 400 MHz) δH 8.86 (d, J = 4.4 Hz, 1H), 8.48 (d, 
J = 9.0 Hz, 1H), 8.42 (s, 1H), 8.14 (d, J = 9.0 Hz, 1H), 7.44 (d, J = 4.4 Hz, 1H), 5.33 (s, 1H), 
3.63-3.54 (m, 1H), 3.41 (t, J = 6.5 Hz, 2H), 3.25-3.16 (m, 2H), 2.84 (dt, J = 11.0, 6.4 Hz, 1H), 
2.59-2.55 (m, 1H), 1.99-1.91 (m, 2H), 1.91-1.86 (m, 1H), 1.63-1.58 (m, 5H), 1.43-1.37 (m, 2H), 
1.25-1.21 (m, 2H), 0.91 (t, J = 7.4 Hz, 3H), 0.79 (t, J = 7.4 Hz, 3H); 
 
3.2.4 Towards the total synthesis of lycorine  
 
(3aR*, 7aS*, 7S*)-(tert-Butylsilanyloxy)-2,2-dimethyl-(7,7a)-dihydro-(3a)H-
benzo[1,3]dioxol-4-one (113)7 
 
Chemical Formula: C15H26O4Si 
Exact Mass: 298.16 
Molecular Weight: 298.45 
 
To a solution of endoperoxide 11 (1.00 g, 5.43 mmol) in CH2Cl2 (17 mL) was added 9-acetyl-
demethylquinine (deMeQAc) (95.7 mg, 0.272 mmol) at r.t. The resulting solution was stirred 
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at r.t. for 5 hours. To this solution was added DMF (10 mL) and then CH2Cl2 was removed 
under reduced pressure. A solution of tert-butyldimethylsilyl chloride (4.09 g, 27.2 mmol) in 
DMF (7 mL) was bubbled by N2 for 10 mins. To this solution was added diisopropylethylamine 
(4.83 mL, 27.7 mmol) at r.t. and then the solution was stirred for further 10 minutes. The 
solution was then added to the previous reaction solution at r.t. The resulting solution was 
then stirred at r.t. for 17 hours. The resulting solution was quenched by NaHCO3(aq) (10 mL, 
saturated). The mixture was partitioned between water (10 mL) and EtOAc (50 mL). The 
aqueous phase was extracted by EtOAc (50 mL ×2). The organic phases were combined, 
washed by brine (100 mL), dried over Na2SO4, filtered, and then concentrated in vacuo to 
give brown oil. The brown oil was purified by FC (SiO2, Hexane → EtOAc/Hexane, 1/20) to 
give cyclohexenone 113 as a yellow oil (899.5 mg, 3.01 mmol, 56%).  
 
Rf = 0.29 (EtOAc/Hexane, 1/20); 64% ee; 
1
H NMR (C6D6, 400 MHz) δH 6.74 (ddd, J = 10.3, 
3.8, 1.2 Hz, 1H), 6.05 (ddd, J = 10.3, 1.2, 0.5 Hz, 1H), 4.51 (ddd, J = 3.8, 3.2, 1.2 Hz, 1H), 
4.43-4.32 (m, 2H), 1.39 (s, 3H), 1.37 (s, 3H), 0.89 (s, 9H), 0.14 (s, 3H), 0.12 (s, 3H); m/z (ES+) 
299 [(M+1)+, 100%]. Spectroscopic data are in accord with literature report.7 
 
 
(3aR*, 7aS*, 7S*)-(Triisopropylsilanyloxy)-2,2-dimethyl-(7,7a)-dihydro-(3a)H-
benzo[1,3]dioxol-4-one (130) 
 
Chemical Formula: C18H32O4Si 
Exact Mass: 340.21 
Molecular Weight: 340.53 
 
To a solution of endoperoxide 11 (100.0 mg, 0.543 mmol) in DMF (2.5 mL) was added 
ethyldiisopropylamine (47 µL, 0.27 mmol) at r.t. The resulting solution was stirred at r.t. for 7 
hours. To this solution was added another solution of 2,6-lutidine (0.2 mL, 1.64 mmol) and 
triisopropylsilyl trifluoromethanesulfonate (0.29 mL, 1.09 mmol) in DMF (1.0 mL) at r.t. The 
resulting solution was stirred at r.t. for 17 h and at 40°C for another 2 hours. The reaction 
solution was diluted by EtOAc (30 mL) and then washed with water (30 mL). The aqueous 
phase was extracted by EtOAc (30 mL ×2). The organic phases were combined, washed with 
brine (30 mL), dried over Na2SO4, filtered, and concentrated in vacuo to give a brown oil. The 
brown oil was purified by FC (SiO2, Ether/Pet ether, 2/8) to give cyclohexenone 130 as a 
colourless oil (75.0 mg, 0.220 mmol, 41%). 
 
Rf = 0.67 (Ether); IR (film) 2943, 2868, 1696, 1464, 1383, 1375, 1239, 1225, 1165, 1080, 
1068, 998, 883, 844, 828, 735, 684 cm-1; 1H NMR (CDCl3, 400 MHz) δH 6.81 (ddd, J = 10.4, 
4.1, 1.5 Hz, 1H), 6.05 (d, J = 10.4 Hz, 1H), 4.63 (dd, J = 4.1, 2.7 Hz, 1H), 4.46 (m, 1H), 4.41 
(m, 1H), 1.37 (s, 3H), 1.33 (s, 3H), 0.98-1.11 (m, 21H); 13C NMR (CDCl3, 100 MHz) δC 195.1, 
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147.5, 127.8, 109.9, 79.4, 66.3, 27.3, 25.8, 17.9, 12.1; HRMS (EI+) Calculated for C18H33O4Si 
(M+1)+: 341.2148, Found: 341.2139 (Δ = −2.6 ppm). 
 
(3aR* ,6S* ,7S* ,7aS*)- Trifluoromethanesulfonic acid 7-(tert- butyldimethylsilanyloxy)- 
2,2-dimethyl-6-( 2- morpholin -4- yl- 2- thioxo-ethyl)- 3a,6,7,7a-
tetrahydrobenzo[l,3]dioxol-4-yl ester (119)74 
 
Chemical Formula: C22H36F3NO7S2Si 
Exact Mass: 575.17 
Molecular Weight: 575.73 
 
 
According to the method of Martin, to a solution of lithium hexamethyldisilazide (5.4 mL, 1 M 
in THF, 5.40 mmol) in THF (5.0 mL) was added another solution of ethyl dithioacetate (0.53 
mL, 4.62 mmol) in THF (4.0 mL) dropwise at -70 °C. The solution was warmed up at to -45 °C 
for 30 minutes and then was stirred at -45 °C for 30 minutes. To this solution was added 
another solution of TBS-protected 4-hydroxycyclohexenone 113 (1.15 g, 3.85 mmol) in THF 
(7.0 mL) at -45 °C and then the solution was warmed to -10 °C slowly for 2 hours. The 
reaction solution was cooled down to -70 °C and another solution of Comins reagent (2.42 g, 
6.16 mmol) in THF (5.0 mL) was added to the reaction solution at -70 °C. The reaction 
solution was gradually warmed up to 0 °C over 2 hours and then morpholine (1.68 mL, 19.3 
mmol) was added to the reaction solution at 0°C. The resulting solution was stirred at 0 °C to 
r.t. for 14 hours and then was concentrated in vacuo to give pale red oil. The pale red oil was 
purified by FC (SiO2, Hexane → EtOAc/Hexane, 1/10) to give vinyl triflate 115 as a yellow oil 
(2.17 g, 3.77 mmol, 98%). 
 
Rf = 0.22 (EtOAc/Hexane, 1/10); 1H NMR (CDCl3, 400 MHz) δH 5.64 (dd, J = 2.5, 1.0 Hz, 1H), 
4.64 (dd, J = 5.6, 2.0 Hz, 1H), 4.44 (dt, J = 13.7, 4.6 Hz, 1H), 4.34 (ddd, J = 4.3, 3.2, 1.0 Hz, 
1H), 4.31-4.22 (m, 2H), 3.81-3.68 (m, 6H), 3.60 (m, 1H), 2.83 (dd, J = 15.5, 7.5 Hz, 1H), 2.71 
(dd, J = 15.5, 7.5 Hz, 1H), 1.43 (s, 3H), 1.39 (s, 3H), 0.85 (s, 9H), 0.09 (s, 3H), 0.02 (s, 3H); 
m/z (ES+) 576 [(M+1)+, 100%]. Spectroscopic data are in accord with literature report.74 
 
(3aR*, 6S*, 7S*, 7aS*)-Trifluoromethanesulfonic acid 7-(triisopropylsilanyloxy)-2,2-
dimethyl-6-(2-morpholin-4-yl-2-thioxo-ethyl)-3a,6,7,7a-tetrahydrobenzo[1,3]dioxol-4-yl 
ester (133) 
 
Chemical Formula: C25H42F3NO7S2Si 
Exact Mass: 617.21 
Molecular Weight: 617.81 
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To a solution of lithium hexamethyldisilazide (0.54 mL, 1 M in THF, 0.540 mmol) in THF (1.0 
mL) was added another solution of ethyl dithioacetate (53 µL, 0.46 mmol) in THF (0.5 mL) at -
70 °C. The solution was warmed up to -45 °C for 30 minutes and then was stirred at -45 °C 
for 30 minutes. To this solution was added another solution of triisopropylsilyl-protected 4-
hydroxycyclohexenone 130 (130.0 mg, 0.382 mmol) in THF (1.0 mL) at -45 °C and then the 
solution was warmed to -10 °C slowly for 2 hours. The reaction solution was cooled down to -
70 °C and another solution of Comins reagent (240.0 mg, 0.611 mmol) in THF (1.0 mL) was 
added to the reaction solution at -70 °C. The reaction solution was gradually warmed up to 0 
°C over 2 hours and then morpholine (0.17 mL, 1.91 mmol) was added to the reaction 
solution at 0 °C. The resulting solution was stirred at 0 °C to r.t. for 17 hours and then was 
concentrated in vacuo to give orange oil. The orange oil was purified by FC (SiO2, Hexane → 
EtOAc/Hexane, 1/9) to give vinyl triflate 131 as a yellow oil (172.0 mg, 0.278 mmol, 74%). 
 
Rf = 0.58 (EtOAc/Hexane, 1/2); IR (film) 2945, 2868, 1467, 1420, 1385, 1279, 1246, 1213, 
1142, 1117, 1081, 1020, 919, 883, 800, 681 cm-1; 1H NMR (CDCl3, 400 MHz) δH 5.71 (d, J = 
2.7 Hz, 1H), 4.67 (dd, J = 5.7, 1.8 Hz, 1H), 4.40-4.43 (m, 1H), 4.33-4.40 (m, 2H), 4.29 (dt, J = 
13.7, 5.0 Hz, 1H), 3.67-3.78 (m, 6H), 3.60-3.65 (m, 1H), 2.85 (m, 2H), 1.41 (s, 3H), 1.37 (s, 
3H), 1.03 (m, 21H); 13C NMR (CDCl3, 100 MHz) δC 200.2, 145.6, 120.9, 110.9, 71.9, 70.7, 
66.5, 66.1, 50.1, 49.9, 41.3, 37.9, 27.5, 26.2, 18.0, 12.8; HRMS (ES+) Calculated for 
C25H43NO7F3SiS2 (M+1)+: 618.2202 , Found: 618.2180 (Δ = −3.6 ppm).  
 
(3aR*, 4R*, 5R*, 7aR*)-2-[4-(tert-Butyldimethylsilanyloxy)-2,2-dimethyl-7-phenyl- 
3a,4,5,7a-tetrahydroenzo[1,3]dioxol-5-yl]-1-morpholin-4-ylethanethione (122)74 
 
Chemical Formula: C28H41NO6SSi 
Exact Mass: 547.24 
Molecular Weight: 547.78 
 
 
Preparation of the ate-complex: 
To a solution of 1-bromo-3,4-(methylenedioxy)benzene (84 µL, 0.70 mmol) in Et2O (2.0 mL) 
was added tBuLi (0.9 mL, 1.53 mmol, 1.7 M in pentane) dropwise at -78°C. The solution was 
stirred at -78 °C for 30 minutes.  To this solution was added 9-BBN-OMe solution (1.6 mL, 1.6 
mmol, 1.0 M in hexane) at -78 °C. The solution was slowly warmed up to r.t. for 1.5 hours and 
then was quenched by a solution of K3PO4 (362.7 mg, 1.58 mmol) in water (0.6 mL).  
 
The Suzuki coupling: 
A solution of vinyl triflate 119 (200.0 mg, 0.347 mmol) in DMF (8.0 mL) was degased by 
freeze-thaw technique three times and then was transferred by canula into the previous ate-
complex solution at r.t.. The resulting solution was degased by bubbling N2 for another 30 
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minutes. To this solution was added PdCl2(dppf)CH2Cl2 (28.6 mg, 0.035 mmol) at r.t. The 
resulting black solution was stirred at room temperature for 3 hours. To the black solution was 
added more PdCl2(dppf)CH2Cl2 (28.6 mg, 0.035 mmol) at room temperature and then the 
solution was stirred at r.t. for 17 hours. The resulting black solution was diluted with Et2O (50 
mL) and then was washed with water (50 mL). The organic phases were combined, washed 
with brine (50 mL), dried over Na2SO4, filtered, and concentrated in vacuo to give a black oil. 
The black oil was purified by FC (Al2O3, Hexane/EtOAc, 8/2) to give thioamide 119 as a 
colourless oil (114.0 mg, 0.208 mmol, 60%). [Amide 128 was also isolated (31.6 mg, 0.059 
mmol, 17%). The combined yield for the Suzuki coupling reaction was 77%.] 
 
Rf = 0.38 (EtOAc/Hexane, 1/2); 1H NMR (CDCl3, 400 MHz) δH 7.00-6.98 (m, 2H), 6.76 (d, J = 
8.0 Hz, 1H), 6.09 (d, J = 4.1 Hz, 1H), 5.93 (s, 2H), 4.98 (d, J = 5.9 Hz, 1H), 4.47-4.39 (m, 1H), 
4.32-4.26 (m, 1H), 4.18 (t, J = 6.5 Hz, 1H), 4.11 (dd, J = 7.0, 4.2 Hz, 1H), 3.77-3.73 (m, 4H), 
3.66-3.62 (m, 2H), 3.26-3.13 (m, 2H), 2.72 (dd, J = 14.0, 9.8 Hz, 1H), 1.43 (s, 3H), 1.41 (s, 
3H), 0.87 (s, 9H), 0.13 (s, 3H), 0.07 (s, 3H); HRMS (ES+) Calculated for C28H42NO6SSi 
(M+1)+: 548.2502, Found: 548.2498 (Δ = −0.7 ppm). Spectroscopic data are in accord with 
literature report.74 
 
(3aR* ,6R*,7R*, 7aR*)-2-[7-(tert-Butyldimethylsilanyloxy )-2,2-dimethyl-3a,6,7, 7a- 
tetrahydro-[ 4,5']bi[benzo[l,3]dioxolyl]-6-yl]-1-morpholin -4-ylethanone (130)74 
 
Chemical Formula: C28H41NO7Si 
Exact Mass: 531.27 
Molecular Weight: 531.71 
 
 
To a solution of thioamide 122 (236.0 mg, 0.431 mmol) and water (0.1 mL) in acetonitrile (1.0 
mL) was added Fetizon’s reagent (628.0 mg, 1.08 mmol) at room temperature. The resulting 
mixture was stirred at room temperature for 17 hours. The mixture was filtered and the filtrate 
was concentrated in vacuo to give amide 130 as a yellow oil (204.0 mg, 0.384 mmol, 89%). 
 
Rf = 0.22 (EtOAc/Hexane, 1/2); 1H NMR (CDCl3, 400 MHz) δH 6.99-6.96 (m, 2H), 6.75 (d, J = 
7.9 Hz, 1H), 6.04 (d, J = 4.4 Hz, 1H), 5.92 (s, 2H), 4.97 (d, J = 5.9 Hz, 1H), 4.17-4.11 (m, 1H), 
4.07 (dd, J = 6.6, 4.5 Hz, 1H), 3.66-3.60 (m, 6H), 3.43-3.38 (m, 2H), 3.09 (m, 1H), 2.75 (dd, J 
= 16.0, 4.8 Hz, 1H), 2.19 (dd, J = 16.0, 9.5 Hz, 1H), 1.41 (s, 3H), 1.40 (s, 3H), 0.86 (s, 9H), 
0.11 (s, 3H), 0.05 (s, 3H); m/z (ES+) 532 [(M+1)+, 100%]. Spectroscopic data are in accord 
with literature report.74 
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(3aR*, 6R*, 7R*, 7aR*)-[7-(tert-Butyldimethylsilanyloxy)-2,2-dimethyl-3a,6,7,7a-
tetrahydro-[ 4,5']bi[benzo[l,3]dioxolyl]-6-yl]acetaldehyde  (146)74 
 
Chemical Formula: C24H34O6Si 
Exact Mass: 446.21 
Molecular Weight: 446.61 
 
 
Preparation of DIBAL-H-nBuLi ate complex: 0.25 M in THF 
To a solution of diisobutylaluminum hydride (1.25 mL, 1.25 mmol, 1.0 M DIBAL-H in hexane) 
in THF (3.25 mL) was added another solution of n-BuLi (0.5 mL, 1.25 mmol, 2.5 M in hexane) 
dropwise at 0 °C. The resulting solution was stirred at 0 °C for 20 minutes. 
 
The reductuion of amide 130 by DIBAL-H-nBuLi ate complex:  
To a solution of amide 130 (10.0 mg, 0.019 mmol) in THF (0.5 mL) was added DIBAL-H-nBuLi 
ate complex (0.25 M, 0.1 mL, 0.025 mmol) at 0°C and then the solution was stirred at 0°C for 
another 3 hours. The reaction was quenched by a solution of acetic acid (14 uL) in THF (1 mL) 
at 0°C. The resulting solution was partitioned between NaOH(aq) (1 M, 5 mL) and CH2Cl2 (10 
mL). The aqueous phase was extracted by CH2Cl2 (10 mL). The organic phases were 
combined, washed by brine (10 mL), dried over Na2SO4, filtered, and concentrated in vacuo 
to give aldehyde 146 as a yellow oil (8.9 mg, 0.019 mmol, quantitative). The aldehyde was 
used in the next step without further purification. 
 
1H NMR (CDCl3, 400 MHz) δH 9.83 (s, 1H), 6.97-6.95 (m, 2H), 6.76 (d, J = 7.9 Hz, 1H), 5.93 
(s, 2H), 4.96 (d, J = 5.9 Hz, 1H), 4.18 (t, J = 6.4 Hz, 1H), 4.02 (dd, J = 6.8, 4.5 Hz, 1H), 3.09 
(dt, J = 9.5, 5.0 Hz, 1H), 2.84 (dd, J = 17.4, 5.5 Hz, 1H), 2.41 (ddd, J = 17.5, 8.4, 1.4 Hz, 1H), 
2.05 (s, 3H), 1.83 (s, 3H), 0.86 (s, 9H), 0.11 (s, 3H), 0.05 (s, 3H); m/z (ES+) 447 [(M+1)+, 
55%], 429 [(M-18)+, 100%]. ). Spectroscopic data are in accord with literature report.74 
 
 
(Z) and (E)-(3aR* ,6R*, 7R*, 7aR*)-[7-(tert-Butyldimethylsilanyloxy)-2,2-dimethyl-
3a,6,7,7a-tetrahydro-[4,5']bi[benzo[1,3]dioxolyl]-6-yl]acetaldehyde oximes (148)74 
 
Chemical Formula: C24H35NO6Si  
Exact Mass: 461.22 
Molecular Weight: 461.62 
 
 
To a solution of aldehyde 146 (8.9 mg, 0.019 mmol) and hydroxylamine hydrochloride (4.2 mg, 
0.060 mmol) in methanol (1.0 mL) was added NaOAc (4.9 mg, 0.060 mmol) at room 
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temperature. The resulting solution was stirred at room temperature for 3 hours. The solvent 
was evaporated and the residue was extracted by CH2Cl2 (30 mL). The organic phase was 
washed by NaHCO3(aq) (10 mL, saturated), dried over Na2SO4, filtered, and concentrated in 
vacuo to give oxime 148 as a light yellow oil (6.0 mg, 0.013 mmol, 66% over two steps).  
 
Rf = 0.73 and 0.64 (EtOAc/Hexane, 4/1); For trans-oxime 148: 1H NMR (CDCl3, 400 MHz) δH 
7.49 (t, J = 5.9 Hz, 1H), 6.98-6.94 (m, 2H), 6.76 (d, J = 7.9 Hz, 1H), 5.93 (s, 2H), 5.86 (d, J = 
3.7 Hz, 1H), 4.96 (d, J = 6.0 Hz, 1H), 4.25 (t, J = 6.0 Hz, 1H), 4.06 (m, 1H), 2.73 (m, 1H), 2.54 
(dt, J = 9.1, 5.5 Hz, 1H), 2.22 (ddd, J = 15.3, 9.3, 6.5 Hz, 1H), 1.40 (s, 3H), 1.30 (s, 3H), 0.86 
(s, 9H), 0.11 (s, 3H), 0.07 (s, 3H); For cis-oxime 148: 1H NMR (CDCl3, 400 MHz) δH 6.98-
6.94 (m, 2H), 6.84 (t, J = 5.4 Hz, 1H), 6.77 (d, J = 7.9 Hz, 1H), 5.93 (s, 2H), 5.84 (d, J = 3.7 
Hz, 1H), 4.94 (d, J = 6.0 Hz, 1H), 4.22 (t, J = 6.0 Hz, 1H), 4.05 (m, 1H), 2.74 (m, 1H), 2.64-
2.47 (m, 2H), 1.40 (s, 3H), 1.30 (s, 3H), 0.86 (s, 9H), 0.11 (s, 3H), 0.07 (s, 3H); m/z (ES+) 462 
[(M+1)+, 92%]. Spectroscopic data are in accord with literature report.74 
 
(3aR*, 6R*, 7R*, 7aR*)-[N-{2-[7-(tert-Butyldimethylsiianyloxy)-2,2-dimethyl- 
3a,6,7,7 a-tetrahydro-[4,5']bi[benzo[I,3]dioxolyl]-6-yl]ethyl }hydroxylamine (159)74 
 
Chemical Formula: C24H37NO6Si 
Exact Mass: 463.24 
Molecular Weight: 463.64 
 
To a solution of oxime 148 (80.0 mg, 0.173 mmol) and sodium cyanoborohydride (23.9 mg, 
0.381 mmol) in MeOH (20 mL) was added 5 droplet of methyl orange in MeOH at 0 °C. To 
this solution was added acetic acid (30 mL) until the colour changed to pink. The resulting 
solution was stirred at 0 °C for further 3 hours. The resulting pink solution was quenched by 
NaOH (aqueous, 2 M, 320 mL) while the temperature of this solution was carefully kept at 0 
°C. The mixture was extracted by CH2Cl2 (50 mL ×3). The organic phases were combined, 
dried over Na2SO4, filtered, and concentrated in vacuo to give alkylhydroxylamine 159 as a 
light yellow foam (78.0 mg). The yellow foam was subjected to the intramolecular Cope-type 
hydroamination without further purification.  
 
Rf = 0.38 (Et2O);1H NMR (CDCl3, 400 MHz) δH 7.00 – 6.94 (m, 2H), 6.76 (d, J = 8.0 Hz, 1H), 
5.92 (m, 3H), 4.96 (d, J = 5.8 Hz, 1H), 4.23 (t, J = 5.0 Hz, 1H), 3.99 (dd, J = 6.0, 1.4 Hz, 1H), 
3.13-2.98 (m, 2H), 2.53 (dd, J = 8.8, 4.2 Hz, 1H), 2.00-1.91 (m, 1H), 1.57-1.51 (m, 1H), 1.40 
(s, 6H), 0.86 (s, 9H), 0.11 (s, 3H), 0.07 (s, 3H). Spectroscopic data are in accord with 
literature report.74 
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(3aR*, 4R*, 5R*, 6R*, 7R*, 7aR*)-4-(tert-ButyIdimethylsilanyloxy)-7-(Benzo[1,3]dioxol-5-
yl)-2,2-dimethyloctahydro-[1,3]dioxolo[4,5-f]indol-1-ol (175)74 
 
Chemical Formula: C24H31NO6Si 
Exact Mass: 463.24 
Molecular Weight: 463.65 
 
 
A solution of alkylhydroxylamine 159 (yellow foam directly from the previous reduction) and 
sodium cyanoborohydride (13.0 mg, 0.207 mmol) in benzene (18 mL) was stirred at 100 °C in 
a sealed tube for 65 hours. The solution was cooled down, diluted by Et2O (50 mL), and then 
washed by water (20 mL). The aqueous phase was extracted by Et2O (30 mL). The organic 
phases were combined, washed by brine (20 mL), dried over MgSO4, filtered, and 
concentrated in vacuo to give N-hydroxylpyrrolidine 175 as a white foam (68.0 mg). The white 
foam was subjected to the next step without further purification. 
 
Rf = 0.33 (EtOAc/CH2Cl2, 1/9); 1H NMR (CDCl3, 400 MHz) δH 7.52 (d, J = 1.8 Hz, 1H), 7.07-
6.99 (m, 1H), 6.71 (d, J = 7.2 Hz, 1H), 5.31 (d, J = 1.5 Hz, 1H), 5.29 (d, J = 1.5 Hz, 1H), 4.46 
(d, J = 7.2 Hz, 1H), 4.24 (dd, J = 7.6, 2.6 Hz, 1H), 3.83 (dd, J = 3.0, 2.5 Hz, 1H), 3.61 (t, J = 
10.5 Hz, 1H), 3.26-3.22 (m, 1H), 2.77-2.66 (m, 2H), 1.84-1.72 (m, 2H), 1.40 (s, 3H), 1.11 (s, 
3H), 0.99 (s, 9H), 0.00 (s, 3H), -0.02 (s, 3H); m/z (ES+) 464 [(M+1)+, 100%]. Spectroscopic 
data are in accord with literature report.74 
 
 
(3aR*, 4R*, 5R*, 6R*, 7R*, 7aR*)-4-(tert-ButyIdimethylsilanyloxy)-7-(Benzo[1,3]dioxol-5-
yl)-2,2-dimethyloctahydro-[1,3]dioxolo[4,5-f]indole (182) 
 
Chemical Formula: C24H37NO5Si 
Exact Mass: 447.24 
Molecular Weight: 447.65 
 
 
To a solution of the hydroxylamine 175 from the previous step (68.0 mg, white foam) in Et2O 
(30 mL) was added a slurry of Raney nickel in water (0.3 mL) at 0 °C. The resulting mixture 
was stirred under the atmosphere of H2 at room temperature for 3 hours. The reaction was 
then diluted by EtOH (100 mL) and then stirred for a further 10 minutes. The mixture was 
filtered and the solids were washed by EtOH (50 mL). The filtrate was concentrated in vacuo 
to give pyrrolidine 182 as a yellow oil (60.0 mg). The product was used in the next step 
without further purification.  
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Rf = 0.11 (EtOAc/Hexane, 1/1); 1H NMR (CDCl3, 400 MHz) δH 6.97 (d, J = 1.7 Hz, 1H), 6.77 
(dd, J = 7.9, 1.7 Hz, 1H), 6.71 (d, J = 7.9 Hz, 1H), 5.87-5.91 (m, 2H), 4.41 (dd, J = 7.3, 2.1 Hz, 
1H), 4.20 (dd, J = 7.3, 2.5 Hz, 1H), 3.90 (t, J = 2.8 Hz, 1H), 3.35 (dd, J = 10.6, 8.8 Hz, 1H), 
3.11 (dd, J = 10.6, 2.1 Hz, 1H), 3.00 (ddd, J = 10.9, 7.4, 3.2 Hz, 1H), 2.48-2.61 (m, 2H), 1.86-
1.94 (m, 1H), 1.68-1.77 (m, 1H), 1.47 (s, 3H), 1.26 (s, 3H), 0.91 (s, 9H), 0.12 (s, 3H), 0.08 (s, 
3H); HRMS (ES+) Calculated for C24H38NO5Si (M+1)+: 448.2519 , Found: 448.2505 (Δ = −3.1 
ppm). Spectroscopic data are in accord with literature report.74 
 
Ethyl (3aR*, 4R*, 5R*, 6R*, 7R*, 7aR*)-4-(tert-butyIdimethylsilanyloxy)-7-
(Benzo[1,3]dioxol-5-yl)-2,2-dimethyl-[1,3]dioxolo[4,5-f]octahydroindolyl carbamate (183) 
 
 
Chemical Formula: C27H41NO7Si 
Exact Mass: 519.27 
Molecular Weight: 519.71 
 
To a solution of pyrrolidine 182 (60.0 mg, yellow oil from the previous step) in CH2Cl2 (2.0 mL) 
was added triethylamine (56 µL, 0.40 mmol), 4-dimethylaminopyridine (1.6 mg, 0.013 mmol), 
and ethylchloroformte (26 µL, 0.27 mmol) at room temperature. The solution was stirred at 
room temperature for 4 hours. The resulting solution was partitioned between NaHCO3(aq) 
(10.0 mL, saturated) and CH2Cl2 (30 mL). The aqueous phase was extracted by CH2Cl2 (30 
mL). The organic phases were combined, dried over Na2SO4, filtered, and concentrated in 
vacuo to give a yellow oil. The yellow oil was purified by FC (SiO2, EtOAc/Hexane, 1/1) to 
give carbamate 183 as a yellow powder (38.0 mg, 0.073 mmol, 42% from oxime 148 over four 
steps). 
 
Rf = 0.33 (Et2O/ Hexane, 1/1); mp. 42-45 °C; IR (film) 2955, 2934, 2894, 2860, 1693, 1489, 
1444, 1419, 1380, 1253, 1209, 1104, 1062, 1041, 938, 868, 838, 810, 776, 615, 544 cm-1; 1H 
NMR (CDCl3, 400 MHz) δH 7.10 (s, 1H), 6.60 (d, J = 7.6 Hz, 1H), 6.66 (d, J = 7.6 Hz, 1H), 
5.89 (d, J = 1.9 Hz, 1H), 5.88 (d, J = 1.9 Hz, 1H), 4.46 (dd, J = 6.0, 1.6 Hz, 1H), 4.40-4.45 (m, 
1H), 4.13 (dd, J = 7.4, 2.8 Hz, 1H), 3.97 (dd, J = 4.1, 2.8 Hz, 1H), 3.83 (m, 1H), 3.76 (m, 1H), 
3.43 (brs, 1H), 3.20-3.27 (m, 2H), 2.74 (m, 1H), 1.86 (m, 1H), 1.71-1.76 (m, 1H), 1.51 (s, 3H), 
1.30 (s, 3H), 0.91 (m, 3H), 0.90 (s, 9H), 0.13 (s, 3H), 0.09 (s, 3H); 13C NMR (CDCl3, 100 MHz) 
δC 155.7, 147.0, 123.0, 110.4, 108.8, 107.4, 100.6, 77.1, 76.4, 72.3, 60.7, 56.5, 45.9, 44.4, 
37.9, 28.1, 26.5, 25.9, 24.0, 17.9, 14.2, -4.7; HRMS (ES+) Calculated for C27H42NO7Si (M+1)+: 
520.2731, Found: 520.2730 (Δ = −0.2 ppm) 
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(1R*, 2R*, 8R*, 4R*, 5R*, 14R*)-2,2-Dimethyl-[1,3]dioxolo[4,5-a]-3-(tert-
butyIdimethylsilanyloxy)-3,3a,3a1,4,5,12b-hexahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1- 
de]phenanthridin-7(2H)-one (191) 
 
Chemical Formula: C25H35NO6Si 
Exact Mass: 473.22 
Molecular Weight: 473.64 
 
 
To a solution of carbamate 181 (7.0 mg, 0.014 mmol) in CH2Cl2 (2.0 mL) was added Tf2O (11 
µL, 0.067 mmol) and 4-dimethylaminopyridine (1.7 mg, 0.041 mmol) at 0 °C. The resulting 
solution was warmed up to room temperature slowly for 17 hours. The solution was diluted by 
CH2Cl2 (30 mL) and then the solution was washed by NaHCO3(aq) (saturated, 10 mL). The 
aqueous phase was extracted by CH2Cl2 (30 mL). The organic phases were combined, dried 
over MgSO4, filtered, and concentrated in vacuo to give yellow solids. The yellow solids were 
purified by FC (SiO2, Et2O/Hexane, 1/1 → Et2O) to give compound 191 as a yellow oil (1.1 mg, 
0.002 mmol, 17 %). 
 
Rf = 0.4 (Et2O); IR (film) 2928, 2858, 1650, 1610, 1460, 1415, 1382, 1264, 1209, 1085, 1064, 
1039, 995, 933, 866, 838, 777, 564 cm-1; 1H NMR (CDCl3, 400 MHz) δH 7.51 (s, 1H), 6.86 (s, 
1H), 5.97 (s, 2H), 4.89 (dd, J = 7.4, 2.8 Hz, 1H), 4.47 (dd, J = 7.4, 3.3 Hz, 1H), 4.22 (dd, J = 
4.8, 3.3 Hz, 1H), 4.16 (dd, J = 11.7, 8.1 Hz, 1H), 3.90 (dd, J = 13.4, 10.3 Hz, 1H), 3.38 (dd, J 
= 13.4, 2.8 Hz, 1H), 3.24 (td, J = 11.5, 6.3 Hz, 1H), 2.73 (m, 1H), 2.07-2.20 (m, 2H), 1.88 (dt, 
J = 12.9, 7.6 Hz, 2H), 1.38 (s, 3H), 1.36 (s, 3H), 0.83 (s, 9H), 0.10 (s, 3H), 0.07 (s, 3H); 
HRMS (ES+) calculated for C25H36NO6Si (M+1)+: 474.2312, Found: 474.2306 (Δ = −1.3 ppm) 
 
Ethyl (3aR*, 4R*, 5R*, 6R*, 7R*, 7aR*)-4-hydroxy-7-(Benzo[1,3]dioxol-5-yl)-2,2-dimethyl-
[1,3]dioxolo[4,5-f]octahydroindolyl carbamate (202) 
 
Chemical Formula: C21H27NO7 
Exact Mass: 405.18 
Molecular Weight: 405.45 
 
 
To a solution of carbamate 183 (5.0 mg, 0.010 mmol) in THF (1.0 mL) was added tetra-n-
butylamonium fluoride (30 µL, 0.030 mmol, 1 M in THF) at room temperature. The resulting 
solution was stirred at room temperature for 17 hours. The solvent was removed under 
reduced pressure, and the residue was partitioned between CH2Cl2 (30 mL) and NaHCO3 (aq) 
(saturated, 10 mL). The aqueous phase was extracted with CH2Cl2 (30 mL). The organic 
phases were combined, dried over MgSO4, filtered, and concentrated in vacuo to give yellow 
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oil. The yellow oil was purified by FC (SiO2, Et2O/Hexane, 1/1 → Et2O) to give carbamate 202 
as a yellow oil (2.6 mg, 0.0064 mmol, 64%). 
 
Rf = 0.29 (Et2O); IR (film) 3410, 2934, 1666, 1489, 1441, 1382, 1251, 1212, 1106, 1040, 935, 
814, 614 cm-1; 1H NMR (CDCl3, 400 MHz) δH 7.11 (d, J = 1.7 Hz, 1H), 6.74 (d, J = 8.0, 1.2 Hz, 
1H), 6.66 (d, J = 8.0 Hz, 1H), 5.90 (s, 1H), 5.89 (s, 1H), 4.40 – 4.47 (m, 2H), 4.20 (dd, J = 6.9, 
3.6 Hz, 1H), 4.05 (t, J = 4.1 Hz, 1H), 3.72 – 3.80 (m, 2H), 3.45 – 3.55 (m, 1H), 3.32 (td, J = 
10.3, 6.8 Hz, 1H), 3.11 (dd, J = 10.9, 2.2 Hz, 1H), 2.69-2.76 (m, 1H), 1.90 – 1.97 (m, 1H), 
1.83 – 1.89 (m, 1H), 1.52 (s, 3H), 1.30 (s, 3H), 0.92 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 
MHz) δC 155.7, 147.0, 146.1, 135.1, 123.1, 110.5, 108.9, 107.4, 100.6, 77.1, 71.5, 60.8, 57.0, 
45.7, 44.4, 38.6, 27.1, 26.9, 24.3, 14.2; HRMS (ES+) Calculated for C21H28NO7 (M+1)+: 
406.1866 , Found: 406.1854 (Δ = −3.0 ppm).  
 
Ethyl (5R*, 6R*, 7R*, 7aR*)-7-(Benzo[1,3]dioxol-5-yl)-2,2-dimethyl-[1,3]dioxolo[4,5-f]-
2,3,5,6,7,7a-hexahydroindolyl carbamate (204) 
 
Chemical Formula: C21H25NO6 
Exact Mass: 387.17 
Molecular Weight: 387.43 
 
 
To a solution of alcohol 202 (14.0 mg, 0.035 mmol) in CH2Cl2 (2.0 mL) was added 
triethylamine (0.15 mL, 1.05 mmol) and methansulfonyl chloride (27 µL, 0.350 mmol) at room 
temperature. The solution was stirred at room temperature for 17 hours. The resulting solution 
was partitioned between NaHCO3(aq) (10.0 mL, saturated) and CH2Cl2 (30 mL). The aqueous 
phase was extracted by CH2Cl2 (30 mL). The organic phases were combined, dried over 
Na2SO4, filtered, and concentrated in vacuo to give a yellow oil. HRMS (ES+) Calculated for 
C22H30NO9S (M+1) 484.1641, Found 484.1635 (Δ = −1.2 ppm). 
 
A solution of the previous yellow oil and DBU (0.2 mL) in toluene (1.5 mL) was stirred at 110 
°C for 17 hours. The crude mixture was concentrated in vacuo to give a yellow oil. The yellow 
oil was purified by FC (SiO2, Et2O) to give alkene 204 as a yellow oil (7.4 mg, 0.019 mmol, 
55%). 
 
Rf = 0.56 (Et2O); IR (film) 2984, 2895, 1695, 1504, 1489, 1443, 1414, 1235, 1164, 1101, 1054, 
1039, 935, 894, 847, 815, 771 cm-1 ;1H NMR (CDCl3, 400 MHz) δH 7.19 (d, J = 1.6 Hz, 1H), 
6.76 (dd, J = 7.8, 1.7 Hz, 1H), 6.67 (d, J = 7.8 Hz, 1H), 5.91 (s, 1H), 5.89 (s, 1H), 5.69 – 5.65 
(m, 1H), 4.66 (t, J = 5.3 Hz, 1H), 4.62 (d, J = 10.3 Hz, 1H), 4.50 (d, J = 5.7 Hz, 1H), 4.05 (dd, 
J = 11.1, 8.5 Hz, 1H), 3.85 – 3.76 (m, 1H), 3.44-3.51 (m, 1H), 3.10 (td, J = 11.6, 5.4 Hz, 1H), 
2.55 (dd, J = 10.4, 1.9 Hz, 1H), 2.48 (dd, J = 12.4, 9.4 Hz, 1H), 2.33 (dd, J = 13.7, 5.4 Hz, 1H), 
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1.46 (s, 3H), 1.37 (s, 3H), 0.94 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δC 156.3, 
147.3, 147.0, 146.2, 134.2, 123.1, 118.8, 110.4, 108.8, 107.4, 100.7, 76.9, 73.6, 61.1, 59.6, 
52.3, 46.2, 32.7, 27.5, 25.9, 14.2; HRMS (ES+) Calculated for C21H26NO6 (M+1)+: 388.1760, 
Found: 388.1768 (Δ = +2.1 ppm) 
 
Ethyl (5R*, 6R*, 7R*, 7aR*)-5,6-dihydroxy-7-(Benzo[1,3]dioxol-5-yl)-2,3,5,6,7,7a-
hexahydroindolyl carbamate (206) 
 
Chemical Formula: C18H21NO6 
Exact Mass: 347.14 
Molecular Weight: 347.37 
 
 
A solution of alkene 204 (5.0 mg, 0.013 mmol) in HCl (1.0 mL, 3 N) and THF (2.0 mL) was 
stirred at 80 °C for 6 hours. The resulting solution was diluted by CH2Cl2 (10 mL) and then 
washed by NaHCO3(aq) (10 mL, saturated). The aqueous phase was extracted by CH2Cl2 (40 
mL). The organic phases were combined, dried over MgSO4, filtered, and concentrated in 
vacuo to give a yellow oil. The yellow oil was purified by FC (SiO2, Et2O) to give diol 206 as a 
yellow oil (4.5 mg, 0.013 mmol, quantitative). 
 
Rf = 0.23 (Et2O); IR (film) 3399, 2898, 1668, 1488, 1440, 1228, 1037, 935 cm-1; 1H NMR 
(C6D6, 400 MHz) δH 7.64 (d, J = 1.6 Hz, 1H), 6.90 (dd, J = 8.0, 1.6 Hz, 1H), 6.79 (d, J = 8.0 
Hz, 1H), 5.49 (s, 1H), 5.48 (s, 1H), 5.27 (s, 1H), 5.07 (d, J = 10.1 Hz, 1H), 4.13 (t, J = 9.6 Hz, 
1H), 3.93−4.02 (m, 3H), 3.64−3.71 (m, 1H), 2.95 (ddd, J = 12.3, 10.8, 5.2 Hz, 2H), 2.41 (d, J = 
10.0 Hz, 1H), 2.05 (dd, J = 12.5, 4.4 Hz, 1H), 1.77 (dd, J = 13.1, 5.1 Hz, 1H), 0.93 (t, J = 7.1 
Hz, 3H) ; 13C NMR (C6D6, 100 MHz) δC 157.3, 148.4, 147.3, 145.6, 137.0, 123.5, 121.1, 
111.1, 108.2, 101.3, 73.7, 70.0, 61.6, 57.8, 53.8, 47.9, 33.0, 15.0; HRMS (ES+) Calculated for 
C18H22NO6 (M+1)+: 348.1447 , Found: 348.1447 (Δ = 0 ppm). 
 
(4E)-N-Hydroxy-5-(4-fluorophenyl)pent-4-en-1-amine (179)95 
 
Chemical Formula: C11H14FNO 
Exact Mass: 195.11 
                                Molecular Weight: 195.24 
 
To a solution of (4E)-5-(4-fluorophenyl)pent-4-enal-oxime (50.0 mg, 0.259 mmol) in methanol 
(10.0 mL) was added sodium cyanoborohydride (33.0 mg, 0.520 mmol) and methyl orange as 
pH indicator at 0°C. The pH was adjusted to pH = 3~4 by adding a solution of HCl in 
methanol (1/10). The resulting orange solution was stirred at 0 °C for another 2 hours. The 
reaction was quenched by NaOH(aq) (10 mL, 2 M) at 0 °C and then the solution was stirred for 
F
HOHN
HO
O
O N
HH
O
OEt
OH
	   113	  
a further 10 minutes. MeOH was evaporated and the aqueous phase was extracted with 
CH2Cl2 (30 mL ×2). The organic phases were combined, dried over Na2SO4, filtered, and 
concentrated in vacuo to give alkylhydroxylamine 179 as a yellow oil (45.2 mg, 0.232 mmol, 
89%). The product was used in the next step without further purification. 
 
Rf = 0.27 (EtOAc/ Hexane, 1/2); IR (film) 3265, 3037, 2930, 2857, 1601, 1507, 1438, 1413, 
1225, 1158, 1093, 1013, 966, 846, 802, 775 cm-1; 1H NMR (CDCl3, 400 MHz) δH 7.24-7.28 
(m, 2H), 6.89-7.00 (m, 2H), 6.33 (d, J = 15.8 Hz, 1H), 6.08 (dt, J = 15.8, 6.9 Hz, 1H), 2.96 (t, J 
= 7.2 Hz, 2H), 2.23 (app q, J = 6.9 Hz, 2H), 1.7 (app p, J = 7.2 Hz, 2H); 13C NMR (CDCl3, 100 
MHz) δC 161.9 (d, JC-F = 244 Hz, CF), 133.7 (C4), 129.6 (C5), 129.2 (C5HC), 127.3 (d, JC-C-C-F 
= 8 Hz, FCCC), 115.3 (d, JC-C-F = 22 Hz, FCC), 53.2 (C1), 30.4 (C3), 26.6 (C2); 19F NMR 
(CDCl3, 376 MHz) δF -115.5; HRMS (CI+) Calculated for C11H15NOF (M+1)+: 196.1138 , 
Found: 196.1129 (Δ = −4.6 ppm).  
 
2-(4-Fluorobenzyl)-pyrrolidin-1-yl 4-nitrobenzoate  
 
Chemical Formula: C18H17FN2O4 
Exact Mass: 344.12 
Molecular Weight: 344.34 
 
*Hydroxylamine 180 was unstable towards purification and therefore it was trapped by 4-
nitrobenzoyl chloride to form the corresponding ester for the convenience of purification.  
 
A solution of hydroxylamine 179 (10.0 mg, 0.051 mmol) and sodium cyanoborohydride (3.1 
mg, 0.050 mmol) in toluene-d8 (2.0 mL) was stirred at 80 °C for 17 hours. The solution was 
then partitioned between CH2Cl2 (30 mL) and H2O (10 mL). The aqueous phase was 
extracted by CH2Cl2 (30 mL). The organic phases were combined, dried over Na2SO4, filtered, 
and concentrated in vacuo to give a yellow oil. 
 
1H NMR (C6D5CD3, 400 MHz) δH 6.82 (dd, J = 8.5, 5.7 Hz, 2H), 6.75 (t, J = 8.5 Hz, 2H), 3.19-
3.11 (m, 1H), 3.04 (dd, J = 13.2, 4.6 Hz, 1H), 2.83 – 2.72 (m, 1H), 2.67 (dd, J = 18.6, 9.2 Hz, 
1H), 2.38 (dd, J = 12.7, 9.2 Hz, 1H), 1.47-1.36 (m, 3H), 1.18 (m, 1H). 
 
To a solution of the previous oil and triethylamine (70 µL, 0.50 mmol) in CH2Cl2 (4.0 mL) was 
added p-nitrobenzoyl chloride (46.4 mg, 0.250 mmol). The resulting solution was stirred at 
room temperature for 17 hours. The reaction solution was then partitioned between CH2Cl2 
(30.0 mL) and NaHCO3(aq) (10 mL). The aqueous phase was extracted with CH2Cl2 (30 mL). 
The organic phases were combined, dried over Na2SO4, filtered, and concentrated in vacuo to 
give a yellow oil. The yellow oil was purified by FC (SiO2, Et2O/hexane, 1/1) to give 2-(4-
fluorobenzyl)-pyrrolidin-1-yl 4-nitrobenzoate as a yellow oil (11.0 mg, 0.032 mmol, 64%). 
N
F
O
O
O2N
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Rf = 0.31 (Et2O/hexane, 1/1); IR (film) 2950, 1742, 1605, 1528, 1510, 1348, 1261, 1222, 1088, 
1015, 851, 718 cm-1; 1H NMR (CDCl3, 400 MHz) δH 8.22 (d, J = 8.6 Hz, 2H), 7.96 (d, J = 8.6 
Hz, 2H), 7.14 (dd, J = 8.6, 5.6 Hz, 2H), 6.86 (m, 2H), 3.66 (ddd, J = 10.9, 7.2, 4.2 Hz, 1H), 
3.46 (dq, J = 9.4, 6.9 Hz, 1H), 3.05 – 2.93 (m, 2H), 2.78 (dd, J = 13.8, 7.2 Hz, 1H), 2.03 – 
1.88 (m, 3H), 1.65 (m, 1H); 13C NMR (CDCl3, 100 MHz) δC 163.5, 161.5 (JC-F = 243 Hz), 
150.51, 134.5 (d, JC-C-C-F = 12 Hz), 131.3, 130.4, 130.3, 123.4, 115.2 (JC-C-F = 22 Hz), 69.2, 
56.6, 38.8, 20.1; Calculated for C18H18N2O4F (M+1)+: 345.1251, Found: 345.1269 (Δ = +5.2 
ppm).  
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5. Appendix : Single Crystal X-Ray Structure Determinations 
 
Crystal data and structure refinement for 9-n-butyl-6’-aminodihydroquinine TFA salt (69) 
 
Identification code P13058 
Empirical formula C25H34F3N3O 
Formula weight 481.55 
Temperature 100(1) K 
Diffractometer, wavelength SuperNova, Dual, Cu at zero, Atlas, 1.54178 
Å 
Crystal system, space group Tetragonal, P4(1)/w 
Unite cell dimensions a = 11.01074(6) Å 
b = 11.01074(6) Å 
c = 40.0737(4) Å 
α = 90° 
β = 90° 
γ = 90° 
Volume, Z 4858.39 Å3,7 
Density (calculated) 1.153 Mg/m3 
Absorption coefficient 0.88 mm-1 
F(000) 2088 
Crystal colour / morphology Green block 
Crystal size 0.45 × 0.45 × 0.30 mm3 
θ range for data collection 3.31 to 76.07° 
Index ranges  -13<=h<=13, -13<=k<=13, -49<=l<=50 
Reflns collected / unique 51945/9913 [Rint = 0.0140] 
Reflns observed [F>4σ(F)] 9790 
Absorption correction Analytical 
Max. and min. transmission 0.338 and 0.010 
Refinement method CrysAlisPro, Agilent Technologies, 
Version 1.171.35.19 
Data / restraints / parameters 9790 / 1 / 660 
Goodness-of-fit on F2 1.016 
Final R indices [F>4σ(F)] R1 = 0.0396, wR2 = 0.1062 
R indices (all data) R1 = 0.0400, wR2 = 0.1067 
Largest diff. peak, hole 0.416, -0.478 eÅ-3 
Mean and maximum shift/error 0.000 and 0.001 
 
 
F(1)-C(25) 1.345(3) 
F(2)-C(25) 1.331(3) 
F(3)-C(25) 1.335(3) 
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O(1)-C(20) 1.421(2) 
O(1)-C(10) 1.423(2) 
O(2)-C(24) 1.221(3) 
O(3)-C(24) 1.220(3) 
N(1)-C(3) 1.318(2) 
N(1)-C(4) 1.363(2) 
N(2)-C(7) 1.367(3) 
N(3)-C(16) 1.509(2) 
N(3)-C(15) 1.510(2) 
N(3)-C(11) 1.515(2) 
C(1)-C(2) 1.370(2) 
C(1)-C(9) 1.433(2) 
C(1)-C(10) 1.527(2) 
C(2)-C(3) 1.416(2) 
C(4)-C(9) 1.422(2) 
C(4)-C(5) 1.424(2) 
C(5)-C(6) 1.360(3) 
C(6)-C(7) 1.418(3) 
C(7)-C(8) 1.381(3) 
C(8)-C(9) 1.412(2) 
C(10)-C(11) 1.537(2) 
C(11)-C(12) 1.542(2) 
C(12)-C(13) 1.533(2) 
C(13)-C(17) 1.531(3) 
C(13)-C(14) 1.532(3) 
C(14)-C(15) 1.537(3) 
C(16)-C(17) 1.542(2) 
C(17)-C(18) 1.535(3) 
C(18)-C(19) 1.518(3) 
C(20)-C(21) 1.521(3) 
C(21)-C(22) 1.522(3) 
C(22)-C(23) 1.516(3) 
C(24)-C(25) 1.544(3) 
O(1)-O(2) 1.427(11) 
C(20)-O(1)-C(10) 114.22(14) 
C(3)-N(1)-C(4) 116.79(18) 
C(16)-N(3)-C(15) 108.37(14) 
C(16)-N(3)-C(11) 108.84(14) 
C(15)-N(3)-C(11) 113.95(14) 
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C(2)-C(1)-C(9) 118.21(16) 
C(2)-C(1)-C(10) 121.29(15) 
C(9)-C(1)-C(10) 120.48(15) 
C(1)-C(2)-C(3) 119.65(16) 
N(1)-C(3)-C(2) 124.31(16) 
N(1)-C(4)-C(9) 123.82(16) 
N(1)-C(4)-C(5) 117.97(16) 
C(9)-C(4)-C(5) 118.21(16) 
C(6)-C(5)-C(4) 121.16(17) 
C(5)-C(6)-C(7) 120.89(17) 
N(2)-C(7)-C(8) 120.51(18) 
N(2)-C(7)-C(6) 120.21(18) 
C(8)-C(7)-C(6) 119.20(17) 
C(7)-C(8)-C(9) 121.06(16) 
C(8)-C(9)-C(4) 119.45(16) 
C(8)-C(9)-C(1) 123.40(15) 
C(4)-C(9)-C(1) 117.15(15) 
O(1)-C(10)-C(1) 111.72(14) 
O(1)-C(10)-C(11) 107.31(13) 
C(1)-C(10)-C(11) 111.18(14) 
N(3)-C(11)-C(10) 111.21(14) 
N(3)-C(11)-C(12) 108.24(14) 
C(10)-C(11)-C(12) 114.35(14) 
C(13)-C(12)-C(11) 109.43(14) 
C(17)-C(13)-C(14) 109.34(15) 
C(17)-C(13)-C(12) 111.10(15) 
C(14)-C(13)-C(12) 108.11(15) 
C(13)-C(14)-C(15) 109.00(15) 
N(3)-C(15)-C(14) 108.94(15) 
N(3)-C(16)-C(17) 109.56(15) 
C(13)-C(17)-C(18) 114.18(15) 
C(13)-C(17)-C(16) 108.31(15) 
C(18)-C(17)-C(16) 111.04(16) 
C(19)-C(18)-C(17) 112.32(18) 
O(1)-C(20)-C(21) 107.34(16) 
C(20)-C(21)-C(22) 112.00(17) 
C(23)-C(22)-C(21) 113.20(17) 
O(3)-C(24)-O(2) 129.5(2) 
O(3)-C(24)-C(25) 114.84(18) 
	   123	  
O(2)-C(24)-C(25) 115.6(2) 
F(2)-C(25)-F(3) 106.82(18) 
F(2)-C(25)-F(1) 106.03(18) 
F(3)-C(25)-F(1) 106.67(18) 
F(2)-C(25)-C(24) 113.34(17) 
F(3)-C(25)-C(24) 111.0(2) 
F(1)-C(25)-C(24) 112.58(17) 
 
 
